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ABSTRACT 
Extraintestinal pathogenic Escherichia coli (ExPEC) are a group of E. coli 
associated with disease outside the intestinal tract of the host. These organisms are known 
to cause a diversity of disease states in humans and animals. ExPEC are often divided 
into subpathotypes including Neonatal Meningitis E. coli (NMEC), associated with 
neonatal bacterial meningitis (NBM) in humans; uropathogenic E. coli (UPEC), 
associated with urinary tract infections in both humans and animals; and Avian 
Pathogenic E. coli (APEC), which causes colibacillosis in poultry. However, in vivo 
studies have demonstrated that the subpathotypes are more fluid than their names 
recognize. This work compares ExPEC subpathotypes to assess phenotypic and genomic 
differences amongst them. Specifically, differences between the subpathotypes are 
assessed via a phenotypic biofilm assay and polymorphisms in a known virulence factor, 
outer membrane protein A (OmpA). The results indicate that statistically significant 
similarities and differences were found between subpathotypes in their polymorphisms of 
OmpA and ability to form biofilms in certain media. Statistically significant differences 
were observed when the chromosomal differences of these E. coli are assessed via 
Clermont’s phylogenetic typing scheme. Both OmpA polymorphisms and biofilm 
formation results suggest that the phylogenetic groups are important when attempting to 
make generalizations about ExPEC subpathotypes. To examine an ExPEC subpathotype 
in greater resolution than traditional typing schemes allow, NMEC was chosen for a large 
sequencing study as NBM is a devastating disease that affects newborns resulting in 
sepsis and meningitis and mortality rate ranging from 15-40%. An examination of 58 
NMEC genomic sequences found that NMEC had no conserved chromosomal type, as 
x 
indicated via their serogroups, sequence types, phylogenetic groups, or identification of 
four NMEC clades based on the presence of conserved genes for each clade. Nineteen 
completed or nearly completed NMEC chromosomes concurred with this conclusion. An 
examination of NMEC plasmids revealed significant diversity among the Inc replicon 
types including the presence of Col replicons, yet IncFIB replicons were prevalent in 
most NMEC genomes. The NMEC sequencing data suggests that the NMEC 
subpathotype has considerable variation and that no strain should be considered 
prototypical.  
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CHAPTER 1.    INTRODUCTION 
Escherichia coli: The Bacteria of Pathological Variants 
Escherichia coli is an important component of the gut microbiota as it is one of 
the initial colonizers of the gut after birth (1). As an initial colonizer, E. coli acts as a 
pioneer species by consuming the initial oxygen in the gut, so other obligate anaerobes 
can colonize (1-4). Later in life, E. coli may contribute to the health of the gut by 
enhancing the mucosal integrity of the gut and can be consumed as a probiotic (5, 6). E. 
coli is also used in a wide variety of industrial and laboratory applications including drug 
and enzyme production (7, 8). Despite these beneficial attributes, E. coli is also 
associated with a variety of disease states in human and animal hosts. E. coli strains 
responsible for specific disease states using common virulence factors have been grouped 
into pathotypes (9), which can be divided broadly into Intestinal Pathogenic E. coli 
(InPEC) and Extraintestinal Pathogenic E. coli (ExPEC) based on their primary sites of 
infection. Pathotypes or subpathotypes of E. coli may also be referred to as pathovars, a 
grouping of strains with similar distinctive pathogenicity characteristics. 
 
Intestinal Pathogenic E. coli: A Grouping of Queasiness 
Intestinal pathogenic E. coli (InPEC) cause or are associated with disease in the 
gastrointestinal tract. This pathotype consists of six long-standing subpathotypes 
including enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), 
enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli 
(EIEC), and diffusely adherent E. coli (DAEC) (9). More InPEC subpathotypes have also 
been proposed including adherent invasive E. coli (AIEC), necrotoxic E. coli (NTEC), 
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and cell-detaching E. coli (CDEC) (9, 10). Though all InPEC have a primary focus on the 
intestinal tract and may share similar signs of disease, the virulence factors and 
mechanisms by which they cause disease differ. 
 
Enteropathogenic E. coli (EPEC) 
Enteropathogenic E. coli (EPEC) may be one of the most well-studied pathovars 
of E. coli (9). EPEC is the causative agent of acute to persistent diarrhea in children 
worldwide (11). EPEC-caused disease occurs primarily in developing countries and has a 
mortality rate of 30% for infants (12). In adults, the infectious dose of EPEC is high, 
between 108 to 1010 CFU (13). The pathogenesis of EPEC-caused diarrhea involves 
ingestion of EPEC in contaminated water or food, bacterial adhesion to the small 
intestine enterocytes, protein translocation of a receptor from bacteria to host via a type 
III secretion system (T3SS), and pedestal formation through actin filament rearrangement 
(9). The formation of the pedestal destroys the intestinal microvilli, which induces the 
attaching and effacing lesion and lessens the surface area for fluid absorption, which 
contributes to diarrhea (9).  
EPEC’s key virulence factors include the locus of enterocyte effacement 
pathogenicity island (LEE PAI)(14). The LEE PAI encodes a T3SS that encodes Intimin 
and Tir. Tir is translocated from the bacteria into the host cell to be used as a receptor. On 
the surface of the bacteria, Intimin mediates the attachment of EPEC to Tir (15, 16). Tir 
has also been shown to bind to nucleolin, a cell-growth protein that shuttles between the 
nucleus and cytoplasm of the host cell (17). Another virulence factor of EPEC is a 70-100 
kb plasmid known as pEAF for plasmid of EPEC Adherence Factor (9). pEAF encodes 
the bundle forming pilus, which adheres to the host cell, and the plasmid enhances the 
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efficiency of LEE PAI genes (18, 19). Some EPEC, known as atypical EPEC (aEPEC), 
lack the EAF plasmid and do not make the bundle forming pilus, as compared to more 
typical EPEC (aka tEPEC). Globally, atypical EPEC are more often isolated from cases 
of diarrhea in the developed world while tEPEC cases are more prevalent in developing 
countries (18, 20). Genomic analyses indicate that the separation of atypical and typical 
EPEC based on the presence or absence of the bundle forming pilus is likely an 
oversimplification (21). 
 
Enterohemorraghic E. coli (EHEC) 
Like EPEC, enterohemorrhagic E. coli (EHEC) also form a pedestal through 
effectors of the LEE PAI, including Tir and Intimin. Tir is translocated into the host cell 
by the bacteria via a T3SS, and intimin serves as the receptor on the bacterial cell (9). 
EPEC and EHEC both form the pedestal complex, but the Tir proteins are not 
functionally identical due to differences in signaling (22). Another difference is location, 
EPEC’s attaching and effacing (AE) lesions occur in the small intestine while EHEC 
induces the AE lesions in the large intestine (9). Nevertheless, the greatest difference 
between EPEC and EHEC is that EHEC commonly produce a shiga toxin (Stx). Shiga 
toxin E. coli (STEC) can be differentiated from EHEC as STEC strains produce the Stx, 
but not all STEC are EHEC as demonstrated by the 2011 German Outbreak of STEC 
O104:H4 (23). Greater than 380 serotypes of E. coli can produce Stx, but most are not 
associated with disease in humans without also containing the LEE PAI (24). Therefore, 
EHEC may be defined as E. coli that produce the Stx and contain the LEE PAI (9).  
EHEC infections occur via a fecal-oral route, and cattle are a known reservoir 
with 75% of outbreaks attributable to bovine-derived products (24). The low infectious 
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dose of EHEC, 10-100 CFUs, assists in the transmission of the human pathogen (24). 
EHEC causes disease in the large intestine, and disease can manifest as bloody diarrhea, 
non-bloody diarrhea, or hemolytic uremic syndrome (HUS). Bloody diarrhea (or 
hemorrhagic colitis) is a result of local damage in the colon from Stx, which results in the 
termination of protein synthesis by cleaving ribosomal RNA (9). EHEC that cause HUS 
can result in renal failure or death (25). For HUS to occur, Stx production occurs in the 
large intestine before Stx binds to the endothelial cells, is absorbed into the bloodstream, 
and is disseminated (24).   
Upon entering the kidney, Stx damages renal endothelial cells and blocks the 
microvessels through direct toxicity and host immune response related to cytokine and 
chemokine production leading to inflammation (9). Damage within the kidney can lead to 
HUS, which can result in fatal acute renal failure. Treatment of EHEC infection is 
complicated by the production of Stx as antibiotics promote the replication and 
expression of stx genes since the genes are contained on a lambda prophage, which has 
been integrated into the chromosome (26, 27). The Stx also promotes intestinal 
colonization (28).  
In addition to the Stx, EHEC isolates are also known to contain plasmids, which 
encode other virulence factors and toxins (29, 30). Although the most well-known EHEC 
belong to the serogroup O157, EHEC isolates of other O-antigens types are also 
recognized including O26, O103, O111, and O145 (31). Overall, EHEC isolates have 
larger than average genomes for E. coli and their genomes contain large numbers of 
prophages and integrative elements (32). 
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Enterotoxigenic E. coli (ETEC) 
Enterotoxigenic E. coli (ETEC) is responsible for approximately 15-20% of 
diarrheal cases in children under five in developing countries and 60% of traveler’s 
diarrhea (33). ETEC harbor numerous virulence factors, including enterotoxins and 
colonization factors. ETEC contain at least one of two enterotoxins, a heat-labile 
enterotoxin (LT) or a heat-stable one (ST). The LT toxin is nearly identical to the cholera 
toxin of Vibrio cholerae, while the STa toxin is small with only 18-19 amino acids and 
forms three disulphide bridges via six cysteine residues (34). The LT results in chloride 
secretion by secretory crypt cells, leading to watery diarrhea (9). The STa activates 
kinases, which ultimately increase secretion (9). 
In addition to the enterotoxins, ETEC can harbor colonization factors, and more 
than 22 different colonization factors have been described among human ETEC (35). The 
majority of these factors enable ETEC to colonize the small intestine, which brings the 
enterotoxins produced by ETEC in close proximity to the intestinal epithelium. Seventy 
five percent of human ETEC cases involve colonization factors CFA/I, CFA/II, or 
CFA/IV (36). ETEC can also cause disease in suckling animals, but the virulence factors 
differ slightly from its human analog. In animals, the enterotoxins used are the STaP, 
STb, or the LT-II enterotoxin variants (37). Common animal colonization factors are K88 
or K99 antigens (9). 
 
Enteroaggregative E. coli (EAEC) 
Enteroaggregative E. coli (EAEC), previously known as enteroadherent-
aggregative E. coli, produce a thick biofilm and secrete toxins leading to watery diarrhea 
(9, 38). EAEC biofilms are distinct from the biofilms of non-pathogenic E. coli as they 
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are produced independently of biofilm-promoting factors like curli, flagella, and antigen 
43 (39). For these organisms to cause disease, they colonize the mucosa of the small and 
large intestine. To do so, aggregative adherence is critical and is facilitated by 
aggregative adherence fimbriae (AAFs) (39). These adhesins are important in 
classification as their designation as a pathotype is due to their ability to form a “stacked-
brick” formation adherence to HEp-2 cells (40). The designation from the stacked-
bricked phenotype and the lack of LT or ST is the primary classification mechanism of 
the pathotype (9).  
Research has shown EAEC to be genetically heterogeneous, and there is 
controversy regarding conserved virulence factors (41). EAEC is sometimes described as 
diarrheagenic E. coli that produce aggregative adherence in cultured epithelial cells 
without the virulence factors which define EPEC, ETEC, EHEC, or EIEC (42). Although 
no EAEC virulence factor is present in all isolates, several virulence factors have been 
described. Two of its toxins include ShET1 and EAST-1. The ShET1 toxin is also found 
in Shigella flexneri 2a, and EAST-1 is a homolog of the heat-stable enterotoxin of ETEC 
(43, 44). Some EAEC also contain two serine protease autotransporters (SPATEs): Pic 
(protease involved in intestinal colonization) and Pet (plasmid-encoded autotransporter) 
(42, 45). Pic cleaves surface glycoproteins and mediates hemagglutinin and mucus 
cleavage while Pet is a cytotoxin, which leads to cell rounding and detachment (46, 47). 
Like some other diarrheagenic pathotypes, it has been proposed that EAEC be 
separated into typical or atypical (aEAEC) groups. The presence of aggR, a gene 
encoding a global regulator, distinguishes between EAEC and aEAEC. In general, the 
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majority of virulence factors, including AAFs, EAST-1, aggR, and Pet, are encoded by 
100kb pAA plasmids (42, 48).  
 
Enteroinvasive E. coli (EIEC) 
Enteroinvasive E. coli is a major etiologic agent of dysentery in developing 
countries, and the mechanisms of EIEC pathogenesis are similar to those of Shigella. 
Diarrhea occurs following bacterial invasion of enterocytes via endocytosis, leading to 
host cell death (9). A 220 kb virulence plasmid, pInv, is critical to EIEC virulence, as it 
carries the invasion plasmid antigen H gene (ipaH), invasion-associated locus (ial), and 
invasion transcriptional regulation genes (virF and virB) (49). Other potential virulence 
factors include the ShET1 and ShET2 enterotoxins, Pic, and autotransporters SepA and 
SigA (9). Recent research involving 169 genomic sequences has shown a lack of 
monophyletic groups and no distinct evolutionary groups between EIEC and Shigella, 
suggesting Shigella should be classified as enteroinvasive E. coli (50). Nevertheless, 
EIEC isolates appear to cause less severe infections than Shigella species (51). 
 
Diffusely Adherent E. coli (DAEC) 
Diffusely adherent E. coli (DAEC) have been implicated in diarrhea in children 
older than 12 months (52). Like EAEC, DAEC have been defined by their adherence 
pattern to cultured cells as DAEC have a diffuse adherence pattern on HeLa and Hep-2 
cells (39). Additionally, DAEC (like EAEC) are classified into other pathovar groups if 
they contain the virulence factors indicative of a different pathotype. E. coli with the 
DAEC phenotype have been categorized into other E. coli groups including 
uropathogenic E. coli (UPEC), ETEC, or EPEC (53). The Afa/Dr adhesins are important 
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to the DAEC virulence as they assist in eliciting the enterocytes to develop long cellular 
projections, which wrap around the bacteria (9). Nevertheless, without additional 
virulence factors, the role of DAEC in diarrhea is questionable as volunteers that ingested 
1010 CFU of prototypic DAEC strains did not experience diarrhea (53, 54).  
 
Adherent Invasive E. coli (AIEC) 
In 2002, Darfeuille-Michaud described a new pathotype of InPEC, adherent-
invasive E. coli (AIEC) (10). This pathotype colonizes the intestinal mucosa and adheres 
to intestinal epithelial cells. Like EIEC, AIEC are invasive pathogens as AIEC survive 
and replicate intracellularly (55). Clinically, AIEC may be involved in the pathogenesis 
of Crohn’s Disease. AIEC have been enriched from the ileal lesions of Crohn’s Disease 
patients, and AIEC is associated with the ileal mucosa (56). In the ileum, AIEC adheres 
to CEACAM6, which is overexpressed in Crohn’s disease patients (57). Virulence factors 
of AIEC strains include type I fimbriae, long polar fimbriae, pyelonephritis-associated 
pili, S fimbriae, Dr antigen-specific fimbriae, K1 capsule, iron acquisition proteins, the 
vacuolating autotransporter toxin, alpha-hemolysin, cytotoxic necrotizing factor, and the 
IbeA invasin (58). Interestingly, these virulence factors are found in many extraintestinal 
pathogenic E. coli isolates, which is discussed in a later section (59, 60).  
 
Necrotoxic E. coli (NTEC) 
Necrotoxic E. coli (NTEC) are defined based on their production of cytotoxic 
necrotizing factor 1 (CNF1) or 2 (CNF2). With the toxin, NTEC strains were able to 
cause a variety of disease states including diarrhea, systemic infections, septicemia, and 
urinary tract infections (61). Since CNF1 is often found in other pathotypes including 
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AIEC and ExPEC, the NTEC pathotype has become a less common classification for E. 
coli isolates. It may be more relevant to include E. coli with a cytotoxic necrotizing factor 
gene in a pathotype or subpathotype grouping that accounts for their clinical condition. 
As such, UPEC are occasionally subdivided by the presence of cnf1 or cnf2 to distinguish 
between those with the toxin, an NTEC UTI, and those without, an UPEC UTI (62). 
However, this distinction is poorly recognized among the UPEC field.  
 
Cell-Detaching E. coli (CDEC) 
Cell-detaching E. coli (CDEC) are associated with diarrhea in children (9). 
Members of the CDEC pathovar cause cultured epithelial cells to detach from glass or 
plastic. This trait is associated with cell-bound alpha hemolysin (HlyA) (63). HlyA is 
found in other pathotypes of E. coli, which makes the CDEC pathotype similar to the 
NTEC pathotype as other E. coli groupings contain their defining virulence factors. (9, 
64).  
 
Extraintestinal Pathogenic E. coli: The Mix and Match Pathogens 
In 2000, Russo et al. proposed a super grouping of the E. coli causing disease 
outside the intestine and named this pathotype Extraintestinal Pathogenic E. coli (ExPEC) 
(65). This pathotype has several subpathotypes that are named by the host species or 
disease from which they are isolated, including: E. coli that cause colibacillosis in birds 
(Avian Pathogenic E. coli (APEC)), urinary tract infections (Uropathogenic E. coli 
(UPEC)), sepsis (Sepsis Producing E. coli (SPEC)), and bacterial meningitis in newborns 
(Neonatal Meningitis Causing E. coli (NMEC)). The ExPEC terminology acknowledges 
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that ExPEC strains exist on a continuum of virulence due to a wide-variety of virulence 
factors, the inoculum size, and potential pre-existing conditions (65).  
 
Avian Pathogenic E. coli (APEC) 
 Avian pathogenic E. coli (APEC) infections result in severe economic losses 
worldwide to the poultry production industry annually (66). Avian pathogenic E. coli is 
responsible for colibacillosis, a localized or systemic infection that is the most common 
infectious bacterial disease of poultry (60). Colibacillosis can be separated further into 
descriptors of the localized or systemic infection such as colispeticemia, hemorrhagic 
septicemia, air sac disease, swollen-head syndrome, peritonitis, coligranuloma, or 
enteritis. 
 Although colibacillosis is most often reported in commercial chicken, turkey, and 
duck flocks, most avian species are susceptible (60). Even though colibacillosis can affect 
birds of any age, young birds are the most frequently affected and disease severity is 
often greater. Factors that can increase APEC susceptibility include co-infection with 
viruses, bacteria, or parasites or poor environmental conditions such as overcrowding, 
inadequate ventilation, or contaminated water (60). Unfortunately, the pathogenesis of 
APEC is not well characterized, but APEC share a significant number of virulence factors 
with the ExPEC of mammals (67). As such, it has been proposed that APEC or the E. coli 
from poultry may be a reservoir for ExPEC that cause human disease (68, 69).  
 
Uropathogenic E. coli (UPEC) 
Urinary tract infections (UTIs) affect 150 million people annually worldwide and 
are the most common pathogen encountered in ambulatory or emergency settings in the 
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United States (70, 71). Indeed, 40% of women and 12% of men will experience a 
symptomatic UTI in their lifetime (72). Clinically, UTIs are categorized as 
uncomplicated or complicated, but the causative agent for 65-75% for both categories is 
UPEC (73, 74). Complicated UTIs result due to the host defense or urinary tract 
becoming compromised via urinary obstruction, urinary retention, immunosuppression, 
renal failure, pregnancy, or indwelling catheters (73). In the United States, approximately 
75% of complicated UTIs are a result of indwelling catheters, also known as catheter-
associated UTIs (CAUTIs) (75). CAUTIs are the most common nosocomial infection 
(74, 76). Risk factors for CAUTI include diabetes, advanced age, or prolonged 
catherization (73, 75). 
Contrary to complicated UTIs, uncomplicated UTIs affect individuals that are 
healthy and without structural abnormalities to the urinary tract (71, 73). Uncomplicated 
UTIs can be further separated into cystitis and pyelonephritis (71, 73). Cystitis, the 
infection of the lower urinary tract, is a bladder infection that can result in pain, 
hematuria, dysuria, and changes in urination pattern or frequency (73). Risk factors for 
cystitis include a prior UTI, sexual activity, vaginal infection, diabetes, obesity, genetic 
susceptibility, or being of the female sex (77). Pyelonephritis, the infection of the upper 
urinary tract, is a kidney infection that can result in fever, nausea, and vomiting, as well 
as the signs and symptoms of cystitis (73). Significant morbidity and mortality can occur 
due to UTIs, and untreated pyelonephritis can result in sepsis or renal damage or failure 
(72).  
Uncomplicated UTIs occur when UPEC colonizes the urethra before migrating to 
the bladder (73). Pili and adhesins mediate the colonization of the bladder epithelium, 
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which is composed of umbrella cells, intermediate cells, and basal cells (73, 78). Next, 
UPEC binds uroplakins, a major component of the umbrella cell apical membrane. 
Intracellular bacterial community formation occurs in these umbrella cells, which 
promotes survival of UPEC by protecting UPEC from host defenses and antibiotics in a 
biofilm-like environment (79, 80).  
Like intracellular bacterial communities, biofilms are important to UPEC 
pathogenesis as they can result in complicated UTIs when a UPEC biofilm forms on a 
catheter. The production of a biofilm by bacteria result in a different bacterial lifestyle as 
biofilms can prevent treatment by antibiotics, subvert innate defenses, and promote the 
exchange of extracellular DNA, such as plasmids (81). Biofilms form through the initial 
attachment, which leads to irreversible attachment, then maturation and dispersion (81).  
Complicated UTIs occur when UPEC binds to a catheter, kidney or bladder stone 
or is retained by an obstruction within the urinary tract (73). Toxins produced by UPEC 
further result in tissue damage and release nutrients needed for survival. In the kidney, 
UPEC binds to glycolipids on the surface of renal epithelial cells (82). If UPEC crosses 
the tubular epithelial barrier in the kidneys, urosepsis or bacteremia can occur (73, 83). 
The vat, fyuA, chuA, and yfcV genes are UPEC-predictor genes correlated with the 
uropathogenic potential of E. coli isolates (84). A number of publications further 
elaborate the pathogenesis and virulence factors of UPEC (72-74, 77, 84, 85). Virulence 
factors of ExPEC are discussed in the virulence factors section.  
 
Neonatal Meningitis E. coli (NMEC) 
Neonatal Meningitis E. coli (NMEC) is responsible for 28-30% of neonatal 
bacterial meningitis (NBM) cases in developed countries and incidence is between 2-4 
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newborns per 10,000 births (86, 87). However, among preterm and very preterm infants 
NMEC is the leading cause of meningitis (86). Without treatment, NBM is often fatal, 
but NBM also often progresses more quickly than culture results can be obtained for 
initial diagnosis. Therefore, infants that are discharged from the hospital and later present 
with fever, fast or difficult breathing, cough, lethargy, poor feeding, or convulsion should 
be treated with antibiotics (88). With such a mandate, the ratio of non-infected to blood-
culture-positive neonates ranged between 15:1-28:1 (88, 89). Although the use of 
antibiotics on so many false negatives is alarming, it should be noted that false-negative 
blood cultures can occur for NMEC; approximately 37% of NBM cases are initially not 
diagnosed when a single blood culture is performed (86, 90). Therefore, the gold standard 
remains isolation of the bacteria from the cerebrospinal fluid. Eighty-nine percent of 
NBM cases were detected via lumbar puncture in a six-year epidemiological study 
involving 2,951 cases of bacterial meningitis (86). 
Clinically, NBM is currently treated by antibiotics including ampicillin and 
gentamicin with 3rd generation cephalosporins (91). Nevertheless, antibiotic resistant 
NMEC present a unique challenge to treat clinically. The Iqbal et al. clinical case study 
demonstrates this challenge as additional antibiotics such as amikacin did not prevent 
mortality (91). Indeed, treating bacterial infection in newborns is difficult as randomized 
controlled trials for antibiotic therapy resulted in treatment failure and mortality in 
numerous studies of newborns with sepsis (88, 92-94). Further treatment for NBM 
beyond antibiotics may include craniotomy to debride the infected tissue (91). 
Unfortunately, even with survival, serious sequalae may be the result of NBM as 
antibiotics may be correlated with decreased mortality but not morbidity (87). Thirty-one 
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percent of survivors experience neurological sequelae in the form of cerebral palsy, 
epilepsy, hearing impairment, and cognitive impairment (87). In a survey of NBM cases 
(n=200) that occurred from 1985-1987 in England and Wales, 6.5% of the initially-
surviving children had died before age five. At the age of five, 2.9% of NBM-surviving 
children experienced sensorineural hearing loss, 7% suffered from epilepsy, 8% 
experienced a learning problem, and 8.7% had cerebral palsy (n=172) (87).  
The pathogenesis of NMEC is thought to occur by exposure of NMEC to the 
digestive tract perinatally. In the digestive tract, NMEC moves to the intestinal tract and 
attaches to enterocytes and is transcytosed into the bloodstream (39). Furthering the 
importance of the intestinal tract pathogenesis in NMEC infection, experimental evidence 
in a neonatal rat model demonstrates that there is incomplete development of the mucus 
barrier during early neonatal life (95). Once in the bloodstream, NMEC must evade the 
innate immune system. To do this, NMEC mimics the host immune system by producing 
capsular glycoproteins (K1) similar to those of humans (96). Additionally, NMEC invade 
and replicate in macrophages; thus, evading the immune system and further proliferating 
in the bloodstream (97). Such proliferation is responsible for acute bacteremia.  
Bacteremia is associated with meningitis in newborns as experimental evidence 
has found that greater than 103 CFU/mL of blood is more likely to result in NBM and 
death (9, 98). With a high quantity of CFUs in the blood, it is unsurprising that high 
numbers of bacteria are exposed to the blood-brain barrier, a barrier of microvascular 
endothelial cells that separate the central nervous system from the bloodstream (99). 
Virulence factors including outer membrane protein A, invasion of the brain endothelium 
A, and cytotoxic necrotizing factor 1 are thought to be utilized by some NMEC to invade 
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and transverse the blood-brain barrier (39). Alternatively, NMEC may cross the BBB and 
into the CNS by “hiding” in macrophages in a Trojan horse mechanism (100). To cause 
disease, NMEC must survive and inhabit a wide range of niches within the body. To do 
so, it must use a wide range of virulence factors that are described in the virulence factor 
section. 
 
Vaginal E. coli (VEC) 
Although little is known about Vaginal E. coli, it has been proposed to be an 
ExPEC subpathotype as vaginal E. coli may be the reservoir for the fecal-vaginal-
urinary/neonatal transmission among ExPEC (101). VEC is presumed to be a member of 
the ExPEC pathotype due to its location of infection and shared virulence factors with 
other ExPEC (101). Clinically, E. coli colonization of the vagina is associated with pelvic 
inflammatory disease, urinary tract infections, and early-onset neonatal septicemia and 
meningitis (102).  
E. coli infection can result in both male and female infertility. Pelvic 
inflammatory disease results in reproductive disability due to damage to the Fallopian 
tubes and the resulting inflammation of the female upper reproductive tract from VEC 
(103). In males, E. coli can also impair fertility by irreversibly adhering to spermatozoa 
(104-106). Additionally, E. coli is the most-common non-sexually transmitted cause of 
pain, swelling, or inflammation of the epididymis or testicles (107). The Gram-negative 
bacteria is also involved in as many as 80% of prostatitis cases (107).  
E. coli can also lead to the rupture of fetal membranes (108, 109). The premature 
rupture of membranes can be managed after 36 weeks, but if earlier, it may result in up to 
20% of perinatal deaths (110). The premature rupture of membranes is associated with 
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neonatal brain injury and chronic lung injury of the neonate (111). Risk factors for VEC 
include the use of antibiotics within two weeks prior to examination, carriage of Group B 
streptococcus, prior preterm delivery or prior UTI, employment as a sex worker, or the 
presence of cats or dogs in the home (102, 112, 113). Although this dissertation will 
focus on the three well-recognized subpathotypes of ExPEC (APEC, NMEC, and UPEC), 
information about other ExPEC subpathotypes, such as VEC, may be included when 
readily available. 
 
Septicemia E. coli (SPEC) 
Septicemia E. coli results in sepsis for the host. This ExPEC subpathotype is often 
represented within the other subpathotypes as APEC, NMEC, and UPEC and can result 
in sepsis in certain situations. Therefore, the boundaries between these subpathotypes and 
SPEC remain unclear. Some ExPEC literature, including that by Ron (2007), defines all 
ExPEC subpathotypes as septicemic (114). There may be a correlation between the clonal 
lineage or O-antigen of E. coli and septicemia (114).  
 
ExPEC Models & Infections 
Although the ExPEC subpathotypes have been presented here independently, 
there is growing evidence that the subpathotypes may be able to cause the same disease 
in different hosts. In 2010, Tivendale et al. demonstrated that APEC isolates could result 
in NBM in a neonatal rat model, and NMEC isolates could cause disease in chicks as 
well as the deaths of chick embryos (115). Likewise, certain APEC isolates have shown 
the ability to grow in urine similar to UPEC (116). In a chicken model, APEC and UPEC 
isolates also demonstrated a similar lethal dose (LD50) (117). Additionally, an in vivo 
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murine model showed APEC and UPEC isolates express genes in a similar tendency 
(117). Thus, there is mounting evidence of a zoonotic potential for APEC for humans 
(115, 118-120). Although these characteristics blur the line between the subpathotypes, 
the clinical definition of the isolates is the rationale for studying each individual 
subpathotype, and the subpathotypes are known to contain certain virulence factors with 
different prevalences (121). Therefore, caution is warranted when attempting to identify 
subpathotypes solely by a phenotypic characteristic or virulence factor. Throughout this 
dissertation APEC, NMEC, and UPEC will be used to identify the initial host and 
apparent disease in keeping with previous works (68, 115, 122-124). 
 
Virulence Factors of ExPEC Subpathotypes 
Virulence factors allow bacteria to replicate and disseminate within hosts, which 
results in disease. The virulence factors associated with ExPEC, and the genes that 
encode them, can be broadly divided into different functional categories including 
adhesion, invasion, iron acquisition, toxins, and protectins; key virulence factors are 
described within their respective category (125).  
Adhesins 
Adhesion is critical for the pathogenesis of many bacteria, including the E. coli 
ExPEC pathotype. Key adhesins of ExPEC include the type I fimbriae (Fim), the Pap or 
P fimbriae (Pap/Prf), S/FIC fimbriae (Sfa/Foc), N-acetyl D-glucasamine-specific fimbriae 
(Gaf), M-agglutinin (Bma), afimbrial adhesin (Afa), and temperature sensitive 
hemagglutinin (Tsh) (64, 125).  
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Type I fimbriae (fim) 
The type I fimbriae (Fim) binds to D-mannose-containing structures through the 
FimH protein (126). The fimH gene contains regions of conservation and variability in 
APEC, NMEC, and UPEC (127-130). Point mutations in fimH have also been shown to 
lead to increased urovirulence (129, 131). Interestingly, the polymorphisms in fimH also 
correspond to the chromosomal history of the E. coli isolate as assigned by phylogenetic 
group, and fimH polymorphisms have been suggested as a way to type strains (130, 132). 
These point mutations may help explain the differing role of FimH in pathogenesis as 
fimH is ubiquitous in Escherichia coli. 
Although it has a slightly different role in the pathogenesis of APEC, NMEC, and 
UPEC, FimH acts as an adhesin for all three subpathotypes. In UPEC strains, FimH is 
important for adhesion and invasion of the intestinal epithelium by ExPEC strain CP9 
(133). When a fimH- mutant cystitis isolate was used to colonize the gut, there was 
reduced persistence of the strain (134). Additionally, FimH is needed by UPEC for 
binding the host mannosylated uroplakins that coat the umbrella cells of the bladder 
(135). The type I fimbriae is also required for the production of intracellular bacterial 
communities, a biofilm-like environment which confers protection to the bacteria (80). In 
NMEC, type I fimbriae interact with human brain microvascular endothelial cells 
(HBMEC) (136). FimH is not only an adhesin for HBMEC, but the protein triggers 
signaling that allows NMEC to invade via the host’s CD48 receptor (137). In APEC 
strains, the type I fimbriae is expressed during the initial colonization of the tracheal 
epithelial cells (60). Additionally, FimH is necessary for adhesion to cultured chicken 
tracheal cells in vitro (138). 
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A variety of ExPEC vaccines have been developed and tested with respect to 
FimH (139-142). Nevertheless, immunization with the binding domain of fimH did not 
provide protection to chickens against APEC (142). 
Pap fimbriae or P pili 
While the type I fimbriae is critical for UPEC binding in lower UTIs, the P pili 
are necessary for pyelonephritis to occur as the P pili adhere to renal tissue (82). Of 531 
UPEC surveyed, the P pili (as indicated by papC, the usher in P pilus assembly) was 
present in approximately 60% of isolates (143). In APEC, P pili are commonly expressed 
among isolates that colonize the blood, air sacs, kidney, blood, and pericardial fluid, but 
the P pili are not present in isolates that colonize the trachea (144). It has been suggested 
that in some pathogenic APEC, the P pili can be exchanged for other adhesins (145). P 
pili genes have been shown to vary among different APEC collections (22.7%, 30%, and 
40.4%) (64, 146, 147). Interestingly, this variation may be due to some selection by the 
poultry host as Rodriguez-Siek et al. observed that APEC from turkeys were far more 
likely to contain papC than APEC from chickens (64). papC was present in 35.6% of 
NMEC isolates (143) and 45% of vaginal E. coli (VEC) isolates (101). Even though 
papC is not present within ExPEC subpathotypes at the same prevalence, it has been 
proposed to be a molecular marker of the pathotype along with tsh, iucD, and cnf (148). 
 FIC fimbriae (foc) 
 The FIC fimbriae are encoded by the foc gene cluster, which is related to the S 
fimbriae genetic cluster (149). The FIC and S fimbriae are part of the same super family, 
but they bind different receptors (149). UPEC use FIC fimbriae to bind kidney tubular 
cells (150). The importance of the FIC fimbriae remains understudied in APEC and 
NMEC. 
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 S fimbriae (sfa) 
 S-fimbriae bind to luminal surfaces of the vascular endothelium of neonatal rat 
brain tissues by binding to sialic galactosides (151). S-fimbriae also adhere to the 
enterocytes and the bladder and kidney epithelium (151). As the S fimbriae and FIC 
fimbriae are part of the same superfamily, they are often surveyed together. A majority of 
NMEC strains (51.1%) contain sfa or foc unlike UPEC (26.4%) or APEC (4.4%) (143).  
 Dr adhesins 
 Dr adhesins use the Dr blood group antigen or decay accelerating factor as 
receptors (9). UPEC use the Dr adhesins to adhere to enterocytes and cell lines derived 
from the kidneys (151). An isogenic UPEC mutant was less virulent in a mouse model of 
pyelonephritis (152). 
 M-agglutinin (bma) 
 The M-agglutinin adhesin is involved in the binding of UPEC to uroepithelial 
cells, but the adhesin is rarely found in UPEC that cause pyelonephritis (153, 154). 
Interestingly, bmaE is statistically more likely to be present in UPEC strains that were 
resistant to both nalidixic acid and ampicillin (155). Overall, the gene may be associated 
with the ExPEC pathotype, but it remains underexplored (156).  
Afimbrial adhesin (afa) 
Afimbrial adhesins are adhesins that form fimbriae that are difficult to view, and 
it is strongly suggested that afa plays an important role in UPEC pathogenesis (152, 157). 
When a large collection of ExPEC isolates was examined, none of the ExPEC 
subpathotypes had a majority of isolates containing afa, but NMEC had the greatest 
percent of isolates containing afa (25.6%) (143). 
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 Hek outer membrane protein (hek) 
 In NMEC strain RS218, the Hek outer membrane protein can cause agglutination 
of red blood cells and can mediate autoaggregation (158). When expressed by E. coli, the 
protein can facilitate adherence and invasion of epithelial cells (158). The process of 
adherence and invasion requires heparin-containing proteoglycans on the host cell surface 
(159). The prevalence of the Hek outer membrane protein within the ExPEC community 
remains underexplored.  
 Temperature sensitive hemagglutinin (tsh) 
 Tsh is both a protease and agglutinin, and tsh confers a hemagglutinin-positive 
phenotype at 26 ˚C (160). Tsh uses hemoglobin, fibronectin, or collagen as a receptor and 
has been shown to adhere to chicken erythrocytes (151). Approximately 53, 31, and 3% 
of APEC, NMEC, and UPEC contain tsh, respectively (143, 147). Of the tsh-positive 
APEC, a majority were ranked as the most virulent isolates, but tsh is not associated with 
plasmid virulence, unlike iss or iucA (161, 162). The tsh gene is identified as a defining 
part of the APEC pathotype (64). Historically, the vat autotransporter was also identified 
as tsh (84). 
Invasins    
Like adhesion to the host’s tissue, invasion of host tissue is often critical to the 
pathogenesis of a wide range of bacteria, including ExPEC subpathotypes. Adhesins and 
invasins are often specialized surface proteins on the bacteria and are necessary for 
pathogenesis, and a distinction between adhesins and invasins remains obscure (163). 
Therefore, this section distinguishes invasins from adhesins as proteins historically 
termed invasins within the literature. 
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Invasion of brain endothelium (ibeA) 
 An important NMEC invasin is IbeA, which was discovered in the prototypic 
NMEC strain RS218, and is encoded by the ibeA gene; it is found in approximately 59% 
of NMEC isolates (143, 164). ibeA is also known as ibe10, and the gene is encoded on a 
20.3 kb pathogenicity island known as GimA, which is associated with phylogenetic 
group B2 (164-166). Experimentally, IbeA was shown to significantly increase invasion 
of cultured human brain microvascular endothelial cells, a lab model of the blood brain 
barrier, by binding to the host receptor vimentin (100, 164). Interestingly, IbeA has been 
experimentally shown to assist AIEC in colonizing the mouse intestine, which prompts us 
to ask if IbeA may form a similar function in NMEC pathogenesis (167). Although ibeA 
is found in AIEC and other E. coli strains, some researchers have suggested defining the 
NMEC subpathotype by the presence of ibeA and the K1 capsular antigen (69). 
 In contrast to NMEC, fewer APEC and UPEC contain ibeA, 14.2 and 19.2% of 
isolates, respectively (143). In APEC isolates, experimental evidence has shown that 
IbeA may assist in the regulation of type I fimbriae (FimH) and increase resistance to 
hydrogen peroxide (H2O2) killing (168). Regulation of FimH is critical as FimH is an 
important adhesin for the ExPEC subpathotypes. Additionally, IbeA enhanced the 
invasion of brain microvascular endothelial cells by an APEC isolate (169). The deletion 
of ibeA also lead to decreased biofilm formation by an APEC isolate (170).  
 Invasion of brain endothelium (ibeB) 
 Although ibeA and ibeB both contribute to the invasion of the brain microvascular 
endothelial cells, the two genes are not located within the same operon or pathogenicity 
island (165, 166). In APEC, an ibeB deletion resulted in reduced virulence and invasion 
of a chicken fibroblast cell line (171). For NMEC strain RS218∆ibeB, the strain was less 
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invasive towards BMEC in vitro, and there were significantly fewer animals with E. coli 
present in the CSF when newborn rats were infected (172). When the gene of ibeB was 
examined, it was determined to be identical to cusC, an outer membrane porin that is part 
of the copper/silver transport system (Nielsen et al., unpublished).  
 Invasion of the brain endothelium (ibeC) 
 The IbeC protein contributes to the invasion of BMEC (99). In a recent NMEC 
outbreak in Spain, all bacteria contained ibeC, unlike other invasins sometimes absent 
like ibeA (173). ibeC is not on the same genetic island as ibeA (165), and the IbeC protein 
sequence is identical to that of CptA, a phosphoethanolamine transferase (Nielsen et al., 
unpublished data). 
 Genetic island associated with newborn meningitis (gimB) 
 In APEC strains that caused severe cellulitis in broiler chickens, gimB is 
associated with increased disease severity, and in NMEC, gimB is associated with 
increased invasion of host cells (174, 175). The genetic island containing gimB is not the 
same island as GimA. 8.8%-9.7% of APEC, 22.6% of UPEC, and 56.7% of NMEC 
contain gimB (143, 174).  
Arylsulfatase (aslA) 
 aslA contributes to invasion of brain microvascular endothelial cells in vivo and in 
vitro as demonstrated by NMEC isolate RS218 (176). However, the aslA gene remains 
understudied within the ExPEC pathotype. 
Iron regulation 
 For many hosts, the first line of defense against pathogens is nutritional 
immunity; arguably, the sequestration of iron is one of the most important factors in 
protecting the host (177). To compete as a successful pathogen in a host, ExPEC must 
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acquire iron. Therefore, it is unsurprising that many virulence genes function to acquire 
or regulate iron. Siderophores can assist bacteria in the capture of iron. Of all the proteins 
associated with ExPEC iron acquisition, the majority of them are regulated by Fur (178). 
Aerobactin synthesis and transport (iucABCD) 
The iucABCD operon encodes a siderophore and has been found in surveyed 
NMEC plasmids (179, 180). During the growth of non-pathogenic E. coli Nissle 1917 in 
urine or a biofilm community, iucABCD was significantly upregulated (181). When iucD 
was knocked-out from both an APEC and UPEC strain, there were fewer lesions in the 
heart, liver, and lung of infected chickens (180). iuc has also been shown to 
experimentally contribute to the virulence of APEC strain c7122 (182). 
Enterobactin receptor (iha) 
In UPEC strains, Iha promotes adherence to uroepithelial cells and acts as a 
receptor (183). In a mouse model, iha was expressed in the kidney, and UPEC strains 
with iha outcompeted their deletion counterparts (183, 184). NMEC (26.7%) and UPEC 
(39.2%) genomes were more likely to contain iha compared to APEC (3.5%) (143). 
Eit operon (eitA) 
The Eit operon encodes an ABC iron transporter and a periplasmic binding 
protein. Interestingly the Eit operon is more likely to be present in APEC isolates (37.2%) 
compared to NMEC or UPEC (4.3-5.6%) (143). The operon is found in APEC plasmid-
linked pathogenicity islands (60). 
Metal transporter (feoB) 
FeoB is a metal transporter that is the primary mechanism for mediated ferrous 
(Fe2+) iron uptake (60). In a combined ∆feoB-∆sit strain, APEC c7122 demonstrated 
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increased colonization of the liver, but there was a decreased persistence of the strain in 
the blood (185). feoB has a higher prevalence in asymptomatic bacteriuria in children 
than other UPEC types (186). 
Iron responsive element (ireA) 
ireA encodes an outer membrane protein and is found on a chromosomal 
pathogenicity island in strain APEC O1 (187, 188). Expression of ireA is greatly 
enhanced in human urine or blood (189). In a mouse urinary tract infection model, ireA 
significantly contributed to colonization of the bladder (189). ireA is more prevalent in 
APEC isolates compared to NMEC or UPEC (143). The ireA gene may play a role in 
adhesion and stress resistance in APEC (188).  
Ferric aerobactin receptor precursor (iutA) 
The ferric aerobactin receptor gene, iutA, encodes an outer membrane receptor. 
iutA is a core gene of NMEC plasmids and is localized to APEC plasmid-linked 
pathogenicity islands (60, 179). APEC isolates responsible for colibacillosis were 
significantly more likely to contain the iutA gene (190). Indeed, 77.8% and 80.8% of 
NMEC and APEC, respectively, carry iutA (143). The prevalence of iutA is lower for 
UPEC (48.4%), but UPEC belonging to phylogenetic group B2 with iutA were more 
likely to be resistant to nalidixic acid and susceptible to gentamicin (143, 155).  
Salmochelins synthesis and transport (iroBCDEN) 
The Salmochelin operon contains the catecholate siderophore receptor gene, iroN 
(60). iroN has been shown to experimentally contribute to the virulence of APEC strain 
c7122, and iroN was strongly upregulated by APEC in chick embryos (182, 191). In a 
neonatal rat meningitis model, NMEC lacking iroN was less virulent and resulted in a 
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lower level of bacteremia (192). When iroN was knocked-out from both an APEC and 
UPEC strain and challenged in chickens, no lesions were present in the heart, liver, or 
lungs 24 hours post-infection (180). iroBCDEN are core plasmid genes of NMEC 
plasmids and are located on APEC plasmid-linked pathogenicity islands (60, 179). 
During the growth of E. coli strain Nissle 1917 in urine or a biofilm community, 
iroBCDEN was significantly upregulated (181).  
Iron transporter (sitABCD) 
 First discovered in Salmonella species, sitABCD is an operon that encodes 
divalent metal ion transporters (193). The importance of having sitA is demonstrated for 
the ExPEC subpathotypes as the gene was detected in 83.4-95.6% of each of the 
subpathotypes examined (143). In an APEC isolate c7122, the presence of the sitABCD 
genes resulted in increased transport of iron and manganese, and the operon also provides 
some resistance to H2O2 (194). In APEC, reduced colonization of the lungs, liver, and 
spleen was seen in a ∆sit strain (185). The operon has been found on both the 
chromosome and on APEC colicin-V-type virulence plasmids (143, 194). The sitABCD 
operon is found within NMEC plasmids and is found on APEC plasmid-linked 
pathogenicity islands (60, 179). During the growth of non-pathogenic E. coli Nissle 1917 
in urine or a biofilm community, sitABCD was significantly upregulated (181).  
Heme receptor (chuA) 
ChuA is an outer membrane protein that is a heme receptor and is produced in 
response to iron deficient environments (195). Heme uptake via chuA is involved in 
bladder and kidney colonization by UPEC (196). Notably, chuA is also a part of the E. 
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coli phylogenetic typing schemes (197, 198). As it is used to sort E. coli by their 
phylogenetic groups, chuA is found on the chromosome.  
Yersiniabactin receptor/synthesis (fyuA/irp2) 
 The Yersiniabactin operon was discovered as a mechanism by which Yersinia 
acquire iron in a mouse model of infection, resulting in virulence to the mice (199). In 
1998, it was reported that the pathogenicity island was present in E. coli that caused in 
sepsis in their human hosts, and in 2001, the Yersiniabactin genes were found in APEC 
that resulted in death via colibacillosis (146, 199). The genes of the Yersiniabactin 
operon are localized to chromosomal pathogenicity islands described in APEC (60) with 
58.2% of isolates positive for the fyuA gene; in contrast, 80.6% of UPEC isolates and 
68.9% of NMEC harbored fyuA. (143).  
 Heme receptor (hma) 
 The Hma protein binds hemin. An hma mutant was outcompeted by the wild-type 
UPEC strain CFT073 in the kidneys and spleens of a murine model, and a chuA-hma 
mutant was unable to successfully colonize the murine kidneys, unlike the wild-type 
UPEC strain CFT073 (200). The prevalence of Hma in the ExPEC subpathotypes 
remains underexplored. 
Toxins 
Important virulence factors of ExPEC include endotoxins and exotoxins. In Gram 
negative bacteria, endotoxins are part of the LPS and are a complex of lipid and 
polysaccharide (201). The O-serogroup, a typing mechanism of E. coli, composes part of 
the LPS. Endotoxins can cause fever, inflammation, and lethal shock (201). Exotoxins are 
a group of toxins composed of proteins and enzymes secreted from pathogenic bacteria.  
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 Cytotoxic necrotizing factor 1 (cnf1) 
CNF1 is an exotoxin that activates GTPases and stimulates myosin rearrangement 
(202). CNF1 contributes to the ability of NMEC strain RS218 to cross the blood brain 
barrier; the receptor for CNF1 is known as 67LR or RPSA (203, 204). Yet, only 4.4% of 
NMEC harbored cnf1. 1.3% of tested APEC isolates carried cnf1 while 23.4% of UPEC 
harbored the toxin gene (143). For UPEC, expression of CNF1 results in bladder 
inflammation (205). The influence of CNF1 on APEC virulence remains underexplored. 
 Hemolysin (hlyA) 
 The alpha-hemolysin, HlyA, is a pore-forming toxin that triggers proteolysis of 
host cell proteins, which results in inflammation and a loss of cell adhesion (206). As a 
result of the HlyA toxin, UPEC can invade and disseminate through the superficial facet 
cells (39). HlyA also allows UPEC to disable macrophages (206). When the UPEC 
isolate CFT073 was grown in urine, the hlyA hemolysin gene was induced, but it was not 
in other non-ExPEC E. coli (181). While a majority of human ExPEC contain the hlyA 
gene, the gene was less likely to be found in APEC (67). 
Hemolysin (hlyF) 
A majority of APEC (75.4%) and NMEC (58.9%) isolates contained hlyF in 
contrast to UPEC (5.6%) when the subpathotypes were surveyed (143). Due to its 
presence in APEC, HlyF has been termed the avian E. coli hemolysin (60). The 
hemolysin is encoded on plasmids within a cluster of virulence genes in APEC strains 
(207, 208). Further work on hlyF has demonstrated that the gene is directly involved with 
the enhanced production of outer membrane vesicles that are associated with the release 
of toxins (209). 
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Cytolethal distending toxin (cdtB) 
The cytolethal distending toxin-B protein is suggested to have DNA-damaging 
properties and shares sequencing homology to mammalian DNase I (210). Although the 
cdtB gene is present in less than 8% of APEC and UPEC, the gene is present in 
approximately 38% of NMEC (121, 124). The cytolethal distending toxin may have been 
transferred to certain ExPEC by phage transduction as the toxins are flanked by lambdoid 
prophage genes (211). 
Vaculating autotransporter toxin (vat) 
 vat encodes a serine protease autotransporter (SPATE). The toxin induces cytoxic 
effects similar to those of VacA by H. pylori by creating intracellular vacuoles (212). An 
APEC vat- mutant demonstrated no virulence in broiler chickens (212). The vat gene was 
approximately present in half of APEC, NMEC, and UPEC isolates tested (67) and is 
located on chromosomal pathogenicity islands (60).  
Secreted autotransporter toxin (sat) 
Sat is significantly associated with clinical pyelonephritis (213). The toxin is a 
SPATE, similar to Vat (213). The toxin was cytopathic to kidney and bladder cell lines 
and was able to elicit a strong antibody response after UPEC strain CFT073 was used to 
infect mice (213). Sat is more common in NMEC (34.6%) and UPEC (21.2%) compared 
to APEC (0.4%) (67).  
Protectins 
Protectins prevent complementation by the immune system and are commonly 
membrane-bound proteins. By preventing death via the immune system, ExPEC are able 
to further disseminate throughout their host, resulting in further disease.  
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Outer membrane protein A (ompA) 
OmpA is an outer membrane protein that performs a wide-variety of functions in 
different E. coli types (214). In NMEC, OmpA promotes bloodstream survival and assists 
in crossing the blood brain barrier (172, 215, 216). Structurally, the loops of OmpA 
contribute to NMEC’s survival and entry into the human brain microvascular endothelial 
cells (HBMEC) by binding the Ecgp glycoprotein (217, 218). The protein also 
contributes to the binding and survival of NMEC inside macrophages (219). As a result, 
it has been suggested that OmpA might be a good vaccine target to prevent NMEC 
infection (220). Nevertheless, the effect OmpA has on invasion is not additive with other 
virulence factors, like IbeB (172). When UPEC were used to infect a murine UTI model, 
deletion of ompA prevented formation of the intracellular bacterial communities and 
reduced bacterial counts in the bladder (221). Although ompA is found in nearly all E. 
coli, OmpA is known to contain differences within its protein sequence (214, 222).  
Outer membrane protein T (ompT) 
OmpT is an outer membrane protease. The majority of APEC and UPEC have 
ompT chromosomally, and a majority of APEC and NMEC have ompT episomely (143). 
ompT is frequently associated with urinary tract infections and usp, a uropathogenic 
specific protein associated with pyelonephritis (223). OmpT may allow longer 
persistence of E. coli in the urinary tract by enabling resistance to the antimicrobial 
activity of urinary cationic peptides (224). The deletion of ompT from an APEC strain 
reduced the adherence and invasion to BMEC by 43.8 and 28.8%, respectively (225). 
ompT deletion also resulted in reduced colonization and invasion in the brains, lungs, and 
blood 1.7-2-fold in murine or duckling models (225). ompT inactivation also resulted in 
8.7 or 15.2-fold reduced virulence in murine or duckling models, respectively (225).  
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Increased serum survival (iss) 
Iss is an outer membrane protein associated with complement resistance (226). 
Experimentally, iss increased the lethal dose (LD50) of APEC 100-fold in day-old chicks 
(60, 227). iss was also strongly up-regulated when chick embryos were infected with 
APEC (191). UPEC of phylogenetic group B2 containing iss were significantly more 
likely to be resistant to nalidixic acid (155). When initially surveyed the iss gene was 
found on the plasmids of 82.7%, 55.6%, and 26.6% APEC, NMEC, and UPEC examined, 
respectively (143). The gene is statistically more prevalent in APEC than avian fecal E. 
coli (64). 
Studies on iss are complicated as iss closely resembles another gene, bor. The two 
genes have been shown to be 88.4-95.5% identical, and the iss gene is often misannotated 
as bor (228). Bor, encoded by bor, is a protein that commonly occurs in E. coli as an 
outer membrane protein and is derived from lambda (226, 228, 229). Additionally, the 
generation of Iss-specific antibodies has been hampered by their cross-reactivity to Bor 
(226). Johnson et al. (2009) characterized the iss gene into three different types. Although 
iss was thought to occur exclusively on virulence plasmids, only iss type 1 is specifically 
plasmid borne (228). Among APEC and NMEC strains, iss type 1 was the most prevalent 
(78% and 66%, respectively) (228). The prevalence of bor was lower for human ExPEC 
(4%) than APEC (25%) (228). Although the Bor protein is found widely among avian E. 
coli pathogens and commensals, it may also play a role in serum resistance (226, 229). 
K capsular antigen (kps) 
In 1974, Robbins et al. discovered a relationship between the capsular (K1) 
polysaccharide and neonatal meningitis as 84% of NMEC had the K1 antigen (230). 
32 
Indeed, the importance of the capsular polysaccharide persists in the literature as NMEC 
may be alternatively described as Escherichia coli K1. The K1 antigen protects NMEC 
from a host immune response by enhancing serum resistance (231). NMEC with the K1 
antigen are concealed from the immune system by the K1 capsule since the K1 antigen is 
composed of a sialic acid (232). Sialic acids are self-recognition molecules and are 
common on the surface of host cells (233). The K1 antigen also prevents lysosomal 
fusion in HBMEC when NMEC are localized within a membrane-bound vacuole (234). 
Thus, live bacteria can transverse the BBB. NMEC isolates appear to differ from APEC 
and UPEC regarding the prevalence of the K1 capsule. A majority of NMEC (70-84%) 
contain the K1 capsular antigen in contrast to APEC (15.7%) and UPEC (29.2%) (143, 
230). 
TraT 
TraT is a plasmid-encoded outer membrane protein. The protein enhances 
resistance to phagocytosis of the bacterium (235). traT is associated with the K1 capsule 
and ColV plasmids (236). TraT promotes surface exclusion by preventing DNA transfer 
during conjugation; therefore, it prevents the acquisition of similar plasmids (237). TraT 
may also interact with OmpA (238). A majority of APEC (78.1%), NMEC (85.6%), and 
UPEC (67.8%) contain traT (143).  
 
Although not every putative ExPEC virulence factor has been presented here, the 
virulence factors documented demonstrate the numerous possibilities in which an ExPEC 
strain may become virulent. Clearly, no single ExPEC isolate or subpathotype contains 
33 
all of these virulence factors, but the “mix-and-match” virulence factor approach makes it 
difficult to investigate, treat, and prevent infections in both avian and human hosts. 
 
Virulence plasmids of ExPEC 
 Although virulence factors can be critical to the severity and disease outcome, the 
vectors by which these virulence factors move should not be overlooked. Transmissible 
plasmids that carry a significant number of virulence factors are common among the 
ExPEC subpathotypes (60, 179). Indeed, these plasmids are occasionally considered 
virulence factors themselves as these plasmids have been associated with improved 
growth in urine and under acidic pH conditions, resistance to chlorine and disinfectants, 
and bacteriophage resistance (239, 240). Virulence plasmids of ExPEC are commonly 
classified by colicin or replicon type.  
 Colicin Typing 
Colicins are produced by strains of E. coli carrying a plasmid encoding colicin 
genes and are toxic to other strains of E. coli not carrying this plasmid (241). Colicins kill 
susceptible strains by binding outer membrane proteins and are translocated in the 
periplasm before they form a voltage-dependent channel in the inner membrane or use 
their endonuclease activity on the host’s genetic material (241). Because colicins are 
carried on colicinogenic plasmids, some plasmids have been named after the colicins they 
carry (191, 207, 208, 227, 240). Some colicin-related genes include cvaC, cbi, and cma. 
Some plasmids of APEC have been named after the colicin they carry, such as 
pAPECO1-ColBM, pAPEC-O2-ColV, and pAPEC-O103-ColBM (207, 208, 240). The 
ColV plasmids have long been associated with the ExPEC pathotype, and they were 
named because a colibacillosis strain produced “principle V”, which lysed other cells 
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(239). Further work illustrated that these ColV plasmids carried numerous virulence 
factors including genes such as iss, traT, and tsh as well as iron acquisition operons (182, 
242).  
The prevalence of different colicins varies among the ExPEC subpathotypes. 
When screened for the cvaC, the colicin V precursor gene, 67.5% of APEC and 54.4% of 
NMEC contained ColV; only 5.6% of UPEC carried cvaC (143). When screened for cmi, 
the colicin-M immunity gene, approximately 25% of APEC carried the gene while less 
than 5% of NMEC or UPEC did (140). Colicin B is a channel-forming colicin encoded 
by cba. Approximately 4% of UPEC, 21% of NMEC, and 34.3% of APEC carry the cba 
gene (143). The higher prevalence of the different colicins for the APEC subpathotype 
compared to the NMEC and UPEC subpathotypes presents an interesting observation. 
Yet, the presence of these genes does not imply a plasmid for each colicin type as hybrid 
plasmids exist, like hybrid ColBM plasmids (240).  
 Replicons 
The failure to maintain stable plasmids of a similar type in bacteria is known as 
plasmid incompatibility. Plasmid incompatibility families are named beginning with 
“Inc”. These Inc families have also been described by correlations to the biological 
functions of the things they encode. For example, the different IncF plasmids are capable 
of carrying MDR, transfer, and virulence function genes while IncT are plasmids capable 
of carrying transfer and DNA metabolism functions (239).  
In 2005, Carattoli et al. revolutionized the high-throughput naming of plasmids by 
developing a PCR-based replicon typing method (243). When the PCR-based scheme 
was applied to a large collection of ExPEC, 86.9% of APEC, and 80.0% of NMEC, and 
33.5% of UPEC contained the IncFIB replicon (143). Other replicon types occurring in 
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more than 10% of one ExPEC subpathotype include IncB/O, IncFIC, IncP, IncFIIA, 
IncI1, and IncN (143). With genomic data, in silico analyses can be performed to detect 
the replicons present in a given strain via PlasmidFinder (244). With an ever-growing 
number of replicons being added to the database, it is evident that there is still much to 
discover in plasmid biology.  
 
Classification Schemes Used with E. coli 
 In addition to grouping virulence plasmids by replicon or pathogenic E. coli into 
pathotypes, various methods are employed to parse E. coli into distinct cohorts according 
to certain traits. In the past, there were many typing schemes that attempted to infer the 
genetic relatedness among isolates. In addition to the use of serology, which classifies E. 
coli by antibody recognition of surface structures, such as O-antigen, pili and capsule, a 
number of typing methods rely on discerning genetic relatedness among isolates, such as 
Sequence Typing, Phylogenetic Typing, fim typing, and other such schemes. One of the 
newest and most thorough tools to assess the genetic relatedness of E. coli is whole 
genome sequencing. Interestingly, the information gathered from the various E. coli 
typing schemes is still used to infer the E. coli types from sequencing data. Relevant E. 
coli typing schemes including the serotype, multi-locus sequence typing (MLST), and 
phylogenetic group have been applied to sequencing data. In this dissertation, wherever 
possible, the results of APEC, NMEC, and UPEC are included within each typing scheme 
when available.  
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Serotyping 
In the 1940s, serotyping was developed by Kauffmann. To serotype, E. coli are 
assigned to different groups based on serological detection of certain O, H, and K 
antigens (245, 246). The serogroup is composed of the O-antigens, the exterior 
lipopolysaccharides of the LPS; the K antigen, the capsular antigen; and the H or flagellar 
antigen (247). The term serogroup refers to typing of E. coli by its O-antigen only; 
whereas, serotype refers to a more comprehensive type, including O-antigen and H and/or 
K antigen typing (9). There are currently 187 recognized serogroups (248). Due to the 
effort required for serological typing, DNA- or computational-based methods are gaining 
use as a substitute method to assign E. coli to serotypes (249). These newer methods may 
also overcome the difficulty with cross reactivity of some O-group antisera (248). Recent 
research examining the serogroups and DNA sequences of O-antigens has indicated that 
several serogroups or serogroup subdivisions may be redundant (248).  
Common APEC serogroups in the United States and Germany include O2, O8, 
O18, and O78 (64, 147). Nevertheless, other serogroups are also present as represented 
by APEC O1, the first completely sequenced APEC that has an O1 serogroup (187). In 
NMEC, the most common serogroup is O18, followed by O1, O7, and O83 (124). For 
UPEC, the most common serogroup was O6, with serogroups O1, O2, O4, O18, and O75 
common as well (121). Thus, there are shared serogroups between APEC, NMEC, and 
UPEC isolates. However, serogroups cannot fully explain E. coli isolates as 25% of E. 
coli remain untypeable, and these isolates are categorized as negative, rough, 
autoagglutinating, or belonging to multiple groups (248). The importance of the K-
antigen to virulence is discussed within the virulence factor section. 
 
37 
Multi-locus sequence typing 
Multi-locus sequence typing (MLST) is a PCR and Sanger sequencing-based 
typing scheme. Three MLST schemes exist, and the schemes may be referenced by their 
location of MLST databases or their inventor. The Warwick or Achtman scheme may be 
one of the most used MLST schemes, and the scheme contains the 4,499 sequence types 
(ST), more than any other MLST scheme (250, 251). Some Achtman STs may be 
associated with extended-spectrum B-lactamase-producing E. coli (252). The Pasteur 
Institute scheme contains 771 STs (251, 253). The Achtman and Pasteur schemes have 
wide appeal as both can be completed computationally via the Center for Genomic 
Epidemiology (254). The Michigan State MLST contains 1,081 STs, but this MLST may 
favor pathogenic STEC due to the sequencing data collected (251). The Michigan State 
MLST is computationally available from shigatox.net. Several MLST reviews have been 
published (251, 255). 
Although few ExPEC have published MLST data, some common NMEC 
Achtman STs were ST95, ST390, ST3157, and 3194 (119, 256, 257). Common APEC 
STs include ST95, ST1354, ST1827, and ST3191, and UPEC STs commonly included 
ST95 and ST1349 (119). Therefore, the ExPEC commonly shared ST95 among the 
currently available data, yet a larger sample size would allow for improved analyses. 
 
Phylogenetic groups 
The original phylogenetic types were based on the profiles of multilocus enzyme 
electrophoresis (MLEE) results for E. coli pathotypes. In this scheme, 10 enzyme loci and 
the sequence of the mdh gene were used to study the genetic relationships of pathogenic 
E. coli and Shigella. With MLEE, Whittam et al. discovered statistically distinct 
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groupings of E. coli (258) that became known as phylogenetic groups, and these groups 
were correlated with the presence of virulence factors (259).  
In 2000, phylogenetic groups were built upon as Clermont et al. released a 
phylogenetic typing scheme, which was based on the presence or absence of three DNA 
targets—chuA, yjaA, and TspE4.C2. These three DNA targets separated E. coli isolates 
into four groups—A, B1, B2, and D (198). However, the accuracy of the method was 
limited with an 80-85% accuracy to MLST data, but the information gained from the 
typing may still be biologically relevant (122, 260). Therefore, several other phylogenetic 
typing schemes were proposed (261, 262). In 2013, Clermont et al. published a revised 
phylogenetic typing scheme to improve the original, which was based on six targets. 
These six targets separate E. coli isolates into nine groups—A, B1, B2, C, D, E, F, Clade 
I, and unknown (197). The results of Clermont’s phylogenetic typing schemes are 
correlated with MLST data (251). The proportions for each ExPEC subpathotype are 
shown in Figure 1.1.  
 
Whole Genome Sequencing Comparisons & Significance 
 Although Caratolli et al. streamlined replicon typing via PCR, the comparison of 
plasmid replicons has further been transformed in an era of whole genome sequencing 
(WGS) (243). With genomic assemblies, it is feasible to screen for replicons, antibiotic 
resistance genes, and insertion elements in a more time efficient manner through tools 
such as PlasmidFinder, ResFinder, ISEscan, or FimTyper (244, 263). However, the 
greatest benefit of such tools and WGS is the ability to determine potential patterns or 
novel genes, which may have gone undetected using more traditional tools, such as PCR. 
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WGS has even lead some individuals to ask if pathotypes are still relevant in a WGS era 
(53). Although such a question is intriguing, WGS tools can certainly allow us to closely 
examine the pathotypes and subpathotypes of E. coli. 
 The majority of conclusions drawn about virulence factors and pathogenesis of 
the ExPEC subpathotypes have been the result of work on a few isolates. In NMEC, the 
majority of known virulence factors have been discovered in RS218 and its rifampicin-
resistant derivate strain, E44. For example, the importance of genes such as ibeA, ibeB, 
ibeC, ompA, cnf1, and yjiP were discovered using NMEC strain RS218 (164, 172, 215, 
264-266). Nevertheless, in the last decade, more NMEC are being sequenced to provide a 
more comprehensive view of ExPEC and its subpathotypes. For example, NMEC strains 
CE10, IHE3034, NMEC O18, RS218, and S88 have completed chromosomes publicly 
available and genomic assemblies are currently available for SP-4, SP-5, SP-13, SP-46, 
and SP-45 (267-271). Nevertheless, no large-scale genomic comparison has been 
completed with these isolates. With an expanding number of genome sequences, we may 
be able to more clearly delineate NMEC chromosomal and plasmid-linked pathogenicity 
islands. Therefore, 48 additional NMEC were sequenced with an Illumina MiSeq 
instrument and 14 of these isolates were chosen for sequencing with Pacific Bioscience’s 
RSII instrument.  
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Figure 1.1: Phylogenetic groupings between the different ExPEC subpathotypes. 
The data presented here is published in Logue et al. 2017 (123) and shows significant changes occurred between the 
distributions of phylogenetic groups for the subpathotypes (x-axis) when the old and new typing schemes were applied. 
Phylogenetic group B2 was more common among human ExPEC while revised phylogenetic group C was more common 
among APEC isolates. 
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In addition to the NMEC isolates sequenced, this work also sequenced avian 
pathogenic isolate APEC O2-211. The sequencing of APEC O2-211 provides additional 
plasmid sequences to compare against other landmark APEC plasmids, such as pAPEC-
O1-ColBM and pAPEC-O2-ColV, for future work (207, 208). Comparisons of the APEC 
and NMEC virulence plasmids is critical as these plasmids carry a significant number of 
virulence factors. With an examination of the different genomic sequences, there is the 
distinct possibility of finding patterns between the clinical features of the isolates and 
their genomic constituents.  
 
Aims 
The aims of the dissertation presented here include an examination of the 
differences between the chromosomal history of extraintestinal pathogenic E. coli via 
assignment to a phylogenetic group and the phenotypic and genomic information 
associated with the phylogenetic groups and subpathotypes.  
 
Organization of this Dissertation 
 The dissertation presented here is organized into seven chapters in a journal 
format. Chapter 1 is a literature review of Escherichia coli with an emphasis on the 
ExPEC pathotype and E. coli classification and typing schemes. Chapter 2 examines the 
association between phylogenetic groups, ExPEC subpathotypes, and biofilm formation. 
Chapter 3 is an investigation of the polymorphisms of the ExPEC virulence factor outer 
membrane protein A (OmpA) and the association between the polymorphism patterns, 
phylogenetic groups, sequence types, subpathotypes, and serology of E. coli. Chapter 4 
introduces the complete genome of APEC O2-211, an APEC strain that was isolated from 
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the air sac of a chick. Chapter 5 announces the complete genome of NMEC-O75 
(MCJCHV-1), an NMEC isolate that resulted in the death of an infant at day 45 of life. 
Chapter 6 is a genomic analysis of the NMEC subpathotype. Chapter 7 is a conclusion of 
the work presented within this dissertation. 
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Abstract 
Extraintestinal pathogenic Escherichia coli (ExPEC) include avian pathogenic E. 
coli (APEC), neonatal meningitis E. coli (NMEC), and uropathogenic E. coli (UPEC) and 
are responsible for significant animal and human morbidity and mortality. This study 
sought to investigate if biofilm formation by ExPEC likely contributes to these losses 
since biofilms are associated with recurrent urinary tract infections, antibiotic resistance, 
and bacterial exchange of genetic material. Therefore, the goal of this study was to 
examine differences in biofilm formation among a collection of ExPEC and to ascertain 
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if there is a relationship between their ability to produce biofilms and their assignment to 
phylogenetic groups in three media types—M63, diluted TSB, and BHI. Our results 
suggest that ExPEC produce relatively different levels of biofilm formation in the media 
tested as APEC (70.4%, p=0.0064) and NMEC (84.4%, p=0.0093) isolates were poor 
biofilm formers in minimal medium M63 while UPEC isolates produced significantly 
higher ODs under nutrient-limited conditions with 25% of strains producing strong 
biofilms in diluted TSB (p=0.0204). Additionally, E. coli phylogenetic assignment using 
Clermont’s original and revised typing scheme demonstrated significant differences 
among the phylogenetic groups in the different media. When the original phylogenetic 
group isolates previously typed as group D were phylogenetically typed under the revised 
scheme and examined, they showed substantial variation in their ability to form biofilms, 
which may explain the significant values of revised phylogenetic groups E and F in M63 
(p=0.0291, 0.0024). Our data indicates that biofilm formation is correlated with 
phylogenetic classification and subpathotype or commensal grouping of E. coli strains.  
 
Introduction 
Extraintestinal pathogenic E. coli (ExPEC) is a pathotype of Escherichia coli 
responsible for morbidity and mortality in a wide range of hosts. In humans, neonatal 
meningitis E. coli (NMEC) is responsible for approximately 28-29% of cases of neonatal 
bacterial meningitis with a mortality rate of 12% (1, 2). Uropathogenic E. coli (UPEC) is 
responsible for the greatest number of both catheter-associated urinary tract infections 
and uncomplicated urinary tract infections worldwide (3). Serious cases of urinary tract 
infections can result in pyelonephritis, potentially leading to sepsis and death. Avian 
pathogenic E. coli (APEC) is a non-human subpathotype of ExPEC and the causative 
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agent of colibacillosis in poultry. Collectively, human infections caused by ExPEC 
strains result in billions of dollars in healthcare costs annually, while APEC also poses a 
significant financial burden to the poultry industry (3, 4). In addition, ExPEC 
subpathotypes from different host sources have also been shown to exhibit genomic (5) 
and phenotypic similarities (6, 7).  
Biofilms are complex communities of surface-associated microorganisms that are 
enclosed in a structured, highly hydrated extracellular polysaccharide (8, 9). In 
themselves, biofilms are a distinct bacterial lifestyle since biofilm formation promotes 
resistance to antibiotics and sanitation as well as exchange of DNA (10, 11). Biofilms can 
lead to persistent and chronic infections in humans, and an estimated 65% of hospital 
infections are of biofilm origin (12). Additionally, persistence of APEC in the poultry 
production environment may be due to biofilm development on plastic surfaces such as 
water feeding systems (13, 14). Escherichia coli K1 biofilms have also been isolated 
from neonatal nasogastric feeding tubes (15), and biofilm-like intracellular bacterial 
communities (IBCs) are known to play in important role in the pathogenesis of UPEC 
since IBC formation allows UPEC to continue colonization of the bladder and resist 
expulsion (3, 16, 17). The ability of ExPEC to exchange DNA in biofilms is also of 
concern due to potential acquisition of virulence and antimicrobial resistance plasmids 
(18, 19).  
Although biofilm analyses have been done independently in APEC (20), UPEC 
(21), and NMEC (22), cross comparisons among these ExPEC subpathotypes are 
problematic due to procedural differences in the studies. This lack of comparative data 
can be a roadblock to study of the zoonotic potential of ExPEC, development of universal 
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mitigation strategies to control ExPEC-caused diseases, and our understanding of 
ExPEC’s environmental persistence, transmission and pathogenesis. Additionally, failure 
to understand the differences in biofilm production between ExPEC and their commensal 
E. coli counterparts, including avian fecal E. coli (AFEC) and human fecal E. coli 
(HFEC), can undermine our understanding of ExPEC’s disease pathogenesis and prevent 
clarity on the importance of biofilm production in the survival of ExPEC outside vs. 
inside the host.   
 Another issue that may limit our clarity on the importance of biofilm production 
to ExPEC pathogenesis is that previous studies (20-22) of ExPEC biofilm production 
were analyzed by phylogenetic assignment according to the original typing scheme of 
Clermont (23). Here, we compare different ExPEC, assigned to different phylogenetic 
groups using Clermont’s more recent and refined typing scheme (24). Such data may lend 
great insight into the role of biofilm in pathogenesis since phylogenetic group assignment 
may predict an E. coli’s capacity to cause disease (25).   
In addition to looking for differences in biofilm production between ExPEC and 
E. coli commensals, among members of different ExPEC subpathotypes, and members of 
different phylogenetic groups, we sought to determine if these differences were best 
discerned under three different conditions of growth, including nutrient-poor, nutrient-
limited, or nutrient-rich conditions (20).  
In the present study, we seek to remedy deficits in our understanding of ExPEC 
biofilm production. To do so, biofilm production of ExPEC from APEC, NMEC and 
UPEC subpathotypes and their commensal counterparts, all assigned to phylogenetic 
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groups according to Clermont’s original and revised typing schemes and using the same 
methodology under three conditions of growth was assessed. 
 
Materials and methods 
Strain selection 
To assess biofilm formation, 175 E. coli isolates were tested including 108 
ExPEC strains and 67 commensal E. coli strains. These isolates were randomly selected 
from collections that have been described previously (7, 18, 26-29), and efforts were 
made to ensure that members of all phylogenetic groups were represented. Since Logue et 
al. (2017) demonstrated natural differences in the distribution of the phylogenetic groups 
among isolates of the different subpathotypes, this study did not equilibrate the isolates 
selected based on their subpathotypes or commensal classification thus avoiding 
production of erroneous results when generalizing the groups (29). Table 2.1 provides 
information about the isolates examined in this study, and data for each strain is found in 
the supplementary file. 
 
Biofilm assay 
Isolates to be tested were struck from frozen stock to tryptic soy agar (TSA, 
Difco, BD, Franklin Lakes, NJ, USA) and incubated at 37 ºC for 18 to 24 hours. Three 
colonies were selected per strain and incubated for 16 hours in Luria Bertani (LB) Miller 
broth (Difco). These cultures were tested based on methods previously described (20, 30, 
31). Previous work has demonstrated that the assay used here, a 96-well microtiter plate 
with crystal violet staining, has a high repeatability and broad applicability and is useful 
for the examination of the early stages of biofilm development (31-34). After incubation 
71 
  
for 16 hours, the strains were diluted 1:100 with each broth; these included brain heart 
infusion (BHI) broth (Bacto), 1/20 diluted tryptic soy broth (TSB) (Bacto), and M63 
minimal media (20, 35). 200 uL aliquots of each diluted strain in medium were dispensed 
into seven wells of a Sarstedt 96-well flat bottom microtest plate (Sarstedt, Nümbrecht, 
Germany). Uninoculated medium was used as a negative control in the eighth well. Plates 
were incubated at 37 ºC for 24 hours without shaking before the contents of the plates 
were decanted, and the plates washed once with sterile deionized water. Following 
washing, microplates were stained for 30 minutes with 200 uL of 0.1% crystal violet 
solution (J.T. Baker Chemical Co., Phillipsburg, N.J.). After staining, the plates were 
washed four times with sterile deionized water and allowed to air-dry for one hour. 
Following drying, the biofilms were resolubilized with 200 uL of an 80:20 solution of 
ethanol and acetone, and 150 uL of the resulting solution was transferred into a new 
plate. Biofilm formation was quantified by measuring the optical density (OD) of the 
dissolved crystal violet at 600 nm using an ELx808 Ultra MicroPlate Reader with Gen5 
Microplate Reader and Imaging software (Bio-Tek Instruments, Winooski, VT). The 
ODs of the three biological replicates in seven wells were averaged for each test strain in 
each medium tested. 
 
Clermont’s phylogenetic typing 
All isolates were assigned to phylogenetic group based on the original and revised 
Clermont phylogenetic typing schemes (23, 24). These protocols have been described 
previously and are based on amplification of the chuA and yjaA genes as well as the 
TSPE4.C2 DNA fragment (23) or revised chuA, yjaA, and TspE4.C2 DNA fragment 
along with the arpA and trpA genes (24, 29). Amplified products were run on a 2% 
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agarose gel in 1X TAE buffer with known controls (ECOR collection) and classification 
of the strains was determined by the presence or absence of gene products.  
  
Table 2.1: Isolates used in this study as classified by subpathotype or commensal 
category and Clermont’s phylogenetic typing schemes. 
Original Scheme Revised Scheme 
  
n= A B1 B2 D A B1 B2 C D E F 
ExPEC APEC 44 11 4 7 22 4 4 6 8 5 9 8 
 
NMEC 32 8 2 15 7 5 2 15 3 1 1 5 
 
UPEC 32 9 5 7 11 4 5 5 5 7 1 5 
Commensal AFEC 33 9 6 8 10 5 5 4 4 5 5 5 
 
HFEC 34 9 6 9 10 7 6 8 1 6 1 5 
Sum 
 
175 46 23 46 60 25 22 38 21 24 17 28 
Extraintestinal pathogenic E. coli (ExPEC) subpathotypes examined included avian 
pathogenic E. coli (APEC), neonatal meningitis E. coli (NMEC), and uropathogenic E. 
coli (UPEC). Commensal E. coli isolates included could be separated by host—avian 
fecal E. coli (AFEC) and human fecal E. coli (HFEC).  
 
Biostatistics 
The ODs measured for the negative control wells for each test strain and media 
combination were measured and averaged. The ODs for each test strain in a given 
medium were averaged and normalized against the negative control by subtracting the 
average OD of the negative control from the average OD of the test strain. Statistical 
analyses were performed in MATLAB (Mathworks®) using the normalized, average data 
for each test strain in each of the three media. As the obtained ODs deviate from a normal 
distribution, the Kruskal-Wallis (KW) test (one-way ANOVA on ranks) was used as a 
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non-parametric test to determine significant differences in biofilm formation between the 
original or revised Clermont’s phylogenetic types or subpathotype or commensal E. coli 
(36). Multiple comparisons were performed in relation to ANOVA using Tukey’s honest 
significant difference test (HSD) to reduce the incidence of Type I error (37). Direct 
comparisons between two groups were made using the Mann-Whitney U test (MW) (38).  
To reduce human bias introduced by setting cutoffs for levels of biofilm 
formation, cluster analysis was performed by an unsupervised machine learning 
technique. For each medium, isolates were clustered by level of biofilm formation using 
k-means clustering (39) with four means identified to represent negligible, low, moderate, 
and high levels of biofilm formation; the use of these four categories is consistent with 
previous work (20, 30). The k-means algorithm was performed with the L1-norm; 10,000 
replicates for each media were performed to produce optimal clustering. When biofilm 
production was treated as a discrete classifier, the chi-square test of homogeneity was 
used to determine statistically significant differences. Significance for all statistical tests 
was determined at the α=0.05 level. 
 
Results 
Overall associations of medium and biofilm production 
In the three different media tested, biofilm formation exhibited limited correlation 
between media (Pearson’s correlation coefficient: M63 to TSB, r=0. 3461, M63 to BHI, 
r=0. 3217, BHI to TSB, r=0. 1892), which suggests biofilm formation in each medium 
should be examined individually. In general, the optical densities were significantly 
greater for isolates when grown in M63 than in diluted TSB or BHI (KW, p=1.492E-09). 
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Supplementary figure 2.1 shows the optical densities of each medium for all strains 
examined with the standard error of mean included.  
When all E. coli were classified as a negligible, low, moderate, or high biofilm in 
each medium using k-means clustering (Figure 2.1), approximately 33.1% of E. coli 
strains formed moderate or high biofilms in M63; classification of moderate or high 
biofilms in diluted TSB and BHI were lower at 23.4 and 26.9% respectively (Figure 2.2, 
Supplementary Table 2.1). The final OD measurements of each strain tested are available 
in the supplementary file. 
 
Associations between biofilm formation by E. coli commensals and ExPEC 
subpathotypes 
When all test strains were examined in M63 broth and classified as negligible, 
low, moderate, or high biofilm producers, strains classified as APEC and NMEC were 
found to be significantly weaker biofilm producers (χ2, p=0.0064 and 0.0092, 
respectively) among all of the E. coli examined. In APEC, the majority of strains (56.8%) 
produced negligible biofilms while the majority of NMEC (53.1%) produced low-level 
biofilms (Figure 2.2). UPEC, AFEC, and HFEC strains could not be differentiated from 
any other E. coli groups (MW, p= 0.6007, 0.6371, 0.4956, respectively). In addition, the 
majority of UPEC (62.5%), AFEC (57.6%), and HFEC (52.9%) isolates produced low or 
moderate biofilms using k-means clustering (Figure 2.2). 
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Figure 2.1: k-means Clustering of E. coli by Media 
k-means clustering was used to determine the level of biofilm production for each E. coli 
isolate in four categories: negligible (red), low (green), moderate (blue), and high 
(purple). 
 
In diluted TSB, UPEC strains produced significantly higher ODs compared to 
APEC, NMEC, AFEC, and HFEC isolates (MW, p=0.02045, Figure 2.3). Even though 
UPEC did not produce a significant p-value (χ2, p=0.0505) when the biofilm levels of 
UPEC strains were categorized, a greater proportion of UPEC strains classified as high-
level biofilm formers (25%) compared to any other commensal or ExPEC group (Figure 
2.2). In contrast, most (range 53-73%) of the APEC, NMEC, AFEC, and HFEC isolates 
produced negligible biofilms in 1/20 TSB (Figure 2.2). 
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Figure 2.2: Prevalence of Biofilm Formation in ExPEC subpathotypes and E. coli 
Commensals. 
Percentage of negligible (red), low (green), moderate (blue), and high (purple) biofilm 
forming isolates by subpathotype or commensal E. coli designation. APEC and NMEC 
are significantly different in their abilities to form biofilms in M63 (0.0064 and 0.0093, 
respectively). 
 
In BHI, no significant differences were observed for the ODs of the groups 
(Figure 2.2), yet more APEC and NMEC strains were categorized as negligible biofilm 
producers than any other category of biofilm (38.6 and 37.5%, respectively, Figure 2.2). 
AFEC and HFEC isolates produced more low-level biofilms than any other category of 
biofilm formation (54.5 and 44.1%, respectively). Additionally, HFEC produced more 
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high-level biofilms than the isolates from any other subpathotype or commensal group 
(14.7%, Figure 2.2).  
 
 
Figure 2.3: Optical Density of ExPEC and Commensal E. coli Strains. 
Biofilm formation relative to the ExPEC commensal and subpathotype classification and 
media: M63 (red), 1/20 TSB (green), and BHI (blue). The mean OD600 is plotted; error 
bars represent ± standard error of mean. 
 
Associations between biofilm formation by E. coli and host 
Since APEC and NMEC showed significant OD differences in M63 broth, we 
attempted to determine if there were differences between E. coli isolated from chickens 
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(APEC and AFEC) or humans (NMEC, UPEC, HFEC). Interestingly, no significant 
differences were observed between strains isolated from the two hosts, suggesting that 
biofilm formation is not associated solely with the host origin of the strain 
(Supplementary Figure 2.2).  
 
Associations between Clermont’s original phylogenetic groups and biofilm 
formation 
Significant differences were observed between the ODs of each isolate classified 
by Clermont’s original phylogenetic groups when all E. coli were compared in M63 broth 
(KW, p=0.0055, Figure 2.4). The OD of phylogenetic group B2 showed significantly 
greater biofilm formation than phylogenetic group A (HSD, p=0.0131, Figure 2.4). The 
majority of phylogenetic group A strains were found to be significantly different (χ2, 
p=0.0172) than the other E. coli when the level of biofilm production was examined. A 
majority of group A isolates produced negligible biofilms (55.6%, Table 2.2). There were 
no significant differences between groups B2 and B1 or D since a greater prevalence of 
these isolates produced moderate or high-level biofilms at 43.5, 41.3, and 27.9%, 
respectively among the isolates examined (Table 2.2). 
Like M63, significant differences were observed between all E. coli grown in 
diluted TSB (KW, p=2.999E-3, Figure 2.4). When the ODs of phylogenetic groups B1 
and B2 were examined, these groups demonstrated significantly greater biofilm 
formation than phylogenetic group A (HSD, p=0.01084 and p=8.366E-3, respectively). 
When the biofilm level of phylogenetic group B2 was compared to others, it was 
significantly different (χ2, p=0.0183) than the other phylogenetic groups, and 45.7% of 
group B2 produced low or moderate biofilms (Table 2.2). 43.5% of phylogenetic group 
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B1 isolates produced moderate or high biofilms while the majority of phylogenetic group 
A and D isolates produced negligible biofilms (75.6 and 62.3%, respectively, Table 2.2). 
Phylogenetic groups A, B2, and D were statistically different from the other 
phylogenetic groups (χ2, p=0.0047, p=0.0240, p=0.0367, respectively) in BHI when their 
biofilm levels were assessed. The majority of phylogenetic group A isolates (75.6%) 
produced negligible or low-level biofilms (Table 2.2). Phylogenetic group B2 isolates 
(60.9%) formed more low-level biofilms than any other group. Phylogenetic group D 
strains (31.1%) produced more moderate level biofilms than phylogenetic groups A, B1, 
or B2 (Table 2.2). 
 
Associations between Clermont’s revised phylogenetic groups and E. coli biofilm 
formation 
A Kruskal-Wallis test based on the ODs of each isolate classified by Clermont’s 
revised phylogenetic typing scheme identified significant differences among the revised 
phylogenetic groups and strains grown in M63 (p=1.627E-5). The OD of phylogenetic 
groups A and F were less than groups B2 or E (p values in Supplementary file, Figure 
2.5). The ODs of phylogenetic group C compared to any different phylogenetic group 
were not significant, but the difference between group C and E was suggestive of a 
possible difference (p=0.0527). When their biofilm levels were compared to the 
remaining isolates using the χ2 test, phylogenetic groups A, E, and F were significantly 
different (p=0.0243, p=0.0290, p=0.0024, respectively, Supplementary table 2.2). In 
M63, phylogenetic groups A and F overwhelmingly produced negligible biofilms, (60 
and 67.9%, respectively, Figure 2.6). In contrast, phylogenetic group E was the most 
prolific biofilm former with 58.8% of isolates forming moderate or high biofilms (Figure 
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2.6). Of the other phylogenetic groups, 50% of phylogenetic group D isolates formed low 
biofilms, and 57.1% of phylogenetic group C isolates formed negligible biofilms (Figure 
2.6). The majority of phylogenetic group B2 isolates (65.8%) produced low or moderate 
biofilms (Figure 2.6). 
 
Table 2.2: Chi-square Discrete Categorization of E. coli by Clermont’s Original 
Phylogenetic Groups*. 
 M63  
 Negligible Low Moderate High p 
A 55.6% 17.8% 15.6% 11.1% 0.0172 
B1 21.7% 34.8% 39.1% 4.3% 0.0847 
B2 21.7% 37.0% 23.9% 17.4% 0.0803 
D 39.3% 32.8% 18.0% 9.8% 0.7572 
      
 1/20 TSB  
 Negligible Low Moderate High p 
A 75.6% 13.3% 6.7% 4.4% 0.0644 
B1 47.8% 8.7% 17.4% 26.1% 0.0750 
B2 45.7% 23.9% 21.7% 8.7% 0.0183 
D 62.3% 18.0% 4.9% 14.8% 0.2369 
 BHI  
 Negligible Low Moderate High p 
A 46.7% 28.9% 11.1% 13.3% 0.0047 
B1 34.8% 34.8% 21.7% 8.7% 0.9032 
B2 21.7% 60.9% 13.0% 4.3% 0.0240 
D 26.2% 39.3% 31.1% 3.3% 0.0368 
      
* Percentages may not add up to 100.0% due to rounding. Bolded values indicate p  < 
0.05. 
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Figure 2.4: Optical Density of E. coli isolates as Designated Using Clermont’s 
Original Phylogenetic Groups.  
Biofilm formation relative to Clermont’s original phylogenetic typing scheme and media: 
M63 (red), 1/20 TSB (green), and BHI (blue). The mean OD600 is plotted; error bars 
represent ± standard error of mean. 
 
Like M63, a Kruskal-Wallis test based on the OD of tested isolates and 
Clermont’s revised phylogenetic typing scheme identified significant differences in 
diluted TSB (p=4.501E-7, Figure 2.5). The ODs of the different phylogenetic groups 
revealed phylogenetic groups A and F were characterized by significantly lower biofilm 
ODs than other phylogenetic groups with higher optical densities observed for B1, B2, D, 
and E (HSD, p-values in supplementary file, Figure 2.5). Phylogenetic group C was not 
statistically different from any group. When the level of biofilm formation was 
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determined via k-means clustering, phylogenetic groups A, B1, and B2 were all 
significantly different from the other phylogenetic groups (χ2, p=0.0161, p=0.0176, 
p=0.0078, Figure 2.6, Supplementary table 2). A majority of isolates classified as 
phylogenetic groups A, C, D, and F produced negligible biofilms (88.0, 66.7, 50, and 
78.6% respectively, Figure 2.6). 50.0 and 41.2% of isolates from phylogenetic groups B2 
and E produced low and moderate biofilms, respectively (Figure 2.6). Isolates identified 
as phylogenetic group B1 produced more high-level biofilms than any other group in 
diluted TSB (31.8% of isolates examined, Figure 2.6). 
In BHI, phylogenetic groups A and B2 were statistically different from groups 
other than themselves (χ2, p=0.0001 and p=0.0258, Supplementary table 2.2). 56% of 
phylogenetic group A isolates produced negligible biofilms while 63.2% of phylogenetic 
group B2 isolates produced low-level biofilms (Figure 2.6). For phylogenetic group E, 
47.1% of the isolates examined formed low-level biofilms (9.1%, Figure 2.6). 
 
Discussion 
In extraintestinal pathogenic E. coli, there is substantial morbidity and mortality 
associated with urinary tract infections and neonatal meningitis in humans as well as 
colibacillosis in avian hosts. The suffering and costs associated with diseases caused by 
ExPEC are undoubtedly significant (3, 4). Therefore, we assessed the associations 
between APEC, NMEC, UPEC, AFEC, and HFEC with biofilm formation using the 
crystal violet phenotype assay. Additionally, we examined the genetic similarity of the 
bacterial isolates tested and their ability to form biofilms using Clermont’s original and 
revised phylogenetic typing schemes. Although previous work has been done surveying 
biofilm formation in APEC and AFEC (20), NMEC and HFEC (22), UPEC (21), and E. 
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coli derived from raw meat and eggs (40), this study is the first to examine biofilm 
formation across the subpathotype and commensal groups under standardized conditions, 
and the work presented demonstrates a novel, unbiased way to classify biofilms in a high 
throughput manner. 
In order to classify biofilm formation, we utilized a machine learning-based 
clustering methodology to remove human bias in classifying the negligible, low, 
moderate, and high biofilm forming groups. The four biofilm categories used in this 
study were selected to allow for comparison with the earlier work of our lab reported by 
Skyberg et al. (20). We believe this method to be advantageous to other methods 
previously used to distinguish the relative formation of biofilms as we do not classify 
biofilms by an author drawn cutoff or use a standard deviation system from the control 
wells (20-22, 31, 40, 41), yet we do note that the approach presented may classify isolates 
slightly differently than previous methods. In a recent study by Mitchell et al. (41), 94% 
of ExPEC-like E. coli were found to produce biofilms in Luria-Bertani medium. These 
numbers differ significantly from our strain classifications here, but these E. coli strains 
were assayed in round-bottom 96-well plates. Additionally, the E. coli strains were 
reported to be isolated from meat and eggs, not ill avian or human hosts (41). These 
isolates had their subpathotype identified based on the presence or absence of genes 
associated with virulence or phenotypic differences. The current study classified the 
pathotype based on the source of the original isolate and the presence or absence of 
disease, similar to literature precedent (20, 21, 42). Therefore, APEC isolates were 
isolated from diseased birds while NMEC and UPEC were isolated from cases of 
neonatal meningitis or urinary tract infections in humans. AFEC and HFEC isolates were 
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obtained from avian or human hosts, respectively, which did not demonstrate apparent 
disease.  
 
 
Figure 2.5: Optical Density of E. coli isolates as Designated Using Clermont’s 
Revised Phylogenetic Groups.  
Biofilm formation relative to Clermont’s revised phylogenetic group and media: M63 
(red), 1/20 TSB (green), and BHI (blue). The mean OD600 is plotted; error bars represent 
+/- standard error of mean. 
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Figure 2.6: Prevalence of Biofilm Formation by E. coli classified using Clermont’s 
Revised Phylogenetic Groups in Each Medium.  
Cumulative percentage of negligible (red), low (green), moderate (blue), and high 
(purple) biofilm forming isolates by Clermont’s revised phylogenetic groups. The 
significant differences between groups are shown in Supplementary Table 2.2.  
 
Interestingly, when we tested ExPEC isolates, we found our results to be 
analogous to previous work with ExPEC sensu stricto. For NMEC, it has previously been 
reported that approximately 77.4% of isolates form biofilms in Luria-Bertani broth, and 
52.8% of isolates form biofilms in a minimal medium (22). Although we did not test the 
nutrient-rich Luria-Bertani medium, we did find that a majority (68.8%) of NMEC 
formed biofilms in a minimal medium, yet the majority of these biofilms were classified 
as low-level biofilms (53.1%). Likewise, Skyberg et al. found that the majority of APEC 
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(range 53.3-98.1%) and AFEC (range 56.3-83.4%) formed “none/weak” biofilms in M63, 
1/20 TSB, and BHI (20). We concur that a majority of APEC (range 70.4-84.1%) and 
AFEC (range 60.6-84.8%) produce negligible and low biofilms in all media tested, but 
we found that the production of moderate- or high-level biofilms was slightly greater 
when compared with Skyberg et al. (20).  
Like APEC and NMEC, subtle differences were observed for UPEC strains when 
they were examined based on their biofilm classification and previously reported studies. 
Soto et al. found 40-43% of UPEC produce biofilms (21) while the current study found 
that 37.5% of UPEC produced moderate- or high-level biofilms in minimal medium. 
Nevertheless, the similarity of biofilm production among these ExPEC, even with slightly 
different methods of biofilm classifications between studies, gives us confidence in 
utilizing a k-means clustering methodology for biofilm classification. 
To our knowledge, this is the first time an unbiased cluster analysis-based 
approach has been used to classify biofilm formation, yet machine learning clustering 
techniques have been used to examine other biological systems such as sensing 
contamination in the food industry (43, 44) and identification of bacteria responsible for 
urinary tract infections (45). Nevertheless, there are limitations to clustering techniques 
as biological systems can be variable and statistical significance can be lost. When we 
performed the statistical Mann-Whitney test on the continuous optical densities of the 
isolates, UPEC was significantly different than the other E. coli tested in diluted TSB. 
However, discretization of the data occurred when the E. coli were sorted into the four 
biofilm levels, and significance was lost. Even with a loss of significance, the sorting of 
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E. coli into the four classes of biofilm production is central to deliberation and reflection 
regarding similarities and differences among strains. 
 
Potential impact of subpathotypes and pathogenesis on biofilm formation 
In M63 medium, APEC and NMEC were significantly different from the other E. 
coli when their biofilm levels were categorized. The bulk of APEC and NMEC strains 
were classified either as negligible or low biofilm producers while UPEC, AFEC, and 
HFEC strains could not be differentiated. The limited biofilm production of the APEC 
and NMEC subpathotypes and the inability to separate E. coli based on their host of 
isolation (human or avian) leads to further evidence that APEC may be a zoonotic 
pathogen (6, 27, 46).  
Although UPEC could not be differentiated from AFEC and HFEC in M63 broth, 
it had statistically greater ODs in diluted TSB than the other E. coli tested. Undoubtedly, 
the ability of UPEC to produce biofilms is well-documented (21, 47). It is well-known 
that virulence factors associated with the adhesion of UPEC in the host include the F1C, 
P, S, and Type I pili as well as the Dr adhesins (3, 48). If the ability to produce biofilms 
promotes adherence by UPEC, the negligible or weaker biofilms produced by APEC and 
NMEC may be expected as expulsion from the urinary tract is not a major impediment to 
their ability to cause disease. Nevertheless, the UPEC selected for this study may have 
been inadvertently selected by the ability to survive in a urinary catheter as the isolates 
studied here were isolated from hospitalized patients; survival in a catheter presumably 
may be aided by a biofilm. Unfortunately, there is no way to ascertain whether these 
isolates were isolated from urine or urinary catheters.  
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Interestingly, both groups known to reside in the intestinal tract, AFEC (69.7%) 
and HFEC (82.4%), produce more biofilms in the rich medium, BHI. A different gut 
dwelling E. coli pathotype, enteroaggreative E. coli (EAEC) has also shown an ability to 
produce robust biofilms in BHI (49), suggesting that E. coli of the gut may be more 
suited to biofilm production in nutrient-rich conditions.  
 
 Association between phylogenetic typing and biofilm formation 
In Clermont’s original typing scheme, E. coli strains were subtyped into four 
groups: A, B1, B2, and D (23). Original phylogenetic group A isolates are found as 
commensals in the human gut (50), in sediment environments (51), or as pathogens in 
poultry (29). However, phylogenetic group A may be best known for containing the 
laboratory strain MG1655 K12 (52). When the ability to produce biofilms was examined 
for phylogenetic group A isolates, a majority of isolates formed negligible biofilms in 
each media, the only group to do so in all three media types. While group A and B1 have 
been proposed to be sister clades (53) and have been shown to be inversely related in 
some aquatic environments (54), group B1 produced more high-level biofilms than any 
other group in diluted TSB. Group B1 has been shown to occur more often than group A 
in aquatic environments during high temperature seasons, and the production of biofilms 
could promote adhesion to surfaces in these warmer temperatures (54). Phylogenetic 
group B2 has long been known as a group containing many human pathogens, including 
NMEC (22, 29), UPEC (7, 21, 29), and strains belonging to irritable bowel disease 
patients (55). Phylogenetic group B2 had significantly different biofilm levels than the 
other groups in media that was more nutrient rich—diluted TSB and BHI (Table 4). In 
these media, B2 isolates produced more biofilms than any other group. Finally, 
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significant differences for group D occurred solely in BHI as group D produced more 
moderate level biofilms than any other group. While classification of the isolates by 
Clermont’s original phylogenetic typing scheme yielded interesting results, the scheme 
was revised in 2013 as a means to better classify some of the inconsistencies in the 
original typing scheme. We include the scheme here as a means to interpret the potential 
influence of the original phylogenetic group for research already completed. 
In 2008, Gordon et al. found that 80-85% of the phylogenetic group memberships 
assignment under Clermont’s original scheme were correct with assignment to groups B1 
and B2 correct for 95% of assignments (56). Therefore, the scheme was revised in 2013 
to include E. coli specific groups that are used to classify E. coli: A, B1, B2, C, D, E, F, 
and Clade I (24). Logue et al. (2017) found significant phylogenetic group changes when 
classification of ExPEC and commensal E. coli strains were examined using the new 
phylogenetic typing scheme (29). In APEC and UPEC, significant changes were 
observed from groups A to C and D to E or F (29). In NMEC, group D isolates changed 
to group F (29). Upon our re-categorization according to Clermont’s revised phylogenetic 
typing scheme (24), we found E. coli isolates of group E to be the most prolific producers 
of biofilms in minimal medium. Unfortunately, little is known about group E, but it may 
consist of pathogens such as diarrheagenic E. coli (57). Unlike phylogenetic group E, 
group F produced the lowest optical density, suggesting poor biofilm capability in 
minimal and nutrient limited media under the conditions of this study. The relatively low 
production of biofilms by group F is thought-provoking as group F strains have been 
shown to contain relatively high numbers of virulence, resistance, and pathogenicity 
island associated genes when examined in E. coli stains isolated from poultry (29). The 
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B2 phylogenetic group has been suggested to be a sister group to phylogenetic group F 
(58, 59), but we found tested B2 strains were relatively good at producing biofilms in all 
media, significantly contrasting with group F. Thus, an investigation of the genetic 
differences between phylogenetic group B2 and F is warranted.  
 
Conclusion 
The work presented here is novel and uses a machine learning based approach to 
remove human bias in the classification of biofilms among a collection or ExPEC and 
their commensal counterparts. This study has also demonstrated that there was no 
significant difference between the E. coli isolates from animal and human hosts when 
they were not separated by commensal or subpathotype categories. When isolates were 
separated by their demonstrated pathogenesis in their respective host, biofilm production 
for APEC and NMEC was significantly different from other E. coli in M63 as these 
subpathotypes produced negligible or weaker biofilms. Interestingly, UPEC was a 
significantly better biofilm former than the other E. coli tested in diluted TSB. Clearly, 
further work is necessary to elucidate the mechanisms of pathogenesis and virulence 
factors of ExPEC that contribute to biofilm formation in moderate and high-level biofilm 
formers. When considering the prolific biofilm forming abilities of phylogenetic group E 
in M63, it is evident that more research is warranted to explore this relatively new 
phylogenetic group and its potential association with disease in human and animal hosts.  
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Supplementary Figures 
 
Supplementary Figure 2.1: Optical Densities of E. coli Strains by Media Type 
Biofilm formation relative to the media type with the mean OD600 plotted; error bars 
represent ± standard error of mean. 
 
99 
  
 
Supplementary Figure 2.2: Optical densities of E. coli classified from their host 
source 
Optical densities of E. coli classified from their source of isolation, human (blue) or avian 
(green), with the three different media types. 
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Supplementary Tables 
Supplementary Table 2.1: Chi-square Discrete Categorization of E. coli by 
Commensal and Subpathotype Groups*  
 M63  
 Negligible Low Moderate High p 
APEC 56.8% 13.6% 20.5% 9.1% 0.0064 
NMEC 31.3% 53.1% 6.3% 9.4% 0.0093 
UPEC 28.1% 34.4% 28.1% 9.4% 0.6007 
AFEC 27.3% 33.3% 24.2% 15.2% 0.6371 
HFEC 32.4% 23.5% 29.4% 14.7% 0.4956 
      
 TSB  
 Negligible Low Moderate High p 
APEC 65.9% 18.2% 6.8% 9.1% 0.5807 
NMEC 53.1% 18.8% 21.9% 6.3% 0.1619 
UPEC 43.8% 15.6% 15.6% 25.0% 0.0505 
AFEC 57.6% 21.2% 6.1% 15.2% 0.6197 
HFEC 73.5% 11.8% 8.8% 5.9% 0.2969 
      
 BHI  
 Negligible Low Moderate High p 
APEC 38.6% 36.4% 20.5% 4.5% 0.6064 
NMEC 37.5% 34.4% 21.9% 6.3% 0.7880 
UPEC 31.3% 40.6% 25.0% 3.1% 0.7300 
AFEC 30.3% 54.5% 9.1% 6.1% 0.2530 
HFEC 17.6% 44.1% 23.5% 14.7% 0.0835 
 
* Percentages may not add up to 100.0% due to rounding. 
Values in bold are significant to α < 0.05 
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Supplementary Table 2.2: Chi-square Discrete Categorization of E. coli by 
Clermont’s Revised Phylogenetic Groups* 
 
 M63  
 Negligible Low Moderate High p 
A 60.0% 16.0% 8.0% 16.0% 0.0244 
B1 18.2% 40.9% 36.4% 4.5% 0.0787 
B2 18.4% 39.5% 26.3% 15.8% 0.0717 
C 57.1% 19.0% 19.0% 4.8% 0.1900 
D 20.8% 50.0% 20.8% 8.3% 0.1274 
E 11.8% 29.4% 29.4% 29.4% 0.0291 
F 67.9% 14.3% 14.3% 3.6% 0.0024 
      
 1/20 TSB  
 Negligible Low Moderate High p 
A 88.0% 8.0% 0.0% 4.0% 0.0161 
B1 45.5% 9.1% 13.6% 31.8% 0.0176 
B2 42.1% 26.3% 23.7% 7.9% 0.0078 
C 66.7% 19.0% 14.3% 0.0% 0.3483 
D 50.0% 20.8% 8.3% 20.8% 0.4438 
E 47.1% 29.4% 11.8% 11.8% 0.5437 
F 78.6% 7.1% 3.6% 10.7% 0.1193 
      
 BHI  
 Negligible Low Moderate High p 
A 56.0% 16.0% 8.0% 20.0% 0.0002 
B1 36.4% 31.8% 22.7% 9.1% 0.7861 
B2 18.4% 63.2% 13.2% 5.3% 0.0258 
C 42.9% 38.1% 14.3% 4.8% 0.6573 
D 25.0% 33.3% 37.5% 4.2% 0.1456 
E 17.6% 47.1% 29.4% 5.9% 0.5465 
F 28.6% 50.0% 21.4% 0.0% 0.3986 
 
 
* Percentages may not add up to 100.0% due to rounding. 
Values in bold are significant to α < 0.05 
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Abstract 
 Neonatal Meningitis Escherichia coli (NMEC) is the second-leading cause of 
neonatal bacterial meningitis and is a subpathotype of the Extraintestinal Pathogenic E. 
coli pathotype (ExPEC), which includes Avian Pathogenic E. coli (APEC) and 
Uropathogenic E. coli (UPEC). Virulence factors associated with NMEC include outer 
membrane protein A (OmpA) and the type I fimbriae (FimH), which are also contained 
within APEC and UPEC. Outer membrane protein A (OmpA) contributes to the ability of 
Neonatal Meningitis Escherichia coli (NMEC) to cross the blood-brain barrier and to 
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persist in the bloodstream. OmpA has been suggested as a potential vaccine target for 
ExPEC, but the protein has different amino acid variants, which have the potential to alter 
the pathogenesis or virulence of strains or alter vaccine efficacy. OmpA is present in 
virtually all E. coli, but differences in its amino acid residues have yet to be surveyed in a 
large collection of E. coli as a community and within the ExPEC subpathotypes. 
Additionally, the relationship between the E. coli chromosome and OmpA 
polymorphisms has not been fully examined. Here, we surveyed publicly available 
OmpA sequences (n=493) and sequenced the ompA gene (n=399) from collections of 
ExPEC. Thirty-three different OmpA polymorphism patterns were identified. Often, 
these OmpA polymorphism patterns separated E. coli by their phylogenetic groups or 
sequence types. Among the ExPEC collection, nine polymorphism patterns were 
significantly associated with an ExPEC subpathotype. Additionally, the ExPEC 
subpathotype had fewer polymorphism patterns than publicly available E. coli and was 
thus, more conserved. The polymorphism patterns varied among the subpathotypes for 
phylogenetic groups A, B1, B2, and F.  
 
Introduction 
 
Members of the Extraintestinal Pathogenic Escherichia coli (ExPEC) pathotype 
are adapted for an extraintestinal lifestyle. ExPEC subpathotypes include Neonatal 
Meningitis E. coli (NMEC), Uropathogenic E. coli (UPEC), and Avian Pathogenic E. coli 
(APEC), which are named by the host system or species that they negatively impact (1, 
2). APEC, the causative agent of avian colibacillosis, is responsible for significant 
morbidity, mortality, and financial losses to the poultry production industry worldwide 
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(1). UPEC is the leading cause of uncomplicated and catheter-associated urinary tract 
infections in humans, and serious UPEC infections can result in pyelonephritis, 
potentially leading to sepsis or death (3). NMEC is the causative agent of 28-29% of 
neonatal bacterial meningitis cases (4, 5). NMEC-caused neonatal bacterial meningitis 
has a 33% mortality rate with survivors often suffering lifelong disability (5). Both 
common and distinguishing virulence factors among ExPEC subpathotypes are important 
to examine to explain the pathogenesis or virulence of the pathotype or subpathotypes. 
One virulence factor of particular interest in NMEC is OmpA, an outer membrane protein 
that promotes bloodstream survival and assists in crossing the blood brain barrier (6-8). 
The structure of OmpA assists in our understanding of the protein. Structurally, 
OmpA consists of eight membrane-spanning β-strands that form a β-barrel (9). The N-
terminal domain consists of the first 169 amino acids and was characterized by Patutsch 
and Shulz (10). The C-terminal domain was proposed to interact with the peptidoglycan 
layer (11), but it has yet to be crystalized (12). Nevertheless, it has been shown that 
OmpA can exist as a monomer or dimer and that the soluble C-terminal domain of OmpA 
is responsible for dimerization of the protein (12). The OmpA protein is known to form 
four extracellular loops that have been shown to exhibit residue patterns encoded by 
allelic variants in the ompA gene across the protein’s loops (13). These “alleles” have 
been described in previous works (13-15). Structurally, the loops of OmpA contribute to 
NMEC’s survival and entry into the human brain microvascular endothelial cells 
(HBMEC) by binding the Ecgp glycoprotein (16, 17). Gu et al. (2018) have suggested 
that the loops of OmpA might be a good vaccine target to prevent NMEC infection (18). 
OmpA also contributes to the binding and survival of NMEC in macrophages (19). 
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Additionally, the protein contributes to binding tropism by different types of E. coli (20) 
and acts as a receptor for bacteriophages (13, 14).  
While the contribution of OmpA to NMEC pathogenesis has been demonstrated, 
the importance of OmpA among other ExPEC subpathotypes, such as APEC and UPEC, 
as well as other E. coli pathotypes remains relatively unexplored. Indeed, OmpA is 
present in virtually all E. coli isolates, including commensal strains (14, 21). Is OmpA’s 
relationship to NMEC virulence unique and ascribable to certain polymorphisms? Are 
certain polymorphisms in OmpA unique to NMEC or other ExPEC? Answering such 
questions may give us new insight into ExPEC’s ability to cause disease and its 
evolution, host specificity, or tissue proclivity.   
This study assessed differences in OmpA amino acid sequences among the 
ExPEC subpathotypes and among a wide-variety of different E. coli. An issue that might 
complicate such an analysis is the lack of chromosomal relatedness of the E. coli strains 
being compared since ExPEC subpathotypes have different distributions of the 
phylogenetic groups (22). An association of chromosomal history and polymorphism 
patterns in a virulence factor has precedence as polymorphisms in the adhesin FimH, a 
virulence factor of ExPEC, appear to correspond with a phylogenetic group and increased 
virulence (23). Thus, in the present study, we examined OmpA amino acid sequences in 
different E. coli strains, as classified by their phylogenetic group, serogroups, sequence 
types, and ExPEC subpathotype. 
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Materials and Methods 
in silico Data Acquisition 
To assess phylogenetic similarities across E. coli from many sources, fully closed 
genomic sequences of E. coli were downloaded from the NCBI GenBank Escherichia 
coli Genome Assembly and Annotation report page (Supplementary Table 3.1). The 
downloaded genomes were phylogenetically typed with an in-house script (PhyloTyper), 
which was designed in reference to Clermont’s revised phylogenetic typing scheme (22, 
24). PhyloTyper assigns E. coli isolates to their original and revised phylogenetic groups 
and allows one nucleotide mismatch per primer. The ompA nucleotide sequences were 
obtained from the FASTA file of each genome by an in-house script named RoDTIS 
(Robust DNA Targeting in silico). RoDTIS returns FASTA files of the DNA region of 
interest when given primers in a Microsoft Excel® file. Both scripts and their 
documentation are available at https://github.com/nielsend. The distribution of 
phylogenetic groups for all isolates is shown in Table 3.1. The Warwick sequence types 
(STs) of the genomes from GenBank were obtained by the multi-locus sequencing typing 
(MLST) program based on PubMLST.org (https://github.com/tseemann/mlst) (25). The 
genomes tested (n=493), including their OmpA polymorphism patterns, GenBank 
accession numbers, and phylogenetic group are presented in Supplementary Table 3.1. 
 
ExPEC Strains and DNA Isolation 
A total of 399 ExPEC were used in this study. These 399 ExPEC were selected 
randomly from collections previously described (26-29). The ExPEC isolates were 
previously serogrouped through the Escherichia coli Reference Center (Pennsylvania 
State University) (27, 29), and all ExPEC isolates for which the ompA gene was 
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sequenced were phylogenetically grouped by Clermont’s revised phylogenetic typing 
scheme using previously described protocols (Table 3.1) (22, 26). The 399 ExPEC were 
streaked out onto MacConkey agar plates from -80 °C glycerol stock and incubated at 
37°C for 18-24 hours. Single colonies were selected and inoculated into 2 mL of Luria 
Bertani or Brain Heart Infusion broth. These were incubated at 37 °C for 18-24 hours. 
The cultures were centrifuged for two minutes at 37,000 x g, and the supernatant 
removed. The pellet was then resuspended in 200 uL of sterile water and placed in a 
heating block for 10 minutes at 100 °C before centrifugation to remove cellular debris. 
The supernatant containing the DNA was transferred to a clean tube and frozen at -20 °C 
until use. 
 
ompA Gene Amplification and Sequencing 
The ompA gene was amplified from each strain twice via PCR with two primer 
sets and PCR reactions (Supplementary Table 3.2). PCR conditions using a MasterCycler 
Gradient thermocycler (Eppendorf, Germany) were 94 °C for 3 minutes, followed by 30 
cycles of amplification (denaturation: 30 seconds at 94 °C, annealing: 30 seconds at 54 
°C, extension: 72 °C for 90 seconds), and a final extension at 72 °C for seven minutes. 
PCR products were confirmed on a 2% agarose gel in 1x TAE buffer. The PCR products 
were purified with ExoSAP-IT (Affymetrix) product to remove primers and remaining 
dNTPs according to the manufacturer’s instructions before both PCR products were 
Sanger sequenced at the Iowa State University DNA Sequencing Facility (Ames, IA).  
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Table 3.1: Phylogenetic groups of the ExPEC and publicly available E. coli 
chromosomes examined in this study. 
 Phylogenetic Assignment  
ExPEC Sequences A B1 B2 C D E F Unknown Total 
APEC 21 33 26 59 3 2 25 2 171 
NMEC 5 2 62 3 0 1 7 0 80 
UPEC 5 13 109 7 7 1 6 0 148 
ExPEC Total 31 48 197 69 10 4 38 2 399 
ExPEC Prevalence 7.8% 12.0% 49.4% 17.3% 2.5% 1.0% 9.5% 0.5% 100% 
 
Other Publicly 
Available  
E. coli Sequences 
49 102 98 165 23 5 49 2 493 
Prevalence 9.9% 20.7% 19.9% 33.5% 4.7% 1.0% 9.9% 0.4% 100% 
 
TOTAL 80 150 295 234 33 9 87 4 892 
Total Prevalence 9.0% 16.8% 33.1% 26.2% 3.7% 1.0% 9.8% 0.4% 100% 
 
in silico Analysis of ompA 
Nucleotide sequences of ompA from the above ExPEC strains and from GenBank 
(Supplementary Table 3.1) were imported into Geneious v. 10.2 (BioMatters LTD, 
Auckland, New Zealand), and the sequences were aligned using the Geneious aligner. 
The sequences were trimmed to 975 nucleotides for consistent length among all 
sequences and were translated in silico. Residues were aligned using the Geneious aligner 
with the Blosum 62 cost matrix, and non-unique residue polymorphisms relative to the 
consensus sequence were removed. Polymorphisms that occurred at any position fewer 
than three times among all OmpA sequences were interpreted as potential sequencing 
errors and subsequently excluded from the analysis. The resulting amino acid sequences 
were used as the polymorphism pattern strings. The polymorphism pattern strings were 
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imported into R for analysis, where the TidyVerse and ggplot2 packages were used to 
conduct analyses and generate figures (30, 31). 
 
Statistical analysis 
The Chi-square test of homogeneity was used to determine statistically significant 
differences among the different data sets. Significance for all statistical tests was 
determined at the α=0.05 level. 
 
Results 
The OmpA Protein Has Unique Polymorphism Patterns 
The analysis of the ompA sequences obtained from publicly available sequences 
and from the amplicons generated in the present study revealed 23 different predicted 
polymorphism sites for OmpA among the 892 E. coli strains examined (Figure 3.1A). 
The majority of OmpA polymorphisms are located within the C-terminus region or the 
loops of the protein, which have previously been designated as part of the 
linker/dimerization and N-terminal domains, respectively (Figure 3.1B). Previous studies 
have created naming schemes for certain OmpA polymorphisms, and we first used these 
schemes to explain our results. 
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Figure 3.1: Polymorphisms present in OmpA (3.1A) and their location within the 
OmpA protein (3.1B).  
(3.1A) The x-axis illustrates the relative location of the polymorphism, so individual 
polymorphisms can be identified. The orange and yellow bars beneath the polymorphism 
numbers indicate previous studies that the polymorphisms were identified for OmpA 
although these studies may not have completed analyses based on all the polymorphisms 
identified (13, 20). Polymorphisms identified in this study and the N-terminal and 
linker/dimerization domains examined are indicated by the two green bars, respectively. 
Any amino acid at one position that appeared fewer than three times was not included in 
the analysis. (3.1B) Structure of OmpA, represented by the black and blue line looping 
through the outer membrane, with amino acid sequence polymorphisms indicated at their 
approximate positions. The polymorphisms are numbered as in 3.1A. The OmpA 
structure shown is based on data presented in other work (10, 12, 20).  
 
Comparison of Previous OmpA Variant Naming Schemes to Our Collection 
Previously, Power et al. reported on the prevalence of two OmpA variants 
originally termed “alleles” that were identified as ompA1 and ompA2 (13). When OmpA 
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polymorphisms were examined in the dataset for these variations, positions 2-4, 6, 10, 
and 11-15, the results showed that 555/892 (62.2%) were one variant, the ompA1 allele, 
while 328/892 (36.7%) were another variant, the ompA2 allele (Figure 3.1A, Table 3.2). 
The clustering of the polymorphisms into two large groups of variants with this scheme 
was expected based on previous studies, but interestingly, 9/892 (0.9%) sequences did 
not belong to either of the two ompA variants, suggesting that although most of the 
isolates in the current dataset can be categorized, a subset of variants might require an 
additional or more informative classification. For known pathogenic E. coli, ExPEC 
sensu stricto, 210/399 (52.6%) isolates harbored the ompA1 variant, and 182/399 (45.6%) 
isolates contained the ompA2 variant.  
 
Table 3.2: Historic OmpA variant types 
Variant Loop 2 Loop 3 
ompA1 SVE SY----N 
ompA2 DNI APGASFD 
Variant types were described by Power et al. and Gophna et al. (13, 15). 
 
OmpA variants were further categorized by their outer loop polymorphism 
patterns and linker/dimerization domain polymorphism patterns by Liao et al. (2017) (20) 
resulting in the identification of more polymorphism patterns. Outer loop polymorphism 
patterns I-IV were characterized and named by the abundance of the loop patterns 
(polymorphisms 1-15 and 17, Figure 3.1) and the linker/dimerization domain was 
characterized by classification as α, ß, γ, and δ (polymorphisms 19, 21, and 23, Figure 
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3.1). In this study, to characterize polymorphisms in OmpA using this scheme, the outer 
loop and linker/dimerization domains were concatenated for the analysis and assigned 
identifiers indicated by combinations of Roman numerals and Greek letters. Table 3.3 
shows the overall prevalence of these patterns among all test strains examined by Liao et 
al. and includes our strains for comparison when the same classification approach was 
applied. However, a significant number of our isolates could not be classified, and a new 
classification scheme was developed for this work. 
  
Table 3.3: Liao et al. (20) polymorphism patterns identified by the total collection in 
this study and in Liao et al. 
Pattern Name Pattern This study 
(n=892) 
Liao et al. 
NSVES--VY----NHANG I-α 35.65% 29.50% 
NSVES--VY----NHATA I-δ 12.44% 2.60% 
PDNIA--VPGASFDNANG II-α 8.86% 20.50% 
PDNIA--VPGASFDHANG III-α 11.10% 7.70% 
PDNIA--VPGASFDHVTA III-γ 3.47% 1.30% 
PDNIA--VPGASFDHATA III-δ 9.30% 1.30% 
NSVES--FD----NHATA IV-δ 5.27% 1.30% 
DSVEAHNVT-ESENHANG V-α 0.78% 6.40% 
DSVES--FD----NHATA VII-δ 0.56% 0.00% 
Unassigned  12.57% 20.40% 
 TOTAL 87.43% 70.60% 
 
Using this revised classification scheme, 33 different patterns of polymorphisms 
were found in this study, and these patterns were named based on polymorphisms found 
in the N-terminal and linker/dimerization domains (Table 3.4, Figure 3.1A). Henceforth, 
letters A-X were used to indicate the N-terminal pattern, and 1-7 were used to indicate 
the linker/dimerization domain (Table 3.4). This new scheme classifies the OmpA 
polymorphisms detected in all of the isolates analyzed in this study.  
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Table 3.4: Polymorphism patterns for the different domains and their identifying 
names. 
Polymorphism  
Pattern 
C-terminal Region Dimerization 
Region 
Total 
Count 
ExPEC 
Count 
A3 DDNIIA--VPGASFDYHL AKNVG 3 2 
B3 DDNIIA--VPGASFDYNL AKNVG 3 0 
C3 DDNIVS--VPGVSTDYHL AKNVG 1 0 
D5 DDNIVS--VPGVSTDYHM AKTVG 1 0 
E3 DSVEVAHNVT-ESENWHL AKNVG 7 3 
F4 DSVEVS--FD----NYHM AKTVA 5 2 
F5 DSVEVS--FD----NYHM AKTVG 1 1 
G4 DSVEVS--VY----NYHM AKTVA 4 2 
G7 DSVEVS--VY----NYHM VKTVA 9 7 
H3 NDNIVA--VPGASFDYNL AKNVG 1 1 
I4 NDNIVS--VY----NYHM AKTVA 7 1 
J3 NSVAIS--VY----NYHM AKNVG 1 1 
K2 NSVEIS--VY----NYHM AKNVA 2 0 
K3 NSVEIS--VY----NYHM AKNVG 315 36 
K6 NSVEIS--VY----NYHM ARNVG 3 0 
L4 NSVEVS--FD----NYHM AKTVA 47 37 
L5 NSVEVS--FD----NYHM AKTVG 33 26 
M4 NSVEVS--VY----NYHM AKTVA 111 91 
M5 NSVEVS--VY----NYHM AKTVG 7 4 
N3 NSVKIS--VY----NYHM AKNVG 6 0 
O5 NSVKVS--FD----NYHM AKTVG 1 1 
P3 NSVQIS--VY----NYHM AKNVG 1 1 
Q3 PDDIVA--VPGASFDYHM AKNVG 1 1 
R4 PDNIIA--VPGASFDYHM AKTVA 83 39 
R5 PDNIIA--VPGASFDYHM AKTVG 27 8 
R7 PDNIIA--VPGASFDYHM VKTVA 31 24 
S3 PDNIIA--VPGASFDYNL AKNVG 15 4 
T3 PDNIVA--VPGASFDYHL AKNVG 1 1 
U3 PDNIVA--VPGASFDYHM AKNVG 92 69 
U1 PDNIVA--VPGASFDYHM AKNAG 6 6 
V3 PDNIVA--VPGASFDYNL AKNVG 64 31 
W2 PDNIVS--VPGASTDYHM AKNVA 1 0 
X7 PSVEVS--VY----NYHM VKTVA 2 0 
  n= 892 399 
C-terminal includes polymorphisms 1-18 as seen in Figure 3.1, and the 
linker/dimerization domain includes polymorphisms 19-23 also shown in Figure 3.1.  
114 
  
Phylogenetic Groups Can Explain Some OmpA Polymorphisms in Publicly 
Available E. coli Sequences 
Since E. coli’s assignment to phylogenetic group and content of polymorphisms 
reflect chromosomal structure, we hypothesized that there was a relationship between 
them. Indeed, many of the polymorphism patterns could be assigned to a single 
phylogenetic group (Figure 3.2), suggesting a relationship between OmpA 
polymorphisms and chromosomal history. However, certain OmpA polymorphism 
patterns (I4, K3, L4, L5, R4, R5, S3, U3, V3) were detected among several phylogenetic 
groups (Figure 3.2), with the K3 pattern having the least phylogenetic affiliation. When 
the K3 pattern was examined, it was composed of phylogenetic groups A (12.5%), B1 
(24.4%), C (49.8%), F (12.5%), and Unknown (0.7%), which suggests that some 
polymorphism patterns cannot be associated with one major phylogenetic group. 
Interestingly, the E3 pattern, which does not correlate to either the ompA1 or 
ompA2 variant (Table 3.1), was found only in E. coli assigned to phylogenetic group E 
(Figures 3.2 and 3.3). Within this unique pattern several amino acid residues differed on 
the third loop of OmpA, resulting in an insertion of two amino acids at polymorphism 
number 7 and 8 (Figure 3.1). While all other predicted OmpA sequences contained Gly-
Ala-Ser-Phe (encoded by the ompA2 variant) or a deletion (ompA1 variant), pattern E3 
had a unique variant--Glu-Ser-Glu, a change that is predicted to result in a more acidic 
protein. Some amino acid residues that differ for this pattern are residues 11-14 (Figure 
3.1).  
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Figure 3.2: OmpA amino acid polymorphism patterns (x-axis) as associated with 
Clermont’s revised phylogenetic groups for the E. coli strains analyzed in the 
present study that were accessed from GenBank (n=493). 
Some polymorphisms patterns represent more than one phylogenetic group (y-axis). Any 
polymorphism pattern that occurred fewer than two times was excluded from the 
analysis. 
 
Although the entire polymorphism pattern can be informative, the N-terminal and 
C-terminal domains of the protein differed in their ability to represent the phylogenetic 
groups. Despite the observed differences in its N-terminal domain (described above), 
phylogenetic group E contains the most common linker/dimerization domain pattern 
(AKNVG), which is also seen predominantly in phylogenetic groups A, B1, C and F 
(Figure 3.3A). Nevertheless, E. coli assigned to phylogenetic groups A, C, E, and F also 
exhibited other patterns such as ARNVG, AKNVA, and AKTVA (Figure 3.3).  
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Figure 3.3: OmpA of E. coli strains from GenBank (n=493) can differ by their 
phylogenetic group (x-axis) when examined between the (3A) linker/dimerization 
domain and (3B) N-terminal domain. 
Polymorphism patterns are based on polymorphisms of Figure 3.1A. Any polymorphism 
pattern that occurred fewer than two times was excluded from the analysis. 
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Polymorphisms among the E. coli assigned to the B2 phylogenetic group were of 
particular interest when examining the linker/dimerization domain (Figure 3.3A). 
Members of this phylogenetic group primarily possessed the AKTVA pattern, a pattern 
also found in some members of phylogenetic group F. Additionally, members of the B2 
phylogenetic group contained the AKTVG pattern, a pattern shared with E. coli assigned 
to phylogenetic groups E and all group D isolates. Phylogenetic group B2 was also the 
only group to be composed of the VKTVA pattern. Members of this phylogenetic group 
harbored more polymorphism patterns than any other group. 
When the N-terminus patterns were analyzed (Figure 3.3B), K was the most 
frequent variant observed, occurring in phylogroups A, B1, C, F and unassignable.  In 
addition, groups A and B1 also shared the S and V polymorphism patterns. Like the 
linker/dimerization domain of E. coli assigned to phylogenetic group B2, the N-terminal 
of group B2 was the most diverse among all protein sequences examined, and shared 
similarities with the group D isolates and a minority of those assigned to phylogenetic 
group F (Figure 3.3B). 
Although the linker/dimerization and N-terminus polymorphism patterns could 
differentiate a significant number of phylogenetic groups, a single polymorphism could 
occasionally indicate assignment to the phylogenetic group. For example, the N-terminal 
PDNIVA--VPGASFDYNL (pattern V, Table 3.4, Figure 3.3B) was most closely 
associated with phylogenetic group B1, but this pattern was differentiated from other 
patterns by polymorphisms at positions 17 and 18, where histidine and methionine were 
replaced by asparagine and leucine (Figure 3.1 and Table 3.4). Likewise, phylogenetic 
group B2 dimerization polymorphism patterns were more likely than the other 
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phylogenetic groups to have a threonine and alanine replace an asparagine and glycine at 
polymorphism locations 21 and 23, respectively (Figures 3.1, 3.3B and Table 3.4). 
Interestingly, sequences assigned to phylogenetic group D may be an evolutionary 
“bridge” between phylogenetic group B2 and the other phylogenetic groups as 
polymorphism patterns of phylogenetic group D had a threonine and glycine at the 21 and 
23 polymorphism locations, respectively (Figures 3.1 and 3.3). Likewise, a majority of 
group F had a threonine at position 21. The location of these polymorphisms may be 
functionally important to the protein as polymorphisms 21 and 23 are part of the 
linker/dimerization domain (Figure 3.1) (12). However, in the current study, phylogenetic 
group classification could not fully explain the differences in amino acid residues in 
OmpA as polymorphism patterns K3, R5, S3, and U3 were associated with three or more 
phylogenetic groups. 
 
Some OmpA Polymorphism Patterns Indicate Sequence Type for Publicly Available 
E. coli Sequences 
We also probed for relationships between the occurrence and type of OmpA 
polymorphisms in publicly available E. coli with assignment to Sequence Types (STs). In 
order to make these assignments, MLST was performed in silico on the publicly available 
sequences (n=493) (31), and several STs could be identified by their polymorphism 
patterns. Notably, E. coli assigned to the ST131 group were characterized by a unique 
OmpA polymorphism pattern (Figure 3.4). Since the relationship between polymorphism 
patterns and virulence on the greater E. coli community could not be assessed fully due to 
a lack of known information about all of the publicly available isolates used, only the 
OmpA of ExPEC isolates of known provenance could be examined. 
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Figure 3.4: Association of polymorphism patterns with Warwick sequence types (x-
axis) for publicly-available E. coli (n=493) (25). 
 
Polymorphism Patterns Can Vary with the ExPEC Subpathotype 
 The distribution of nine polymorphism patterns were found to be statistically 
different among APEC, NMEC, and UPEC (Figure 3.5). APEC were more likely to 
exhibit OmpA polymorphism patterns K3, L5, U1, U3, and V3; whereas, UPEC were 
most likely to exhibit patterns L4, M4, R4, and R7. The majority of NMEC contained 
OmpA polymorphism pattern M4, but NMEC also had a greater relative prevalence of 
polymorphism patterns R4 and R5 than one or more of the other subpathotypes (Figure 
3.5). It was also noted that some polymorphism patterns were far less likely to be 
associated with ExPEC subpathotypes. When the ExPEC polymorphism patterns were 
compared to those that were publicly available, polymorphism patterns B3, C3, D5, G4, 
I4, K2, K6, N3, W2, and X7 were absent or were present fewer than two times for the 
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ExPEC group (Figures 3.2 and 3.5). The ExPEC, however, contained pattern U1, a 
pattern correlated with APEC, that was absent from GenBank. Although the majority of 
these differences were statistically significant, the composition of the phylogenetic 
groups within the ExPEC subpathotypes differs (26). Therefore, the polymorphism 
patterns of APEC, NMEC, and UPEC were analyzed against the phylogenetic groups. 
 
 
Figure 3.5: Polymorphism patterns (x-axis) and prevalence (y-axis) of each pattern 
for APEC (n=171), NMEC (n=80), and UPEC (n=148). 
Any polymorphism pattern that occurred fewer than two times was excluded from the 
analysis. Polymorphism patterns G7, L4, L5, M4, R4, R5, R7, U3, V3 are statistically 
significant between the subpathotypes (p <0.05).  
 
Polymorphism Patterns are Associated with ExPEC of Different Subpathotypes and 
Phylogenetic Groups 
As found amongst all the publicly available E. coli sequences examined, the 
phylogenetic groups of the OmpA protein sequences discovered among our ExPEC 
collection could on occasion be predicted by OmpA polymorphism pattern (Figure 3.6). 
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The linker/dimerization domains were examined for the phylogenetic groups, and there 
were distinctions among the subpathotypes (Figure 3.6A). Phylogenetic groups A and B1 
were unanimously composed of the AKNVG dimerization polymorphism pattern. The 
dimerization pattern for phylogenetic group C included an additional unique dimerization 
pattern, AKNAG, and this pattern was only found in APEC. There were also differences 
in the linker/dimerization domains of B2 as NMEC and UPEC contained the unique 
polymorphism pattern VKTVA, which was absent from APEC. However, it should be 
noted that the majority of NMEC and UPEC belong to phylogenetic group B2 (Table 
3.1).  Phylogenetic group F consisted of AKTVA and AKTVG. This differed greatly 
from E. coli in the GenBank collection, as the majority polymorphism pattern was 
AKNVG followed by AKTVA (Figures 3.3A and 3.6A). The ExPEC assigned to group 
B2 were more conserved than the B2 group in the GenBank collection as AKTVG was 
absent (Figures 3A and 6A). It is well-known that a majority of APEC belong to 
phylogenetic group C (26), so it was not surprising to find that APEC had a second 
polymorphism pattern in this group compared to NMEC, as shown by the two 
linker/dimerization domain patterns AKNAG and AKNVG (Figure 3.6A). Nevertheless, 
UPEC did have a different pattern within phylogenetic group C as shown by its two N-
terminal domain patterns (K and U). 
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Figure 3.6: ExPEC subpathotypes polymorphisms differ across the phylogenetic 
groups (facetted plots) by their (6A) linker/dimerization and (6B) N-terminal 
domains 
Polymorphism patterns are based on polymorphisms of Figures 1A. Any polymorphism 
pattern that occurred fewer than two times was excluded from the analysis. 
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 When the N-terminal domain pattern was examined, differences between the 
ExPEC subpathotypes were evident for some of the phylogenetic groups (Figure 3.6B). 
Important subpathotype differences in OmpA polymorphisms were found in ExPEC 
assigned to the B2 and F phylogenetic groups. The UPEC phylogenetic group B2 had a 
greater diversity of polymorphism patterns, and APEC had a different N-terminal domain 
pattern in phylogenetic group F compared to NMEC and UPEC. The unique N-terminal 
domain pattern of phylogenetic group F in APEC was also found in the GenBank 
collection where this pattern was found in the B2, D, and F phylogenetic groups. Data 
presented in Figures 3.3 and 3.6 illustrate that the ExPEC pathotype has a relatively 
conserved OmpA compared to the publicly available E. coli as ExPEC sensu stricto 
appears to have fewer polymorphism patterns in its C-terminal region. Likewise, the 
ExPEC phylogenetic groups consistently contained fewer patterns than their GenBank 
counterparts. 
 
OmpA Polymorphism Patterns are a Relatively Poor Indicator of Serogroup 
Subpathotypes of ExPEC have historically been analyzed by their serogroups, 
which are based on serologic identification of O-antigens (1, 29, 32). Currently, 187 O-
antigen groups are recognized. Here, we only examined ExPEC of serogroups O1, O2, 
O8, O18, O25, O75, O78, and O83, that is, those commonly found in the different 
ExPEC subpathotypes (27, 33-35). The O8, O75, and O83 serogroups were composed of 
one dimerization pattern (Figure 3.7A). The N-terminal of O75 strains consisted of a 
single pattern, pattern L (Figure 3.7B). Additionally, the relationship between the 
serogroups and phylogenetic groups was examined in this study. ExPEC of the O75 and 
O83 serogroups (n=12, 9, respectively) were found only in members of the phylogenetic 
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group B2, while all other ExPEC examined were assigned to multiple phylogenetic 
groups (Supplementary Figure 3.1). Although there is some overlap between the 
phylogenetic groups and serogroups, the serogroups do not appear to predict phylogenetic 
group assignment.  
 
Discussion 
Nomenclature and Distribution of OmpA Polymorphisms among E. coli Sequences 
In this study, ExPEC were more likely to contain the ompA2 allelic variant 
compared to the greater E. coli community that was examined. Previous work by Power 
et al. demonstrated that the ompA2 variant differs between humans and non-domesticated 
vertebrate animals in Australia (13). Experimentally, E. coli with the ompA2 variant have 
been shown to be more resistant to bacteriophages (13). If this observation is 
generalizable to other E. coli, then a majority of the ExPEC may be more resistant to 
bacteriophages than the greater E. coli community as a whole.  
When the phylogenetic groups were examined relative to the allelic variant-typing 
scheme in this study, phylogenetic group E was found to contain an alternate variant to 
ompA1 and ompA2. Previous work has shown that human and avian E. coli pathogens 
and commensals belonging to phylogenetic group E are prolific biofilm formers (28). 
Additionally, experimental evidence has shown that OmpA is important for biofilm 
formation (36-38). Together, these observations suggest that an alternate variant may 
contribute to the success of early biofilm development in E. coli assigned to phylogenetic 
group E. 
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Figure 3.7: Polymorphism differences occur between the ExPEC subpathotypes (x-
axis) when separated by their serogroups (facetted plots). 
The polymorphisms of the (7A) linker/dimerization and (7B) N-terminal domains were 
examined. Any polymorphism pattern that occurred fewer than two times was excluded 
from the analysis. 
126 
  
Re-classifying OmpA 
Structurally, OmpA consists of the N-terminal, linker, and dimerization domains 
(12). Previous work has indicated that OmpA is partially present as a dimer, and the 
dimer interface for the protein is located on the soluble C-terminus and has been named 
the dimerization domain (12). The C-terminal domain also contains a peptidoglycan-
associated motif (39). Next to the dimerization domain is the linker domain (12). The 
region, not part of the linker/dimerization domain, referenced throughout this study as the 
N-terminal domain, has also been shown to have biological relevance. The N-terminal 
domain consists of both loops and transmembrane regions (10, 13-15). These loops 
influence the action of OmpA as a receptor for bacteriophages and adhesion and invasion 
of the brain microvascular endothelial cells of the blood brain barrier (13, 16, 40). In 
contrast to findings reported by Gophna et al., we found the C-terminal domain was less 
highly conserved than previously reported, as distinct polymorphisms occurred in this 
region (15). As such, we thought it important to classify OmpA based on these regions, 
rather than on the variants of the loops (15) while also accounting for the diversity within 
the protein (20).   
When the identification scheme created by Liao was applied to the isolates of this 
study, certain polymorphism patterns were unrepresented (20). As a consequence, a 
significant number of our isolates could not be classified, and a new classification scheme 
was developed. The typing scheme used here has broad applicability to type different E. 
coli OmpA protein sequences as it was developed from nearly 900 different E. coli from 
a variety of sources.  
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Phylogenetic Groups and OmpA Polymorphisms in Publicly Available E. coli 
Sequences 
There is evidence that the E. coli of different phylogenetic groups harbor 
significant genomic differences. When Logue et al. (2017) examined the phylogenetic 
groups of avian pathogenic E. coli and avian fecal E. coli, distinct patterns were observed 
among the presence or absence of virulence genes and pathogenicity islands for some of 
the phylogenetic groups (26). However, the comparison also demonstrated patterns 
within the phylogenetic groups that could not be explained. When we examined the 
OmpA polymorphism patterns by phylogenetic group, B2 members were found to harbor 
more patterns than members of any other group. This finding may have particular 
significance since E. coli that cause extraintestinal disease in humans overwhelmingly are 
assigned to phylogenetic group B2 (26). More polymorphism patterns within the B2 
phylogenetic groups further highlights the complicated nature of the B2 phylogenetic 
group and its role in pathogenesis and hints to the vast ‘mix and match’ array of 
mechanisms by which ExPEC cause disease. In addition to the numerous polymorphism 
patterns for B2, there were differences in the polymorphisms among other phylogenetic 
groups.  
Like phylogenetic group B2, human pathogens are frequently assigned to 
phylogenetic groups D and F (26, 41). Thus, it was interesting to note a potential 
evolutionary “bridge” demonstrated within the linker/dimerization domain by the 
polymorphisms at positions 21 and 23 (Figure 3.1). Certain phylogenetic group D and F 
polymorphisms appeared to be intermediate steps between the polymorphisms of 
phylogenetic group B2 and phylogenetic groups A, B1, and C (Figures 3 and 6). 
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Sequence Types and OmpA Polymorphisms in Publicly Available E. coli Sequences 
Clinically, the ST131 group is considered an epidemic clone responsible for 
urinary tract infections and septicemia (42, 43). ExPEC of the ST131 group are 
associated with virulence, multidrug resistance, community-associated urinary tract 
infections, and sepsis (44). Indeed, this group of organisms is exceedingly important from 
a human health standpoint, as it is considered to be a pandemic clone (44). Considering 
the many utilities of OmpA, it is interesting that the E. coli of ST131 appears to contain a 
different polymorphism pattern, suggesting OmpA may have distinct pathogenic function 
in ST131 (Figure 3.4). Like ST131, other STs were composed of only one polymorphism 
pattern. ST95 consisted of a unique polymorphism pattern that was only shared with a 
group of untypeable MLST E. coli (Figure 3.4). Clinically ST95 is associated with 
bacteremia or neonatal sepsis (45). As such, OmpA may also have a distinct function in 
ST95 pathogens. Nevertheless, a potential pitfall of the differentiation of OmpA 
polymorphisms by STs is the sheer number of sequence types currently available—4,499 
STs (46). Prohibiting an ExPEC-specific MLST analysis is the current lack of 
comprehensive surveys of the sequence types among ExPEC isolates. Alternatively, 
OmpA evolution may occur at a similar rate to differences in the seven genes (adk, icd, 
fumC, recA, mdh, gyrB, and purA) that differentiate the STs (25).  
 
ExPEC OmpA Polymorphism Patterns 
The OmpA loops of NMEC have been experimentally shown to contribute to 
neonatal bacterial meningitis (16, 40). In 2010, Mittal et al. found that loops 1 and 3 are 
needed for NMEC survival in macrophages, loops 1 and 2 are necessary for meningitis, 
and alterations of loop 4 resulted in enhanced severity in NMEC’s pathogenesis (40). 
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Nevertheless, this study found no defining loop pattern for NMEC, which may suggest 
that an NMEC OmpA-targeting vaccine may not be widely efficacious (18). Like NMEC, 
the APEC and UPEC subpathotypes did not have defining patterns. There were, however, 
statistically significant differences between some of the polymorphism patterns and their 
ExPEC subpathotypes, which may agree with the assessment that certain subpathotype 
subsets can be eliminated as zoonotic pathogens (Figure 3.5) (29). Interestingly, the lack 
of any subpathotype-only differences also provides further evidence of a zoonotic 
potential of these organisms (32, 47-49). 
Previous work has demonstrated the ability of certain APEC to cause disease in a 
rat model of human neonatal meningitis and certain NMEC to cause disease in animal 
models of avian colibacillosis (47). Although this work has been an important ‘proof of 
concept’ of these subpathotypes’ zoonotic potential, the isolates tested were members of 
phylogenetic group B2, leaving out a number of other important APEC and NMEC 
phylogenetic groups. Indeed, NMEC OmpA studies have had a singular focus on E. coli 
assigned to group B2 (6, 17, 19). Since there are differences in OmpA within every 
subpathotype and among the different phylogenetic groups (Figures 3.5 and 3.6), the 
question remains if different OmpA polymorphisms contribute to functional differences 
in these organisms to be able to cause disease in a specific host species or tissue type. For 
example, do the ExPEC subpathotypes have different affinities for brain microvascular 
endothelial cells dependent on their different phylogenetic groups? Such questions will 
warrant future investigation.  
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Polymorphism Patterns Associated with ExPEC Subpathotype and Phylogenetic 
Assignment 
 Although the different ExPEC subpathotypes did have significantly different 
OmpA polymorphism patterns, these patterns were often most strongly associated with 
the phylogenetic groups. Interestingly, there were differences found between avian and 
human ExPEC for some phylogenetic group isolates. APEC belonging to phylogenetic 
group F had an N-terminus pattern unlike NMEC and UPEC (Figure 3.6). For isolates 
belonging to phylogenetic group C, UPEC had a unique N-terminus pattern, and APEC 
had a unique linker/dimerization domain. Although we cannot account for these unique 
differences, they may have the potential to confer some environmental or pathogenic 
advantage to the strain possessing them. 
 
Polymorphism Patterns of ExPEC when Examined by Serogroup 
Although OmpA is lodged in the outer membrane of E. coli, Gophna et al. also 
found that E. coli-associated sepsis strains of the serogroup O78 secreted OmpA during 
all growth phases (15). OmpA was secreted both as soluble proteins and in vesicles (50). 
There appears to be a benefit to the bacterium from doing so. That is, secreted OmpA 
provides protection to bacteria from degradation due to host neutrophil elastase through 
competitive inhibition (51). Due to the relative lack of UPEC and NMEC isolates of the 
O78 serogroup within our extensive collection, we could only draw conclusions based on 
APEC O78 isolates (Figure 3.7, n=43). Of these isolates, the majority (83.7%) had one 
linker/dimerization domain pattern and 90.7% of these isolates did share the same N-
terminal domain pattern (Figure 3.7B, pattern U). As there is not one conserved pattern 
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for all O78 strains, not all O78 strains may share these OmpA properties. Alternatively, 
other factors may influence the biological differences observed within the O78 serogroup.  
When the OmpA polymorphisms and serology of ExPEC were examined beyond 
serogroup O78, conserved patterns were observed for serogroups O75 and O83 (Figure 
3.7A), but all isolates with these serogroups typed to phylogenetic group B2. Therefore, 
we sought to identify the relationship between phylogenetic groups and serogroups, and 
we found that serogroups O75 and O83 were the only serogroups to fall within one 
phylogenetic group as the other serogroups (O1, O2, O18, O25, O78) were represented 
by multiple phylogenetic groups. Based on this information, it may be best to examine E. 
coli isolates through the lenses of several typing or subtyping schemes before interpreting 
data.  
 
Conclusion 
This study identified 23 unique polymorphisms and 33 unique polymorphism 
patterns in OmpA sequences of E. coli from different sources, hosts, environments and 
pathotypes. Numerous OmpA polymorphism patterns are associated with certain 
phylogenetic groups of E. coli, while other patterns may indicate specific differences 
among the ExPEC subpathotypes. Phylogenetic groups B2, D, and F have 
polymorphisms in their linker/dimerization domain, which may be of functional 
importance to the pathogenesis and virulence of E. coli. In addition to the phylogenetic 
groups, ST assignment appears to be associated with OmpA polymorphism patterns. 
Members of ST95 and ST131, which are strongly linked to disease, have OmpA 
polymorphisms not present in other sequence types. Further work is needed to 
demonstrate the biological significance of the OmpA polymorphisms identified here, but 
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this study is an important first step to demonstrating potential relationships between 
amino acid differences and their respective function in OmpA. 
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Supplementary Figures 
 
Supplementary Figure 3.1: Number of APEC, NMEC, and UPEC isolates in each 
phylogenetic group (x-axis) identified by serogroup (y-axis). 
 
Supplementary Tables 
Supplementary Table 3.1: Information on the GenBank sequences used in this 
study. 
Due to its large size, this table is available as a supplemental elsewhere for ProQuest. 
 
Supplementary Table 3.2: PCR Primers and Reagents 
Primer Set Polymerase Used Source 
GTTATCTCGTTGGAGATATTCATGG 
GCGGGGTTTTTCTACCAGAC 
USBtaq (Affymetrix) This 
Study 
CACTGGCTGGTTCGCTAC  
GCGGCTGAGTTACAACGTCT  
DreamTaq  
(Thermo Scientific) 
(20) 
 
138 
  
CHAPTER 4.    COMPLETE GENOME SEQUENCE OF AVIAN PATHOGENIC 
ESCHERICHIA COLI STRAIN APEC O2-211 
Modified from an article published in Microbiology Resource Announcements 
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Abstract 
Avian pathogenic Escherichia coli (APEC) is the causative agent of colibacillosis, 
a disease that affects poultry production worldwide and leads to multi-million dollar 
losses annually. Here, we report the genome sequence of an APEC O2-211, an ST117 
strain isolated from a diseased chicken.   
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Genome Announcement 
APEC O2-211 is a serogroup O2, sequence type 117 strain isolated from the air 
sac of a chicken clinically diagnosed with colibacillosis (1). APEC O2-211 is also present 
in the literature as APEC 211 or isolate number 820905 (1-3).  
 
 APEC O2-211 was stored at -80 ˚C in glycerol prior to sequencing, and the isolate 
was cultured on MacConkey agar. Next, a single colony was picked and grown in Luria 
Bertani broth at 37˚C. DNA was extracted using the Qiagen DNeasy Blood and Tissue 
genomic tip kit (Qiagen Hilden, Germany) for Pacific Bioscience (PacBio) sequencing 
and the ChargeSwitch gDNA mini bacteria kit (Life Technologies Carlsbad, CA) for 
Illumina sequencing. DNA yields were quantified using a Qubit fluorimeter dsDNA HS 
kit (Life Technologies Carlsbad, CA). The genomic library for MiSeq sequencing was 
prepared with the Nextera Flex kit (Illumina San Diego, CA), and the SMRTbell™ kit 
(Pacific Biosciences Menlo Park, CA) was used to prepare the genomic library for 
PacBio sequencing with BluePippin (Sage Science Beverly, MA) size selection to target 
a library size of 10 kb. 
 
Genomic sequencing was performed on the PacBio RSII (Pacific Biosciences, 
Menlo Park, CA)) and Illumina MiSeq (Illumina, San Diego, CA) instruments. Two 
SMRT cells were used for PacBio sequencing. The Illumina data were trimmed using 
Trimmomatic v. 0.36 (4) and assembled de novo using the SPAdes assembler v. 3.10.1 
(5). The Pacific Bioscience (PacBio) data were assembled with Canu v. 1.5 (6). Next, the 
PacBio assembly was circularized in Geneious v. 10.2.3 (7) and further corrected and 
polished once with paired Illumina reads utilizing Pilon v. 1.22 (Broad Institute) (8). 
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Potential contigs with plasmids were identified from both sets of sequencing data with 
the PlasmidFinder database (9) in ABRicate (https://github.com/tseemann/abricate). 
Protein-encoding genes and tRNA-carrying genes were assessed via Prokka v. 1.13 (10). 
A complete workflow and assembly reports can be found at 
http://github.com/nielsend/genomeassembly. 
 
 The genome of APEC O2-211 consists of a single chromosome, one large 
plasmid, and two small plasmids. The chromosome consists of 5,114,241 bp and 50.6% 
GC content. It encodes 89 tRNAs and contains 4,783 coding sequences. The large 
plasmid, pAPECO2-211A-ColV is a hybrid IncFIB/IncFIC plasmid. It consists of 
197,773 base pairs with 215 coding sequences and a 49.1% GC content. The two small 
plasmids pAPECO2-211B and pAPECO2-211C have 4,231 and 2,096 base pairs, 
respectively. Genomic comparisons of APEC O2-211 with other extraintestinal 
pathogenic E. coli (ExPEC) are ongoing. 
 
Accession Number(s) 
The chromosome and plasmids have been deposited in GenBank under the 
accession numbers CP006834, CP030791, CP030792, and CP030793. The PacBio and 
Illumina reads are available in the NCBI Sequence Read Archive (SRP158042). 
 
Acknowledgements 
We thank Dr. David Alt and Dr. Darrell Bayles (National Animal Disease Center, 
Ames, IA) for their assistance in sequencing and bioinformatics expertise, respectively. 
This work was supported by the Dean’s Office at Iowa State University’s College of 
141 
  
Veterinary Medicine and USDA ARS CRIS funds. Mention of trade names or 
commercial products in this article is solely for the purpose of providing specific 
information and does not imply recommendation or endorsement by the U.S. Department 
of Agriculture. USDA is an equal opportunity provider and employer. 
 
References 
1. Kapur V, White DG, Wilson RA, Whittam TS. 1992. Outer membrane protein 
patterns mark clones of Escherichia coli O2 and O78 strains that cause avian 
septicemia. Infect Immun 60:1687-1691. 
2. Nielsen DW, Klimavicz JS, Cavender T, Wannemuehler Y, Barbieri NL, Nolan 
LK, Logue CM. 2018. The impact of media, phylogenetic classification, and E. 
coli pathotypes on biofilm formation in extraintestinal and commensal E. coli 
from humans and animals. Front Microbiol 9. 
3. Logue CM, Wannemuehler Y, Nicholson BA, Doetkott C, Barbieri NL, Nolan 
LK. 2017. Comparative analysis of phylogenetic assignment of human and avian 
ExPEC and fecal commensal Escherichia coli using the (previous and revised) 
Clermont phylogenetic typing methods and its impact on avian pathogenic 
Escherichia coli (APEC) classification. Front Microbiol 8:283. 
4. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for 
Illumina sequence data. Bioinformatics 30:2114-2120. 
5. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin 
VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, 
Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly 
algorithm and its applications to single-cell sequencing. J Comput Biol 19:455-
477. 
6. Koren S, Walenz BP, Berlin K, Miller JR, Bergman NH, Phillippy AM. 2017. 
Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and 
repeat separation. Genome Res 27:722-736. 
7. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, 
Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond 
A. 2012. Geneious Basic: An integrated and extendable desktop software platform 
for the organization and analysis of sequence data. Bioinformatics 28:1647-1649. 
8. Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, Cuomo CA, 
Zeng Q, Wortman J, Young SK, Earl AM. 2014. Pilon: an integrated tool for 
142 
  
comprehensive microbial variant detection and genome assembly improvement. 
PLoS One 9:e112963. 
9. Carattoli A, Zankari E, Garcia-Fernandez A, Voldby Larsen M, Lund O, Villa L, 
Moller Aarestrup F, Hasman H. 2014. In silico detection and typing of plasmids 
using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents 
Chemother 58:3895-3903. 
10. Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 
30:2068-2069. 
 
143 
  
CHAPTER 5.    COMPLETE GENOME SEQUENCE OF THE MULTI-DRUG 
RESISTANT NEONATAL MENINGITIS ESCHERICHIA COLI SEROTYPE 
O75:H5:K1 STRAIN MCJCHV-1 (NMEC-O75) 
Modified from an article published in Microbiology Resource Announcements 
 
Daniel W. Nielsen1, Nicole Ricker2, Nicolle L. Barbieri3, James L. Wynn4, Oscar G. 
Gómez-Duarte5, Junaid Iqbal5, Lisa K. Nolan6, Heather K. Allen2, Catherine M. Logue3* 
 
1Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary 
Medicine, Iowa State University, Ames, Iowa 
2 Food Safety and Enteric Pathogens Research Unit, National Animal Disease Center, 
ARS-USDA, Ames, Iowa 
3Department of Population Health, College of Veterinary Medicine, University of 
Georgia, Athens, Georgia 
4 Departments of Pediatrics and Pathology, Immunology, and Laboratory Medicine, 
University of Florida, Gainesville, Florida 
5Division of Pediatric Infectious Diseases, Department of Pediatrics, University at 
Buffalo, The State University of New York, Buffalo, New York 
6Department of Infectious Disease, College of Veterinary Medicine, University of 
Georgia, Athens, Georgia 
 
  
144 
  
Abstract 
Neonatal meningitis Escherichia coli (NMEC) is the second-leading cause of 
neonatal bacterial meningitis (NBM) worldwide. Here, we report the genome sequence of 
a multi-drug resistant, NMEC serotype O75:H5:K1 strain mcjchv-1, which resulted in the 
death of an infant. The O75 serogroup is rare among NMEC isolates; therefore, this strain 
is considered an emergent pathogen.  
 
Genome Announcement 
Although NMEC is the second-leading cause of neonatal bacterial meningitis 
(NBM) after Group B streptococci, NMEC is responsible for the greatest mortality of 
NBM cases (1-3). The NMEC serotype O75:H5:K1 strain mcjchv-1 (NMEC-O75) 
described here was isolated from a 30-day old newborn with meningitis. The patient 
subsequently died of infection complications after 16 days of hospitalization despite 
appropriate antibiotic management (4). Although NMEC strains RS218 (5), CE10 (6), 
IHE3034 (7), NMEC O18 (8), and S88 (9) have been sequenced and are publicly 
available in the NCBI GenBank database, these isolates all belong to serogroups O7 and 
O18, and a depth of clinical information about the strains is not readily available. Here, 
we present the genome sequence of NMEC-O75, a clinical isolate with a previously 
published clinical history (4). 
 NMEC-O75 was grown on MacConkey agar and subsequently in Luria Bertani 
broth at 37˚C. Genomic DNA was extracted using the Qiagen DNeasy Blood and Tissue 
genomic tip kit (Qiagen Hilden, Germany) for Pacific Bioscience (PacBio) sequencing 
and the ChargeSwitch gDNA mini bacteria kit (Life Technologies Carlsbad, CA) for 
Illumina sequencing. DNA yields were quantified using a Qubit fluorimeter dsDNA HS 
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kit (Life Technologies Carlsbad, CA). The genomic library for MiSeq sequencing was 
prepared using the Nextera Flex kit (Illumina San Diego, CA).  
Genomic sequencing was performed on the PacBio RSII (Pacific Biosciences, 
Menlo Park, CA) and Illumina MiSeq (Illumina, San Diego, CA) instruments. Two 
SMRT cells were used for PacBio sequencing. The Illumina data were trimmed using 
Trimmomatic v. 0.36 (10) and assembled de novo using the SPAdes assembler v. 3.10.1 
(11). The Pacific Bioscience (PacBio) data were assembled with Canu v. 1.5 (12). Next, 
the PacBio assembly was circularized in Geneious v. 10.2 (13) and further corrected and 
polished with Pilon v. 1.22 (Broad Institute) (14). Potential contigs with plasmids were 
identified with the PlasmidFinder database (15) in ABRicate 
(https://github.com/tseemann/abricate). Protein-encoding genes and tRNA-carrying genes 
were assessed via Prokka v. 1.13 (16). A complete workflow can be found at 
http://github.com/nielsend/genomeassembly. 
The NMEC-O75 genome consists of a single chromosome, one large plasmid, and 
four small plasmids. The chromosome consists of 4,939,457 bp with 50.6% GC content. 
It encodes 91 tRNAs and contains 4,593 coding sequences. The large plasmid, pNMEC-
O75A, is a hybrid IncFIA/IncFIB plasmid. It consists of 88,420 base pairs and 50.6% GC 
content and contains 97 coding sequences. The four small plasmids pNMEC-O75B, 
pNMEC-O75C, pNMEC-O75D, and pNMEC-O75E range from 1,983 to 6,465 base pairs 
and have 42.6-56.1% GC content. Genomic comparisons of NMEC-O75 with other 
NMEC genomes are ongoing. 
 
146 
  
Accession Numbers 
The chromosome and plasmids have been deposited in GenBank under the 
accession numbers CP030111, CP030112, CP030113, CP030114, CP030115, and 
CP030116.  
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Abstract 
 Neonatal Meningitis Escherichia coli (NMEC) is the leading Gram-negative 
cause of neonatal bacterial meningitis (NBM), a disease that causes mortality in 15-40% 
of infected newborns and can result in permanent sequelae. Despite the clinical 
importance of NMEC, most research has been conducted on a single strain (NMEC strain 
RS218), and much remains unknown about the diversity of the vast NMEC subpathotype. 
To address this research gap, we sequenced, analyzed, and compared 49 clinical isolates 
with the publicly-available NMEC genomes (n=9). We found that all of the examined 
NMEC harbored two conserved genes, which encoded pseudopilins of a T2SS that were 
not found in K-12 strains MG1655 and W3110. Additionally, an analysis of conserved 
genes indicated that the NMEC subpathotype clustered into four different clades. The 
plasmid repertoire was also examined because of the importance of plasmids to NMEC 
virulence. The results showed that plasmid diversity in the NMEC subpathotype was 
greater than simply the IncFIB and ColV plasmids that have been previously shown to be 
associated with the NMEC subpathotype. Small Col plasmids were present within 50% of 
the surveyed isolates, but their biological importance remains unknown. Overall, strain 
RS218 is not representative of the diverse NMEC subpathotype, which suggests that 
potential virulence factors or mechanisms of pathogenesis may remain undiscovered 
without the examination of additional NMEC strains. 
 
Introduction 
 Neonatal meningitis Escherichia coli (NMEC) is a subpathotype of 
Extraintestinal Pathogenic E. coli (ExPEC), which also includes Avian Pathogenic E. coli 
(APEC) and uropathogenic E. coli (UPEC) (1-3). NMEC is the leading Gram-negative 
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cause of neonatal bacterial meningitis (NBM) and second-leading cause of NBM after 
Group B streptococci in developed countries (4). NBM results in a mortality rate ranging 
from 15-40%, but 30% of survivors suffer permanent sequalae such as deafness, epilepsy, 
or intellectual disability (4-7). A myriad of virulence factors have been reported to 
contribute to the virulence and pathogenesis of NMEC such as OmpA, FimH, CNF1, K1 
capsule, and IbeA (8-15). However, no known virulence factors are exclusive to the 
NMEC subpathotype. The virulence factors OmpA and FimH are present in virtually all 
E. coli, and the prevalence of virulence factors such as CNF1, IbeA, and the K1 capsule 
vary by study (16, 17). The NMEC subpathotype also shows diversity by E. coli typing 
schemes as NMEC isolates vary by phylogenetic group assignment and serogroup; there 
is no robust survey of the sequence type (ST) for the NMEC subpathotype. 
Of the seven E. coli-specific phylogenetic groups (A, B1, B2, C, D, E, and F), 
only NMEC belonging to phylogenetic groups B2 and F have been sequenced. NMEC 
phylogenetic group B2 strains that have sequenced chromosomes include IHE3034, 
NMEC O18, NMEC-O75 (MCJCHV-1), RS218, and S88, and the NMEC group F strain 
that has been sequenced is CE10 (18-22). Additionally, genomic assemblies for several 
other NMEC strains are now publicly available (23). Since some virulence genes, such as 
ibeA, are correlated with certain phylogenetic groups, an examination of the 
chromosomal diversity of NMEC is important, so virulence genes from the different 
phylogenetic groups are not overlooked (24). 
In addition to the NMEC chromosome, plasmids appear to contribute to the 
virulence of NMEC in vivo as shown by a pRS218, a large plasmid of the NMEC strain 
RS218 (25). IncF plasmids, especially IncFIB, are associated with the NMEC 
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subpathotype (26, 27). Historically, studies of plasmids in NMEC strains have primarily 
focused on large IncF plasmids and have shown that these plasmids encode genes for 
replication, iron-acquisition, protectins, and adhesins (26, 28). The presence of other 
replicons, such as the Col replicons, remains unexplored.  
 Here, we examine NMEC, using whole genome sequencing (WGS), to ascertain 
the diversity of the subpathotype as WGS provides better resolution than classical typing 
schemes. Such WGS resolution allows clarification of the composition of virulence-
associated genes and identification of plasmids present in the NMEC subpathotype. 
Additionally, WGS data may present potential virulence factors that would otherwise go 
unnoticed within the genomes of diverse NMEC isolates.  
 
Materials & Methods 
Bacterial Strain Selection and DNA Isolation 
Forty-nine NMEC isolates were randomly selected from a collection of 87 strains, 
which have been previously described, phylogenetically typed, and serogrouped (17, 28, 
29). DNA for short-read sequencing was extracted using a ChargeSwitch gDNA mini 
bacteria kit (Life Technologies Carlsbad, CA). DNA for long-read sequencing was 
extracted using a Qiagen DNeasy Blood and Tissue genomic tip kit (Qiagen Hilden, 
Germany) or the ChargeSwitch gDNA mini bacteria kit.  
 
Short-read sequencing and assembly 
Genomic library DNA was prepared using the Nextera XT kit (Illumina San 
Diego, CA) for 48 NMEC strains while one strain was prepared separately using the 
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NexteraFlex kit (Illumina San Diego, CA). The libraries were sequenced on an Illumina 
MiSeq Desktop Sequencer using the MiSeq Reagent Kit v2 for 500 cycles at the USDA 
National Animal Disease Center (Ames, Iowa). The resultant FASTQ files were assessed 
using FASTQC, trimmed using Trimmomatic v. 0.36 (30), and de novo assembled using 
the SPAdes Genome Assembler v. 3.10.1 (31). Assemblies were assessed with Quast (32) 
to determine contig sizes, N50, and assembly size (Supplementary Table 6.1).  
 
Long-read sequencing and assembly 
Thirteen of the 49 NMEC were sequenced via a Pacific Bioscience RSII 
sequencer at the Yale Center for Genomic Analysis (Pacific Biosciences Menlo Park, 
CA) for this study. The resultant reads were assembled de novo using Canu v. 1.5 (33). 
Canu assemblies were polished twice using paired-read data with Pilon v. 1.22 (Broad 
Institute, Cambridge, Massachusetts) (34). The workflow resembles that of previously 
completed ExPEC genomes (35, 36).  
 
NMEC Core Genome, Clades, and Virulence Factor Identification 
The 49 assembled isolates and publicly available sequences (n=9) were annotated 
using Prokka v. 1.13, and the core and pan genome assessed with Roary (37, 38). The 
resultant Roary files were used as input into FastTree to create a Maximum-Likelihood 
phylogenetic tree (37, 39, 40). The final phylogenetic tree was created with the 
Interactive Tree of Life (iTOL) v. 4.2.3 (41, 42). Conserved NMEC genes and NMEC 
clade groupings were obtained from the Roary output. ExPEC-associated virulence genes 
were also identified with ABRicate using a custom ExPEC-specific dataset 
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(github.com/nielsend/NMEC-genomics). The resultant data were analyzed and graphed in 
R using the tidyverse and ggplot packages, respectively (43, 44).  
 
Plasmid & Chromosome Visualization 
Potential plasmid contigs were identified by ABRicate using the PlasmidFinder 
database (45). These contigs were positively identified as plasmids via BLAST, 
circularized in Geneious (46), and annotated with Prokka v 1.13 (38). Plasmids larger 
than 10kbp and NMEC chromosomes were visualized with Blast Ring Image Generator, 
BRIG (47). 
 
Results 
 The ExPEC-associated virulence genes within the NMEC subpathotype were 
surveyed to determine if any virulence-associated genes were conserved within the 
NMEC genomes (Figure 6.1). Genes adhE, csgA, feoA, fimH, ibeC, ompA, potE, and 
umuC were detected in all NMEC genomes (n=58). However, these genes are present in 
most E. coli, like the fimH and ompA genes (48). Although not present in all NMEC 
genomes, genes present in the majority of the NMEC subpathotype included: adhesins 
(aslA, ibeB, matA, matB), iron-associated genes (chuA, feoB, fyuA, irp2, iucA, sitA), the 
toxin usp, plasmid-associated colicin V, protectins (bor, kps, ompT, and traT), and other 
genes (malX, potE, and speF).  When the percent identity of the genes was examined, 
csgA, ompA, and speE, which are genes that were always or nearly-always present, 
contained differences that could result in polymorphisms when translated (Figure 6.1). 
Invasin ibeA was also harbored by the majority of NMEC surveyed but at a lower 
prevalence than expected (53.4%); ibeA has long been defined as being associated with 
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the NMEC subpathotype (49-51). Taken together, the results suggest that the NMEC 
genomes have variation in their carriage of virulence-associated genes, and the NMEC-
associated gene ibeA is a poor indicator of the subpathotype. Nevertheless, the conserved 
genes of NMEC remains unexplored.  
 
NMEC Core Genome Has Two Genes Absent in MG1655 
A comparison of the NMEC genomes (n=58) with Roary resulted in the definition 
of a core genome of 2,531 genes (n>=57), including 550 soft-core genes (55 <= n < 57), 
and 12,570 genes present in fewer than 55 isolates (Supplemental Figure 6.1). 
Phylogenetic analysis of the NMEC core genome revealed that the strains tended to 
group by phylogenetic group, serogroup, or sequence type (Figure 6.2). The inclusion of 
these assignments demonstrates no classification scheme represents all of the NMEC. 
Indeed, Sequence types (ST) of NMEC showed no conserved clonal lineages were 
evident; STs 12, 62, 95, 390, 416, and 567 were identified (Figure 6.2).  The 
acknowledgement that NMEC is a diverse subpathotype is important to understanding 
how NMEC may cause disease.  
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Figure 6.1: Genomes of the NMEC subpathotype show diversity of virulence-
associated genes. 
ExPEC virulence-associated genes (x-axis) are harbored within the NMEC genomes (y-
axis) (1, 3, 16, 17, 52-55). All genes shown have both >=90% coverage and identity. The 
identity is shown from 90% (steel blue) to 100% (blue). Variants of the gene are 
indicated with an underscore and number (e.g. sitA_2). The ExPEC specific virulence-
associated gene sequences FASTA file is available at github.com/nielsend/NMEC-
genomics. 
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Unique core genes to NMEC relative to other E. coli strains may influence the 
pathogenicity of NMEC. Two genes contained within the NMEC core genome that were 
absent in E. coli MG1655, a derivative strain of the original E. coli K-12 isolated from a 
diphtheria patient in 1922, were identified (56, 57). These genes (xcpV and epsH) encode 
minor pseudopilin components of the type II secretion system (T2SS), as annotated in 
Pseudomonas aeruginosa and Vibrio cholerae (58). Further investigation of these genes 
revealed two E. coli homologues that are annotated as gspI and gspH, pseudopilins of the 
T2SS general secretory pathway (59). When all four genes were conceptually translated 
and aligned, approximately 24-25% identity between GspI and XcpV and between GspH 
and EpsH was observed. BLAST analysis revealed that the NMEC subpathotype always 
contained the epsH and xcpV genes, which were absent from MG1655 (Figure 6.3). To 
examine if this observation was unique to MG1655, E. coli strain W3110 was also 
included, and the genome displayed the same absence of epsH and xcpV and presence of 
gspI and gspH as MG1655 (Figure 6.3). Interestingly, gspI and gspH, which were found 
in the K-12 strains, were missing from 11 different NMEC. Every NMEC isolate 
assigned to the B2 phylogenetic group carried this T2SS, but the system was not B2-
specific, as NMEC strains belonging to other phylogenetic groups, such as A and C, also 
harbored the genes (Figures 6.2 and 6.3).  
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Figure 6.2: Maximum-Likelihood phylogenetic tree of NMEC core genome 
alignment. 
NMEC core genome phylogenetic tree with phylogenetic group (inner ring), serogroup 
(middle ring), and Achtman Sequence Type (outer ring) assignments shown around the 
outside of the tree. Serogroup O18ac is included in the serogroup O18 category. 
 
 The NMEC genomic regions encoding the T2SS genes were notably conserved in 
terms of flanking genes, but some variation was evident. The T2SS conserved within the 
NMEC subpathotype was flanked upstream by the glc locus, which is associated with 
glycolate utilization (60). However, there was variation downstream of the T2SS. In the 
majority of strains, virulence-associated capsule formation genes kpsM and neuA were in 
the downstream region. The non-conserved T2SS, carrying the gspI and gspH genes, was 
flanked upstream by ribosomal genes (rps and rpl) and downstream by bacterioferritin-
associated genes (bfr and bfd), a bifunctional enzyme with lysozyme/chitinase activity 
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(chiA), and elongation factors (tufA and fusA) (61-63). For NMEC isolates without the 
non-conserved (gspI and gspH) T2SS, the rps and rpl genes were present upstream of 
gspO, which was immediately upsteam of bacterioferritin genes (bfr and bfd). 
Interestingly, the gspO gene of the general secretory pathway was present, suggesting a 
deletion of the other gsp genes may have occurred. The differences presented among 
these T2SS genes represent a small fraction of the more than 15,000 genes that compose 
the NMEC subpathotype. 
 
 
Figure 6.3: Presence of the T2SS genes among NMEC and K-12 isolates (W3110 and 
MG1655. 
The genes xcpV and epsH are present in one secretion system in all NMEC genomes, and 
gpsH and gspI are present in a different secretion system that is less-conserved in NMEC 
but also present in K-12 strains.  
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NMEC Clades Contain Distinct Conserved Genes 
 An analysis of the pan-genome and a maximum likelihood phylogenetic tree 
revealed four distinct NMEC clades (Figure 6.4A). These four clades also reflect the 
other E. coli typing schemes with NMEC clade 1 consisting predominantly of serogroups 
O18 and O1; clade 2 predominantly consisting of O21; clade 3 predominantly consisting 
of O83; and clade 4 predominantly consisting of O7 and O12. Likewise, the sequence 
types (STs) of NMEC clade 1 were composed primarily of ST 95, ST 390, and ST 416; 
clade 2 is composed of ST 12; clade 3 is composed of ST567; and clade 4 are of the ST62 
type. However, not every serogroup or sequence type assignment matched the clade 
designation as the NMEC pan-genome derived clades offered better resolution of NMEC 
groupings.  
With the four clades derived, this study identified the genes conserved within 
each clade that were not conserved in the other clades (Figure 6.4B). The functions of the 
genes that the different clades contained was variable. Indeed, annotated functions of the 
genes included toxins, toxin-antitoxin systems, transporters, adhesins, porins, hemolysins, 
and OMPs as well as prophage, CRISPR-associated, and plasmid-associated genes (Table 
6.1). Although the influence these genes may have on virulence was not tested, some of 
these genes have the potential to be ExPEC virulence genes. NMEC clades 1, 2, and 3 are 
contained solely within phylogenetic group B2, but NMEC clade 4 consisted of a diverse 
collection of strains classified as the A, B1, C, D, E, and F phylogenetic groups (Figure 
6.4A). The comparative genomic analysis revealed that 255 genes were conserved among 
strains belonging to the B2 phylogenetic group, and these genes included transporters, the 
matA transcriptional regulator, adhesins, and toxin-antitoxin systems (Table 6.2). Specific 
genes of interest conserved within this group included imm, the phage T4 and colicin 
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immunity protein; kpsM, the polysialic acid transport protein; and mntB, the manganese 
transport system. Taken together, the genes conserved among clades 1, 2, and 3 adds to 
our knowledge of the virulence-associated B2 phylogenetic group. 
 
NMEC Chromosomes Are Important in Understanding Chromosomal Diversity 
Thirteen new draft and completed chromosomes allowed us to better visualize the 
NMEC chromosome with those already publicly available (n=6) (Figure 6.5). Notably, 
strain RS218 appears to have large regions not conserved in other NMEC strains (Figure 
6.5). Like RS218, other newly sequenced strains contain unique chromosomal regions 
relative to previously sequenced NMEC isolates; these chromosomes may assist in 
further studying the NMEC subpathotype (Table 6.3). 
 
The NMEC Subpathotype Harbors Unexpected Plasmids 
Analysis of the NMEC genomes, using ABRicate and PlasmidFinder, revealed that the 
majority of NMEC genomes contained the IncFIB plasmid replicon, and other Inc 
replicons included IncFII, IncFIC, IncI1, and IncB/O/K/Z (Supplementary Table 6.2, 
Figure 6.6). IncFIB plasmids are well-recognized as important to the virulence of NMEC 
(25, 28). Long-read sequencing was used to examine the plasmids of 13 NMEC strains 
beyond their replicons; the diversity of plasmids was striking when compared to 
reference NMEC plasmids as shown by pS88 (Figure 6.7).  
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Figure 6.4: NMEC clusters into four clades by the presence of conserved genes.  
 (6.4A) A maximum-likelihood phylogenetic tree of the core NMEC genome with the 
phylogenetic group (left), serogroup (center), and Achtman Sequence Type (ST; right) 
assignments shown. NMEC clades were defined as labeled by color overlaid on the 
NMEC strain names—clade 1 (red), clade 2 (blue), clade 3 (green), and clade 4 (purple). 
All nodes had bootstrap proportions greater than 70%, with the exception of the node 
indicated with a black triangle (6.4B) Non-hypothetical conserved genes to the specific 
clades in 6.4A (and not conserved in the other clades) are shown. Conserved genes for 
each clade are defined as genes present in >= n-1 for each grouping. 
 
(4A)
(4B)
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Table 6.1: Conserved genes unique to each clade with adhesins, toxins, iron 
regulation, and lipoproteins shown. 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
CRISPR-associated genes alpA: DNA-binding transcriptional regulator 
borD: Bacteriophage lambda 
Bor 
abgT: p-aminobenzyl 
glutamate: H+ symporter 
dinD: DNA-damaging inducible 
protein bfpA: Bundle forming pilus 
gadB: Glutamate 
decarboxylase B arsB: arsenite: H+ antiporter 
ehaG: Autotransporter adhesin ccdB: Toxin CcdB kilR: Inhibitor of FtsZ, killing protiein fecA: Ferric citrate OMP 
fliC: Flagellar biosynthesis intZ: Predicted integrase mec: CysO-cystein peptidase frv: PTS permease 
neuA: N-acylneuraminate 
cytidyltransferase 
ompT: Outer membrane 
protease VII 
mleN: Malate-2H(+)/Na(+) 
lactate antiporter hlyE: Hemolysin E 
ompW: Outer membrane 
Proteins 
symE: toxin-like protein of 
SOS psiB: Protein PsiB hyf: Hydrogenase 4 
Prophage genes wzzB: Regulator of O-antigen length 
repB: RepFIB replication 
protein iucC: Aerobactin synthase 
vgrG1: Actin cross-linking toxin ycgV: Putative adhesion & penetration protein 
scrB: Sucrose-6 phosphate 
hydrolase 
lsr: Autinducer-2 ABC 
transporter 
yadC: Putatitive fimbrial-like 
adhesin ydcM: Putative transposase tra: Tra genes 
pup: Putrescine: H+ 
symporter 
yafN: Antitoxin ydeQ: Putative fimbrial-like adhesin 
tsh: Putative adhesion & 
penetration protein 
puuD: Gamma-glutamyl-
gamma-aminobutyrate 
hydrolase 
yafO: mRNA interferase yjjL: Galactonate: H+ symporter yihN: YihN MFS transporter 
sfm: Putative fimbrial-like 
adhesin 
yddB: Putative porin protein  yjjM: Putative DNA-binding transcriptional regulator tisB: Toxic peptide 
ypjA: Adhesin-like 
autotransporter  ylpA: Lipoprotein 
yfeW: Penicillin binding 
protein 
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Table 6.2: Complete and draft chromosomes for 13 NMEC strains and reference 
chromosomes. 
ISOLATE CHROMOSOME SIZE %GC CLOSED CONTIGS 
PHYLOGENETIC 
GROUP SEROGROUP ST 
NM14 5,032,772 50.8%  1 C O7 - 
NM19 4,840,395 50.7%  2 B2 - 567 
NM20 4,902,218 50.6% X 1 D O7 362 
NM23 5,372,956 50.6%  1 F O7 62 
NM26 4,966,497 50.6% X 1 B2 O21 12 
NM27 5,034,177 50.8% X 1 A O12 10 
NM34 5,130,420 50.8%  2 F - 379 
NM45 4,889,182 50.7% X 1 B1 O23 453 
NM52 4,935,851 50.7% X 1 B2 O25 131 
NM55 4,911,895 50.9%  3 C O9 88 
NM73 4,829,265 50.9%  6 B1 O29 58 
NM83 5,221,029 50.8%  12 F O1 59 
NM84 4,735,582 50.6%  1 B2 O21 538 
CE10 5,313,531 50.6% X 1 F O7 62 
IHE3034 5,108,383 50.7% X 1 B2 O18 95 
NMEC 
O18 5,002,781 50.7% X 1 B2 O18 416 
NMEC-
O75 4,939,457 50.6% X 1 B2 O75 1193 
RS218 5,087,638 50.6% X 1 B2 O18 - 
S88 5,032,268 50.7% X 1 B2 O45 95 
Eight strains exist each as a sole contig. NMEC-O75 is also known as MCJCHV-1 or as 
its assembly, NM92. ST or serogroups with a (-) have a result of “untypeable”. 
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Figure 6.5: Complete or nearly-complete sequenced NMEC chromosomes relative to 
NMEC strain RS218. 
Regions of RS218 not present in the other plasmids are indicated in white. Chromosomes 
examined are ordered from the inner-most ring (purple-CE10) to the outer-most ring 
(dark pink-S88). 
 
NMEC Chromosomes
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Figure 6.6: Plasmid replicons within the NMEC genomes. 
The 58 surveyed NMEC genomes (y-axis) with the presence/absence and percent identity 
of replicons (x-axis) shown from 96% identity (light green) to 100% identity (dark 
green). All replicons included had greater than 96% coverage. Reference sequences 
IHE3034 and NMEC-O18 were both clinically isolated from newborns with plasmid 
sequences, but the DNA sequences of the plasmids have not been sequenced or publicly 
released (19).  
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Table 6.3: Large plasmids carried by NMEC isolates. 
Strain Plasmid Size 
(bp) 
%GC Closest Matching Replicon(s) Closed 
NM14 pNM14 142,785 49.4 IncFIB, IncFIC(FII) X 
NM19 pNM19 142,431 49.3 IncFII_1_pSFO_AF401292 
 
X 
NM20 pNM20 184,523 51.1 IncFIA, IncFIC(FII) X 
NM23 pNM23 54,545 49.3 IncFII(29)_1_pUTI89,  
Col156_1 
X 
NM26 pNM26 154,274 51.9 IncFII_1_pSFO,  
Col156_1 
X 
NM27 pNM27A 87,517 49.8 IncFIC(FII), Col156_1 
 
X 
 pNM27B 48,077 44.5 Unknown X 
NM34 pNM34A 74,865 51.7 IncFII(29)_1_pUTI89 X 
 pNM34B 74,564 50.2 IncFII_1_pSFO, Col156_1 
 
X 
 pNM34C 48,392 44.6 Unknown X 
NM45 pNM45 184,477 49.5 IncFIC(FII) X 
NM52 pNM52 148,714 48.2 IncFIC(FII) X 
NM55 pNM55A 155,907 51.3 IncFIB(AP001918), 
IncFIC(FII) 
 
 pNM55B 98,331 47.8 p0111_1 X 
 pNM55C 36,672 57.5 ColRNAI_1 X 
 pNM55D 30,736 59.3 Unknown  
NM83 pNM83A 82,041 53.3 IncB/O/K/Z_2 X 
 pNM83B 74,885 50.2 IncFII_1_pSFO, Col156_1 X 
 pNM83C 33,823 42.0 IncX1_1 X 
 pNM83D 18,573 46.8 Unknown  
NM84 pNM84 142,432 48.0 IncFII_1_pSFO X 
Some plasmids, pNM27A, pNM34C, pNM55D, and pNM83D did not match known 
replicons in PlasmidFinder, but they were included due to their close identity to other 
publicly available plasmids. 
 
Furthermore, plasmids of the same replicon type did not have large conserved 
regions among all plasmids with that replicon (Supplementary figures 6.2 and 6.3). In 
contrast to this, plasmids that carried colicin-V gene (cva) had large conserved regions 
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among NMEC ColV plasmids, even compared to prototypical ColV plasmids, like 
pAPEC-O2-ColV, and other APEC plasmids (Figure 6.8). ColV plasmids have long been 
associated with the ExPEC pathotype and disease (3, 64-67), and the plasmids are known 
to carry sit, tra, psi, cva, ets, iss, and eit virulence or virulence-associated genes (65). The 
association of ColV genes (cva) with ExPEC plasmid-and-virulence-associated genes can 
also be seen when all NMEC isolates were surveyed (Figure 6.1). However, non-ColV 
plasmids were also present within NMEC isolates (Table 6.4 and Figure 6.8). 
 Plasmids with unknown replicons were identified within the NMEC genomes. 
Plasmids pNM27B, pNM34C, pNM55D, and pNM83D had unidentifiable replicons, but 
they shared identity to publicly available plasmids as determined via BLAST (Table 6.4). 
These plasmids showed large regions of dissimilarity via BLAST when compared with 
previously sequenced NMEC plasmids (Figure 6.7). Plasmids pNM27B and pNM34C are 
closely related as both plasmids contained two shared regions that totaled approximately 
40kb, and these two regions predominantly contained hypothetical and phage-associated 
genes. Plasmid pNM55D was similar to the plasmids carried by different 
Enterobacteriaceae, including Klebsiella, Salmonella, Yersinia, Shigella, and Escherichia 
species. Plasmid pNM83D resembled plasmid pVR50D (CP011138.1), a plasmid isolated 
from a uropathogenic E. coli strain although pNM83D was approximately 10kb larger 
(68). The four plasmids with unknown replicons demonstrate the diversity of the larger 
NMEC plasmids, but they were smaller than other plasmids with the exception of the 
IncX and small Col plasmids (Table 6.4).  
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Figure 6.7: NMEC ColV plasmids are similar to each other and other APEC ColV 
plasmids, including the prototypical ColV plasmid pAPEC-O2-ColV (dark blue) 
(65). 
Regions of pS88 not present in the other plasmids are indicated in white. 
 
Along with the Inc replicons, Col replicons were detected in the NMEC 
subpathotype and were present in smaller plasmids that ranged in size from 
approximately 1.5-7.5 kb (Supplementary Table 6.2). The Col156 replicon was found in 
the most NMEC strains, followed by the ColpVC and Col(BS512) replicons (Figure 6.6). 
Nevertheless, when individual plasmids were examined, the ColRNAI_1 replicon was the 
most prevalent. NMEC 27 and SP5 contained the most small plasmids, with each 
carrying six different small plasmids of the Col156, ColRNAI, Col8282, Col(BS512), 
and Col(MG828) replicons.  
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Seventy plasmids were found among the 58 different NMEC strains when the 
small Col replicon-containing plasmids were examined (Supplementary Table 6.2). 
Interestingly, dependent on replicon type, these plasmids appeared to contain distinct 
contents. Nine ColRNAI plasmids ranging from 6.6-6.8 kbp carried the cea gene, which 
encodes colicin 10, a bacteriocin that results in the death of closely related strains (69, 
70). Similarly, five ColRNAI plasmids ranging from 5-6.8 kbp harbored neo and folP, 
genes associated with antibiotic resistance (71, 72). Plasmids with the Col156 replicon 
were likely to have the mobA gene. The small Col(MG828) plasmids often carried 
hypothetical proteins. Other genes identified included genes that encode 
methyltransferases and entry exclusion proteins. In the case that small plasmids were not 
present in a given NMEC strain, a Col replicon may be found within a larger Inc plasmid 
(Table 6.4). 
 
Discussion 
Extraintestinal pathogenic E. coli have been described as having a mix-and-match 
approach to virulence, and the prevalence of different ExPEC-associated virulence genes 
varied within the NMEC genomes (Figure 6.1). The work presented here recognizes the 
critical terminology “NMEC” as some NMEC were missing the K1 capsular antigen 
(Figure 6.1). The K1 capsular antigen was one of the first NMEC virulence factors 
described, and the subpathotype is occasionally referred to as E. coli K1 due to the 
presence of the capsular antigen (14, 73, 74). Likewise, the IbeA invasin, a well-known 
virulence factor of NMEC, was absent from approximately 47% of NMEC strains 
indicating that previous work, which typed E. coli as NMEC if the isolates contained 
certain ExPEC genes and both ibeA and kps, was likely incorrect (51). Similarly, cnf1, 
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which encodes the CNF1 toxin, was absent from a majority of strains examined, but the 
protein was previously reported to be of significant importance to NMEC’s ability to 
cross the blood-brain barrier (8). Genes csgA, ompA, speF, and usp had variable 
nucleotide identity among the genomes, suggesting that there were differences among the 
virulence-associated genes (Figure 6.1). Although work has been completed examining 
the polymorphisms of the OmpA protein of NMEC, csgA and speF remain unexplored in 
the NMEC subpathotype and warrant future examination (Nielsen et al., in preparation).  
 
NMEC Core Genome Harbors Two Unique Genes 
All NMEC isolates sequenced contained two genes that encode minor 
pseudopillins of the T2SS that were absent in the K-12 strains W3110 or MG1655 
(Figure 6.3). These psuedopilins form a pilus-like structure that bridges the periplasmic 
space between the inner and outer membrane, which allows for the secretion of proteins 
such as toxins, cellulases, phospholipases, lipases, and proteases (59). Indeed, the LT and 
CT toxins of enterotoxigenic E. coli and Vibrio, respectively, are secreted through T2SS 
(58, 59). EspH, the GspH homologue found within all NMEC, is hypothesized to form 
the tip of the T2SS’s pseudopilus, which allows EspH to interact with other proteins (57). 
Additionally, GspI, the XcpV homologue from enterotoxigenic E. coli, forms a trimeric 
complex with two additional proteins at the tip of the pseudopilus; this complex likely 
interacts with the T2SS components in the outer membrane (75). Nevertheless, ETEC and 
NMEC are not the only E. coli pathovars to contain a T2SS, strains MG1655 and W3110, 
along with other NMEC, contain another, different T2SS (Figure 6.3). Previous work on 
the T2SS of MG1655 has shown that the secretion system is rarely expressed, but in vitro 
experiments demonstrate the T2SS of MG1655 can promote chitinase secretion (59). The 
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lack of expression could explain the lack of pathogenesis seen by the K-12 strains 
surveyed (59). We hypothesize that this secretion system conserved within the NMEC 
may secrete virulence factors that assist NMEC in causing disease, but further 
investigation is required to determine its expression and ability to cause disease. 
 
NMEC Clades Have Sets of Conserved Genes  
 Serology has long been used to define the clonal groups of many bacteria (76, 77). 
E. coli consists of 187 different O-groups that are often used for typing (78). Likewise, 
clonal lineages of E. coli have been described through sequence typing or by broader 
phylogenetic groups that are correlated with the sequence types (79, 80). The 
identification of NMEC STs is important as the STs are often used to describe clonal 
pandemic ExPEC, especially uropathogens (Johnson et al., in review)(81, 82). Although 
NMEC do not appear to share a conserved Achtman sequence type, serogroup, or 
phylogenetic group, this study identified four characteristic clades (Figure 6.4A). The 
clades carry different conserved genes that have previously been underdescribed or 
undescribed in the literature. A significant number of these genes have the potential to 
contribute to the pathogenicity or virulence of NMEC as the genes encode fimbriae, 
toxins, toxin-antitoxin systems, symporters, antiporters, autotransporters, lipoproteins, 
metallo-regulatory proteins, and metabolic functions as well as numerous others like 
phage, CRISPR-associated, and regulatory genes.  
 Toxins contribute to the pathogenicity of many different E. coli pathovars (83), 
and toxin genes undescribed in NMEC are found in separate clades. Examples of genes 
annotated as toxins include vgrG1 (clade 1), symE and ccdB (clade 2), and tisB (clade 4). 
VgrG-1 is most well-known as a toxin of V. cholerae that cross-links actin and is secreted 
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by a T6SS (84). ccdB encodes a toxin that targets gyrases, E. coli protect themselves with 
ccdA, part of the toxin-antitoxin system. TisB targets the inner membrane of E. coli and 
results in persister cell formation when ciprofloxacin is administered (85, 86). Of course, 
other virulence factors also vary between the clades. Notably, bfpA, a pilus of 
Escherichia coli commonly associated with typical enteropathogenic E. coli, was 
conserved within the second NMEC clade (83, 87). 
 In addition to the underreported genes, the NMEC clades also encode different 
conserved genes for each of the groups associated with the virulence or pathogenesis of 
NMEC (Table 1). Clade 1 carries neuA, a gene involved in the regulation of sialic acid in 
the capsule of some NMEC (88). Clade 2 covers ompT, an outer membrane protease 
associated with the APEC and UPEC subpathotypes (53, 89). Clade 3 harbors tra, tsh, 
repB, and borD, plasmid-associated genes that have been well established in previous 
ExPEC literature (1, 26, 27, 53, 64, 66). Taken together, NMEC clades 1, 2, and 3 each 
carry conserved NMEC associated virulence factors, unlike clade 4. 
 NMEC have long been associated with phylogenetic group B2, and the majority 
of NMEC are classified to this phylogenetic group (Figures 6.2 and 6.4A). Therefore, it is 
unsurprising that NMEC clades 1, 2, and 3 are all contained within phylogenetic group 
B2. These groups contain 255 genes conserved to the B2 phylogenetic group compared to 
NMEC clade 4. Interestingly, this includes the polysialic acid transport protein (kpsM), 
the colicin-E7 immunity protein (imm) as well as numerous toxin-antitoxin systems (hip, 
yefM/yoeB, tabP, etc.), and other potential virulence factors (Table 6.2). Such results 
indicate unique properties of the NMEC B2 phylogenetic group. Indeed, Nielsen et al. (in 
progress) found that the B2 phylogenetic group was more likely to contain more 
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polymorphisms in the NMEC virulence protein Outer Membrane Protein A, encoded by 
ompA. Likewise, Logue et al. reported that the B2 phylogenetic group of ExPEC were 
more likely to contain virulence-associated genes or pathogenicity islands (29).  
In 2008, Johnson et al. found that a mixed cluster of APEC, NMEC, and UPEC 
had similar genotyping patterns (27). Likewise, Logue et al. demonstrated differences in 
phylogenetic group composition among the APEC, NMEC, and UPEC subpathotypes 
(29). The process by which NMEC causes NBM in newborns remains unknown, although 
transmission via the mother is expected (8). Even though APEC causes disease in birds, 
Tivendale et al. demonstrated that APEC could cause neonatal bacterial meningitis in a 
rat model (90). Although this may seem conflicting, it is possible that certain APEC and 
NMEC produce NBM through different mechanisms of the NMEC clades. For example, 
APEC that inflicted NBM in rats belonged to ST95, which resembled Clade 1 NMEC 
(90). Other subpathotypes may also have the ability to cause NBM in newborns. In 
addition to APEC O1, UPEC strains CFT073 and UTI89 resulted in a 0% survival rate 
when mice were subcutaneously injected with the strains (91). Likewise, adherent 
invasive E. coli (AIEC) strain LF82 resulted in a 40% survival rate when subcutaneously 
injected into mice (91). A significant number of AIEC belong to the O83 serogroup, 
which compose the majority of the third NMEC clade (91). Clearly, more research is 
warranted to elaborate on how certain pathotypes may cause disease in alternative hosts 
or niches.  
  
NMEC Chromosomes Publicly Available 
 Currently, there are six completed, publicly-available NMEC chromosomes—
CE10, IHE3034, NMEC O18, NMEC-O75 (MCJCHV-1), RS218, and S88. Of all these 
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isolates, only CE10 does not belong to phylogenetic group B2, as it is classified to 
phylogenetic group F. To further discussion on the importance of chromosomal diversity 
within the NMEC subpathotype, we submit 13 completed or nearly completed 
chromosomes to the scientific community (Table 6.3). These 13 isolates belong to 
phylogenetic groups A, B1, B2, C, D, and F (Table 6.3). Likewise, they ensure coverage 
of each of the NMEC chromosomal types (Figure 6.4A). Clade 1 is represented by 
NMEC O18, IHE3034, RS218, and S88; clade 2 contains NM26 and NMEC-O75 
(MCJCHV-1) (Figure 6.4A). Clade 3 includes NM19, NM52, and NM84, and clade 4 
consists of CE10, NM14, NM20, NM23, NM27, NM34, NM45, NM55, NM73, and 
NM83 (Figure 6.4A). Together, this results in a total of 19 completed or nearly 
completed NMEC chromosomes and 58 NMEC with sequencing data available (Figure 
6.4A, Table 6.3, Figure 6.5). With a diverse set of sequencing data, a toolbox of NMEC 
sequences may further spur exploration of the mechanisms by which this subpathotype 
causes disease. Comparative work on the abundance of now-available sequencing data is 
on-going. 
 
NMEC Replicons  
Tracing plasmids is of epidemiological importance as plasmids can contribute to 
the virulence and antibiotic resistance of their host (92). Plasmids can be identified and 
traced by their replicons via PCR or bioinformatically (45, 92). When the replicons 
within NMEC isolates were surveyed, the IncFIB replicon was the most prevalent (Figure 
6). Our result corresponded with previous work by Johnson et al. (2008) (93). 
Additionally, the IncFIB replicon has been associated with the APEC subpathotype (93, 
94).  
176 
  
 In addition to the well-recognized IncFIB and IncFII plasmid replicons, this 
study found a significant amount of Col replicons. These Col replicons were commonly 
found on small plasmids. Although previous ExPEC studies have sequenced these small 
plasmids, this study examined them in depth (18, 35, 36, 68, 95)(Johnson et al., in 
review). Examination of these plasmids is critical as these plasmids may contribute to 
virulence or have a direct impact on antibiotic resistance. Reducing antibiotic resistance 
is an important factor in decreasing the mortality rates of NMEC (96). Clearly, more 
work is needed to inspect these small plasmids in pathogenic E. coli. 
 When larger plasmids (18 – 185 kb) were examined, interesting differences 
emerged (Table 6.4). Previously, Nicholson et. al examined large NMEC virulence 
plasmids (97.8-157.2 kbp) and found these plasmids had a core genome composed of 
iroBCDEN, repA1, repA2, yubQ, etsABC, traA, traE, iucABCD, iutA, ompT, and iss (28). 
Here, we completed the plasmid sequences examined by Nicholson et al. including 
pNM14, pNM19, and pNM26 (28). Nevertheless, we also increased the number of 
NMEC plasmids studied from 11 to 25 plasmids. In addition to the plasmids with known 
replicons, we found the plasmids with unknown replicons to be of interest. More research 
is necessary to examine the plasmids within NMEC strains and the large number of 
hypothetical genes that they carry. 
 
Conclusion 
In this work, we present the largest NMEC genomic sequencing study to date, 
which examined both chromosomal and episomal sequencing data from 58 NMEC 
isolates. Clearly, the NMEC subpathotype contains a myriad of virulence factors, but 
there is also conservation present. NMEC had a core genome of 2,531 genes, and notably, 
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two of these 2,531 genes were not present in the surveyed K-12 E. coli. These two genes, 
epsH and xcpV are minor pseudopilins of the T2SS, which has been associated with the 
secretion of virulence factors (59). Four NMEC clades were also delineated from the pan 
genome, and these clades shared groups of conserved genes. Further investigation is 
needed to determine any potential role in virulence for conserved, shared genes within 
these clades. NMEC ColV plasmids were similar to previously sequenced plasmids, but 
non-ColV plasmids were also present, and they demonstrated diversity. Clearly, more 
work is needed to elucidate the mechanisms by which NMEC causes disease, investigate 
potential virulence factors, and discover the unknown functions of the many hypothetical 
genes carried on both the plasmids and the chromosomes. 
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Supplementary Figure 6.2: NMEC plasmids carrying the IncFIB replicon relative to 
IncFIB/IncFII plasmid pS88. 
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Supplementary Figure 6.3: NMEC plasmid carrying the IncFII replicon compared 
to IncFIB/IncFII plasmid pS88 
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Supplementary Tables 
Supplementary Table 6.1: Assembly statistics for sequenced E. coli strains & E. coli 
used in this study 
ID Contigs Large 
Contigs 
Largest 
contig 
Total length GC (%) N50 
 
Reference: 
NM02 366 313 167,007 5,221,299 50.65 38,937 
 
 
NM03 128 85 452,586 5,294,023 50.68 223,928 
 
 
NM06 471 346 59,743 4,970,648 50.93 23,613 
 
 
NM07 414 340 138,980 5,214,001 50.65 29,342 
 
 
NM08 87 55 692,599 4,930,509 50.55 266,757 
 
 
NM11 405 335 116,448 5,211,846 50.61 28,142 
 
 
NM14 192 155 283,036 5,069,131 50.68 92,889 
 
 
NM15 207 140 325,626 5,262,260 50.57 89,623 
 
 
NM16 120 76 447,594 4,930,996 50.56 158,443 
 
 
NM18 85 57 703,944 5,103,139 50.58 340,894 
 
 
NM19 147 85 335,651 4,910,728 50.61 119,227 
 
 
NM20 156 90 255,251 5,035,093 50.63 121,749 
 
 
NM22 159 107 262,317 5,221,462 50.71 118,099 
 
 
NM23 409 272 200,647 5,261,475 50.52 41,145 
 
 
NM26 202 112 266,868 5,056,013 50.55 99,233 
 
 
NM27 328 214 174,578 5,047,144 50.69 66,014 
 
 
NM28 141 100 524,611 5,196,498 50.71 136,288 
 
 
NM29 122 74 591,042 5,223,463 50.67 204,007 
 
 
NM30 197 117 402,789 5,244,771 50.66 148,034 
 
 
NM34 476 387 107,868 5,160,639 50.60 26,276 
 
 
NM35 377 235 231,126 5,143,349 50.61 52,674 
 
 
NM36 218 146 250,698 5,178,756 50.52 88,169 
 
 
NM37 151 91 716,672 5,198,133 50.58 245,330 
 
 
NM38 300 214 321,123 5,254,316 50.58 49,848 
 
 
NM40 129 78 349,493 5,088,706 50.40 139,412 
 
 
NM42 206 117 342,737 5,133,181 50.35 110,220 
 
 
NM43 96 68 703,696 5,194,812 50.57 235,940 
 
 
NM45 150 115 308,853 4,997,635 50.64 101,299 
 
 
NM49 87 60 573,840 4,960,651 50.50 178,842 
 
 
NM52 105 55 523,265 5,041,827 50.62 190,976 
 
 
NM55 120 94 364,763 5,106,997 50.71 155,215 
 
 
NM57 85 58 692,979 4,936,656 50.54 201,597 
 
 
NM59 106 73 860,775 4,999,874 50.54 213,069 
 
 
NM60 79 55 520,045 5,277,991 50.60 200,060 
 
 
NM65 85 53 692,823 4,947,064 50.58 211,011 
 
 
NM67 80 53 692,864 4,934,247 50.56 231,520 
 
 
NM70 116 78 507,247 5,156,348 50.56 334,505 
 
 
NM71 78 53 726,101 4,883,899 50.59 233,192 
 
 
NM72 111 70 438,761 5,034,529 50.52 233,612 
 
 
NM73 127 92 376,668 4,758,223 50.81 112,160 
 
 
NM74 371 227 215,018 5,446,521 50.53 70,198 
 
 
NM81 189 101 367,747 5,140,391 50.33 193,524 
 
 
NM82 145 82 423,515 5,186,924 50.54 237,199 
 
 
NM83 362 258 113,581 5,267,783 50.61 41,717 
 
 
NM84 60 37 585,795 4,844,018 50.52 298,373 
 
 
NM86 656 497 82,550 4,972,629 51.19 15,991 
 
 
NM89 134 87 487,548 5,159,155 50.65 267,731 
 
 
NM91 197 140 285,455 5,248,050 50.50 112,115 
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Supplementary Table 6.1. (continued) 
         
NM92* 112 76 510,962 4,998,284 50.57 196,353 
 
* 
CE10 5 - - - - - - (1) 
IHE3034 1 - - - - - - (2) 
NMEC-
O18 
1 - - - - - - (3) 
RS218 2 - - - - - - (4, 5) 
S88 2 - - - - - - (6) 
SP-4 50 - - - - - - (7) 
SP-5 204 - - - - - - (7) 
SP-13 108 - - - - - - (7) 
SP-46 193 - - - - - - (7) 
*NM92 is an assembly of the now completed genome Escherichia coli MCJCHV-1 
(NMEC-O75) (8). 
 
Supplementary Table 6.2: Small plasmids with Col replicons are present in NMEC 
genomes, and numerous strains have multiple plasmids. 
Strain Plasmid Size 
(bp) 
%GC Closest Matching Replicon Features 
NM02 pNM02-1 3257 47.2 ColRNAI_1 rop, yddM 
NM08 pNM08-1 6648 48.5 ColRNAI_1 mbeC, rop, cnl, 2 cea, mbeA, 4 CDS 
NM11 pNM11-1 4237 40.8 Col(MG828)_1 5 CDS 
 
pNM11-2 1552 51.8 Col(MG828)_1 2 CDS 
NM16 pNM16-1 4593 50.5 ColRNAI_1 rop, mbeC, mxibeA, CDS 
 
pNM16-2 1552 51.8 Col(MG828)_1 2 CDS 
NM19 pNM19-1 6211 52.5 ColRNAI_1 6 CDS, neo, folP 
 
pNM19-2 4715 41 ColRNAI_1 2 CDS 
NM22 pNM22-1 4315 43.7 ColRNAI_1 2 CDS, yhdJ 
NM23 pNM23-1 6888 48.6 ColRNAI_1 rop, mbeC, mbeA, cea, 3 CDS 
 
pNM23-2 5163 47.5 Col156_1 mobA, yibT, 3 CDS 
 
pNM23-3 1976 56.3 ColpVC_1 2 CDS 
 
pNM23-4 1549 50.9 Col(MG828)_1 CDS 
NM27 pNM27-1 6753 51.2 Col156_1 mobA, imm, cnl, 4 CDS 
 
pNM27-2 5631 47.4 ColRNAI_1 mbeA, mbeC, rop, 2 CDS 
 
pNM27-3 6647 48.6 ColRNAI_1 mbeA, mbeC, rop, cnl, cea, 3 CDS 
 
pNM27-4 4087 49.9 Col8282_1 repE, 4 CDS 
 
pNM27-5 2089 47.1 Col(BS512)_1 2 CDS 
 
pNM27-6 1552 51.9 Col(MG828)_1 1 CDS 
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Supplementary Table 6.2. (continued) 
NM28 pNM28-1 4593 50.5 ColRNAI_1 mbeC, rop, 3 CDS 
 
pNM28-2 1552 51.9 Col(MG828)_1 2 CDS 
NM34 pNM34-2 5181 47.1 Col156_1 yibT, mobA, 3 CDS 
NM35 pNM35-1 6780 46.9 ColRNAI_1 rop, mbeC, mbeA, cea, 3 CDS 
 
pNM35-2 2089 47.2 Col(BS512)_1__NC_010656_dupe 2 CDS 
 
pNM35-3 1593 56.6 ColpVC_1 1 CDS 
NM36 pNM36-1 3726 51.2 Col156_1 mobA, 2 CDS 
NM45 pNM45-1 6223 52.4 ColRNAI_1 neo, folP, 4 CDS 
NM49 pNM49-1 6222 52.5 ColRNAI_1 neo, folP, 5 CDS 
NM55 pNM55-2 4067 50.1 Col8282_1 mobA, CDS 
NM57 pNM57-1 6200 52.6 ColRNAI_1 neo, folP, 5 CDS 
 
pNM57-2 2443 46.4 ColRNAI_1 2 CDS 
NM67 pNM67-1 6211 52.5 ColRNAI_1 neo, folP, 6 CDS 
NM70 pNM70-1 5716 42.4 Col156_1 cmo, mobA, 4 CDS 
 
pNM70-2 5631 47.4 ColRNAI_1 rop, mbeA, mbeC, CDS 
 
pNM70-3 5295 47.6 Col156_1 yibT, mobA, 2 CDS 
 
pNM70-4 2934 43.6 Col(MG828)_1 2 CDS 
 
pNM70-5 1909 48.9 Col(MG828)_1 1 CDS 
NM74 pNM74-1 6647 48.6 ColRNAI_1 mbeC, rop, cnl, cea, mbeA, 3 CDS 
NM82 pNM82-1 6647 48.6 ColRNAI_1 mbeA, mbeC, cnl, cea, 3 CDS 
 
pNM82-2 5150 47 Col156_1 mbeA, mbeC, rop, 3 CDS 
NM83 pNM83-2 5631 47.4 ColRNAI_1 mbeA, mbeC, rop, 2 CDS 
 
pNM83-5 4066 50.1 Col8282_1 repE, 4 CDS 
 
pNM83-6 2073 48 Col(BS512)_1 2 CDS 
NM86 pNM86-1 6668 48.6 ColRNAI_1 mbeA, mbeC, cnl, cea, 3 CDS 
 
pNM86-2 5689 42.1 Col156_1 cmo, mobA, 4 CDS 
 
pNM86-3 5170 47.1 Col156_1 yibT, mobA, 4 CDS 
 
pNM86-4 4074 50 Col8282_1 2 CDS 
 
pNM86-5 1822 44.5 Col(MG828)_1 mobA, 1 CDS 
NM91 pNM91-1 5163 47.5 Col156_1 yibT, mobA, 4 CDS 
 
pNM91-2 4197 42.4 ColRNAI_1 rop, dcm, 3 CDS 
 
pNM91-3 1549 51.1 Col(MG828)_1 2 CDS 
NM92 pNM92-1 6465 42.6 Col(MGD2)_1 rop, toxN, 4 CDS 
 
pNM92-2 4082 49.4 Col8282_1 repE, 2 CDS 
 
pNM92-3 2113 47.1 Col(BS512)_1 2 CDS 
 
pNM92-4 1983 56.1 ColpVC_1 2 CDS 
 
192 
  
Supplementary Table 6.2. (continued) 
CE10 pCE10B 5163 47.5 Col156_1 mobA, yibT, 4 CDS 
 pCE10C 4197 42.4 ColRNAI_1 rop, dcm, 4 CDS 
 pCE10D 1549 51.1 Col(MG828)_1 1 CDS 
CE10 pCE10B 5163 47.5 Col156_1 mobA, yibT, 4 CDS 
SP5 PNYF02000089 6817 48.5 ColRNAI_1 mbeA, mbeC, rop, cea, 3 CDS 
 
PNYF02000098 5048 47.3 Col156_1 mobA, yibT, 3 CDS 
 
PNYF02000104 4151 49.6 Col8282_1 repE, mobA, CDS 
 
PNYF02000105 4126 42.1 ColRNAI_1 rop, dcm, 3 CDS 
 
PNYF02000123 1998 48.3 Col(MG828)_1 1 CDS 
 
PNYF02000133 1547 50.4 Col(MG828)_1 1 CDS 
SP13 PNYD02000060 2707 43 Col(MG828)_1 2 CDS 
SP46 POSV02000084 7507 48.3 Col156_1 ygaV, norW, mobA, 3 CDS 
 
POSV02000085 7065 47.3 ColRNAI_1 mbeA, mbeC, cea, 3 CDS 
 
POSV02000090 5737 47.2 ColRNAI_1 mbeA, mbeC, 4 CDS 
 
POSV02000129 1626 50.9 Col(MG828)_1 1 CDS 
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CHAPTER 7.    CONCLUSION 
 The Extraintestinal Pathogenic E. coli (ExPEC) pathotype has demonstrated 
significant phenotypic and genomic diversity as evidenced by biofilm formation and data 
from sequencing analyses. ExPEC must clearly utilize virulence factors to cause disease, 
but no known conserved virulence factor has been identified in this study as being 
singularly ExPEC-specific. Indeed, even conserved virulence factors, such as OmpA, 
have significant differences within their protein sequences among the various 
subpathotypes and even within the same subpathotype. Diversity appears to be critical to 
the ExPEC pathotype as shown by the myriad of virulence factors and plasmid contents 
of NMEC. To date, the majority of NMEC studies have focused on prototypical strain 
RS218, but this study has demonstrated that the NMEC subpathotype extends beyond a 
single phylogenetic group, sequence type, or serogroup. With the generation of 
sequencing data from a variety of different NMEC, numerous isolates may be stronger 
candidates for in vivo studies, which could elucidate different mechanisms by which 
ExPEC cause disease. NMEC-O75 is a potential rival for in vivo work to RS218, as 
NMEC-O75 was recently isolated from a severe case of NBM in the United States. Yet, 
other NMEC isolates should also be examined as the phylogenetic groups appear to be 
associated with phenotypic traits and, conceivably, differences in the virulence of NMEC. 
 In conclusion, the ExPEC subpathotypes demonstrated statistically significant 
differences when their biofilm formation and amino acid polymorphisms of OmpA were 
compared. Nevertheless, the phylogenetic groups also had statistically significant 
differences for the same analyses. Taken together, these findings suggest that conclusions 
should be drawn for each subpathotype after the phylogenetic groups are considered. 
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However, the ExPEC subpathotypes are still a clinical concern. NMEC sequencing data 
revealed great diversity within the subpathotype, and future studies characterizing NMEC 
should focus on this diversity, instead of a single prototypical isolate. There is certainly 
opportunity to elucidate the mechanisms of pathogenicity by further study of the putative 
virulence factors identified within the NMEC genomes. Specifically, the T2SS of NMEC 
remains a promising target. Likewise, investigation of the ExPEC plasmids, which have 
been shown to contribute to virulence, is a high priority since the presence of numerous 
unidentifiable, hypothetical genes remains concerning. 
